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Abstract 
Physical inactivity is associated with dysregulation of intramuscular triglyceride (IMTG) metabolism 
leading to the accumulation of fatty acid metabolites and insulin resistance.  This thesis aims to 
provide new information concerning the role of a subset of proteins associated with the metabolic 
regulation of IMTG-containing lipid droplets (LDs), known as the perilipin (PLIN) proteins, 
predominantly using immunofluorescence microscopy.  Chapter 2 demonstrates that PLIN2-containing 
LDs are preferentially targeted for breakdown during moderate-intensity exercise in lean, sedentary 
males.  Chapter 3 reveals that 6 months of endurance training (ET) in obese type 2 diabetes patients 
enhances PLIN2 content in type I fibres.  Chapter 4 demonstrates that improvements in IMTG 
metabolism, including increased expression of PLIN2 and PLIN5, occur in response to both ET and 
sprint interval training (SIT) in lean, sedentary males. In Chapter 5 data is provided to show that RT 
also improves IMTG metabolism and insulin sensitivity in lean, sedentary males.  Chapter 6 
documents the effectiveness of a new constant-workload SIT protocol with regards to improving 
insulin sensitivity in obese individuals.  In conclusion, this thesis generates novel data that contributes 
to our understanding of the underlying mechanisms that govern the relationship between IMTG 
metabolism and insulin sensitivity.      
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1.1 Defining the ‘normal’ human phenotype 
At the most simplistic level, the survival of homo sapiens is dependent on the ability to reproduce, 
feed, and perform physical activity.  Indeed, the procurement of food for our hunter-gatherer ancestors 
of the Late-Paleolithic era (50,000 – 10,000 BC) was highly dependent on the capacity to perform 
physical activity (Bramble and Lieberman, 2004).  Therefore, an inability to perform high levels of 
physical activity resulted in insufficient nutrition and ultimately mortality, and it is likely that the gene 
pool of these individuals would be extinguished before the reproductive age was reached.  In addition, 
food procurement was not always guaranteed (Diamond, 2003), indicating that our hunter-gatherer 
ancestors will have undergone periods of food abundance interspersed with periods of famine.  
Accordingly, a cyclic relationship between food abundance and famine would have existed, in addition 
to a cycle of physical activity and rest.  Neel (Neel, 1962) proposed that these environmental 
pressures would have shaped the human genome over thousands of years, such that certain ‘thrifty’ 
genes were incorporated into the human genome as they inferred a survival advantage over less 
‘thrifty’ ones.  A ‘thrifty’ genotype was characterised by an exceptional efficiency for food intake, 
storage and utilisation.  Thus, individuals possessing a ‘thrifty’ genotype would be best equipped to 
adapt to the oscillating periods of food abundance and famine, and physical activity and rest (Booth et 
al., 2002; Neel, 1999).  Interestingly, the present-day human genome appears to have remained 
unchanged from this period (Cordain et al., 1998), and therefore the ‘physically active genotype’ 
should be considered ‘normal’ (Booth and Lees, 2006). 
 
The hypothesis that our genotype was selected to support obligatory physical activity is in line with the 
proposal that ‘thrifty’ genes were selected to promote greater efficiency of food utilisation (Neel, 1962).  
In accordance, ‘thrifty’ genes particularly target the regulation of the two major sources of fuel storage 
in humans: carbohydrate and fat (or glycogen and triglyceride) (Chakravarthy and Booth, 2004).  A 
cycle of glycogen depletion and repletion is consistent with environmental oscillations between food 
abundance and famine.  However, the need to preserve muscle glycogen for the purpose of providing 
rapid energy for immediate tasks to enable survival was also of high priority (Chakravarthy and Booth, 
2004), highlighting the importance of triglyceride as a substrate source.  Therefore, the capacity to 
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cycle between glycogen and triglyceride as a substrate source supports the ‘physically active 
genotype’ that is fundamental for the existence of our species. 
 
It is becoming increasingly apparent that the ‘physically active genotype’ selected over 10,000 years 
ago is not compatible with the relatively sedentary nature of our current lifestyle.  In fact, it is now 
almost a decade ago that the U.S. Centers for Disease Control (CDC) first specified physical inactivity 
as a cause of metabolic disease (Mokdad et al., 2004), which include obesity, insulin resistance and 
type 2 diabetes, and ultimately cardiovascular disease.  Notably, exercise capacity is the strongest 
predictor of mortality risk compared to more clinical variables or established risk factors, such as 
hypertension, smoking or diabetes (Myers et al., 2002).  In addition, low muscular fitness or strength is 
associated with greater risk of mortality and increased incidence of metabolic syndrome (Jurca et al., 
2005). Increasing the level of physical activity can reduce the risk of mortality by an equivalent 
(Paffenbarger et al., 1993) or greater magnitude (Blair et al., 1995) compared to the modification of 
other risk factors, such as giving up smoking.  Given that ‘thrifty’ genes were selected to promote 
efficient food storage and utilisation making physical activity possible, it is perhaps not surprising that 
common metabolic disorders are linked to the dysregulation of substrate metabolism due to physical 
inactivity.  This PhD thesis will predominantly focus on one substrate source, skeletal muscle 
triglyceride, and the regulation of its metabolism.  In addition, the therapeutic effect of exercise training 
in its various forms will be considered with regards to skeletal muscle triglyceride metabolism, and its 
association with insulin sensitivity. 
 
1.2 Insulin-mediated glucose homeostasis 
Carbohydrates ingested during a meal are broken down to their most basic constituents during the 
digestion process, and are absorbed through the gut and into the circulation as glucose.  In response 
to a postprandial rise in plasma glucose concentrations, insulin is secreted from the pancreas into the 
circulation.  Insulin binds to its receptors on the plasma membrane of skeletal muscle, liver and 
adipose tissue, and promotes glucose removal from the circulation into these tissues.  Postprandial 
glucose uptake into these tissues maintains plasma glucose levels at approximately 5 mmol.l-1, and 
circumvents a situation in which chronic hyperglycaemia may occur.  On entering skeletal muscle, liver 
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or adipose tissue, glucose can be used to provide energy through glycolytic processes, or be shunted 
towards storage as glycogen (or in adipose tissue converted to palmitate through de novo lipogenesis 
or used to provide the glycerol backbone of triacylglycerol (TAG)). 
 
Skeletal muscle is the major site of glucose uptake, with skeletal muscle being responsible for ~80% 
of glucose removal from the circulation in healthy lean insulin sensitive individuals during a 
hyperinsulinaemic euglycemic clamp (DeFronzo et al., 1981; Thiebaud et al., 1982).  When studied 
under more physiological conditions, such as following a mixed meal after a ~15 h overnight fast, 
skeletal muscle glucose uptake remains high, accounting for ~50% of glucose disposal (splanchnic 
glucose disposal accounts for the other 50%) (Capaldo et al., 1999).  Therefore, it is logical that insulin 
will stimulate skeletal muscle glucose uptake through the direct action of insulin on the plasma 
membrane of skeletal muscle fibres, and significantly contribute to the maintenance of whole body 
glucose homeostasis.  In addition, insulin is also able to stimulate the recruitment of the microvascular 
system, thereby promoting greater delivery of insulin and other substrates (i.e. glucose) to the muscle 
fibre (for recent reviews see (Barrett et al., 2009; Barrett et al., 2011; Clark, 2008; Muniyappa et al., 
2007).  Whilst acknowledging the potential importance of insulin action on the microvascular system in 
mediating insulin-mediated glucose disposal, this thesis will predominantly focus on intramuscular 
metabolic factors determining insulin action on skeletal muscle fibres and glycemic control.    
 
1.2.1 Insulin-mediated glucose uptake into skeletal muscle 
Glucose uptake into skeletal muscle occurs primarily through facilitated diffusion, a process in which 
the glucose transporter proteins play a fundamental role.  Together, 14 glucose transporter isoforms 
have been identified (Uldry and Thorens, 2004), although glucose transporter 4 (GLUT4) is the 
predominant insulin responsive isoform required for glucose uptake into skeletal muscle (Watson and 
Pessin, 2001).  Under fasted conditions GLUT4 resides in intracellular cytosolic microvesicles, but in 
the fed state (i.e. under conditions leading to elevated plasma insulin concentrations) GLUT4 
microvesicles translocate to the plasma membrane where the GLUT4 protein is deposited and 
ultimately facilitates glucose uptake into the muscle fibre.  The mechanism by which insulin promotes 
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GLUT4 redistribution to the plasma membrane has been well studied, and it now appears that that the 
process of GLUT4 translocation is dependent on multiple intracellular signalling events. 
 
The cascade of signalling events which results in GLUT4 translocation to the plasma membrane is 
initiated by insulin binding to the extracellular α-subunit of the insulin receptor (IR), thus stimulating 
tyrosine autophosphorylation of the transmembrane IR β-subunit and activation of the intrinsic tyrosine 
kinase (Fig. 1.1).  In turn, a number of substrate proteins are phosphorylated and recruited to the IR, 
including the insulin receptor substrate (IRS) proteins.  Specifically, phosphorylation of Tyr960 on the IR 
β-subunit recruits and binds the phosphotyrosine binding (PTB) domain of IRS-1.  Furthermore, IR 
tyrosine kinase activity phosphorylates IRS-1 on a number of tyrosine residues which subsequently 
bind with high affinity to src-homology (SH) 2 (SH2) domains of signal transducing proteins.  
Phosphorylation of IRS-1 on Tyr608 and Tyr628 residues generates the major docking site for the signal 
transducing protein phosphoinositide (PI) 3-kinase (PI3-K) (Esposito et al., 2001).  PI3-K is composed 
of a p85 regulatory subunit, which contains two SH2 domains that bind to phosphopeptides of IRS-1, 
and a p110 catalytic subunit.  PI3-K subsequently catalyzes the phosphorylation of PI at the D-3 
position of the inositol ring to produce phosphatidylinositol-3-phosphates, and in particular 
phosphatidylinositol-3,4,5-triphosphate (PI-(3,4,5)-P3 or PIP3).  PIP3 directly interacts with the 
pleckstrin homology (PH) domain of phosphoinositide-dependent kinase 1 (PDK1), protein kinase B 
(Akt/PKB), and atypical protein kinase C isoforms (aPKC), which recruits these proteins to the plasma 
membrane.  Upon recruitment, PDK1 promotes phosphorylation of both Akt/PKB and aPKC isoforms 
on threonine residues located in their catalytic domain.  In particular, phosphorylation of Akt/PKB on 
Thr308 and Ser473 residues results in its activation, and activated Akt/PKB downstream targets include 
glycogen synthase kinase-3 (GSK-3) and TBC 1 domain family, member 4 (TBC1D4, also known as 
AS160).  Akt/PKB inactivates GSK-3 through phosphorylation of the Ser9 residue in parallel to protein 
phosphatase-1 activation, which subsequently relieves inhibition of the enzyme glycogen synthase 
leading to its activation and enhanced glycogen synthesis.  Under basal conditions, the GTPase-
activating protein domain of TBC1D4 retains Rab proteins in an inactive GDP-bound state that 
prevents GLUT4 translocation to the plasma membrane.  Upon insulin stimulation, activated Akt/PKB 
phosphorylates TBC1D4, suppressing the GTPase activity, potentially through the binding of 14-3-3 
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protein (Geraghty et al., 2007).  As a consequence, Rab proteins become GTP-loaded leading to 
reorganisation of the cytoskeleton that is required for GLUT4 mobilisation and glucose uptake (Vind et 
al., 2011). 
 
Insulin-mediated GLUT4 translocation is also possible through an IRS-PI3-K-independent pathway 
(Fig. 1.1), as pharmacological inhibition of PI3-K does not completely block insulin-mediated glucose 
uptake.  Similarly, pharmacological activation of intermediates of the IRS-PI3-K pathway does not 
necessarily promote glucose uptake (reviewed in (Kanzaki, 2006).  Consequently it is apparent that 
complete activation of insulin-mediated GLUT4 translocation leading to glucose uptake requires an 
integrated response from the PI3-K-dependent and PI3-K-independent pathways.  More specifically, 
tyrosine activation of IR stimulates the recruitment of c-CBl to the IR by two adaptor proteins, APS and 
CAP, in order to form an APS-CBl-CAP complex.  This activation of the CBl protein subsequently 
promotes activation of TC10, which is required for GLUT4 translocation (Bogan, 2012). 
 
Following translocation to specific fusion sites, GLUT4 vesicles are required to undergo a process of 
facilitated fusion with the plasma membrane in order to allow glucose uptake.  In this process, a 
number of SNAP receptors (SNAREs) on the target membrane (t- or Q-SNAREs) interact with SNARE 
proteins on the transport vesicle membrane (v- or R-SNAREs).  Briefly, the v-SNARE vesicle-
associated membrane protein-2 (VAMP2) attaches to the t-SNAREs, SNAP23 and syntaxin 4, leading 
to the formation of a SNARE complex.  Consequently, the plasma membrane and GLUT4 vesicle 
membrane are brought into close proximity, promoting the fusion of the lipid bilayers and incorporation 
of GLUT4 within the plasma membrane.  Insulin regulates this fusion process through a number of 
interacting proteins that either facilitate or promote the assembly of the SNARE complex.  For 
example, insulin-stimulated activation of aPKC promotes phosphorylation of Munc18c leading to its 
dissociation from syntaxin 4 (Jewell et al., 2011).  In addition, activated aPKC phosphorylates VAMP2 
(Farese and Sajan, 2010), permitting its association with syntaxin 4 and enabling the SNARE complex 
to form and facilitate GLUT4 fusion.  The reader is directed to two excellent reviews (Bryant and 
Gould, 2011; Leney and Tavare, 2009) for a further, detailed overview of the role of SNARE proteins 
in insulin-stimulated glucose uptake. 
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Figure 1.1 Insulin-mediated glucose uptake into skeletal muscle 
aPKC atypical protein kinase C, Akt/PKB protein kinase B, GLUT4 glucose transporter 4, IR insulin 
receptor, IRS-1 insulin receptor substrate-1, PDK phosphoinositide-dependent kinase 1, PI3-K 
phosphoinositide 3-kinase, PIP2 phosphatidylinositol 4,5-bisphosphate, PIP3 phosphatidylinositol-
3,4,5-triphosphate, Rab-GDP Rab guanosine disphosphate, Rab-GDP Rab guanosine triphosphate, 
TBC1D4 TBC 1 domain family member 4.  
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1.2.2 Contraction-mediated glucose uptake into skeletal muscle 
Skeletal muscle glucose uptake is also increased during exercise via a mechanism that is insulin 
independent. Like physiological increases in insulin, muscle contraction stimulates the translocation of 
GLUT4 from the intracellular vesicles to the plasma membrane and t-tubules, thereby permitting 
glucose uptake into the muscle fibre.  In contrast to insulin, muscle contraction does not activate 
components of the proximal insulin signalling cascade, as concluded from the observation that 
incubation of rat soleus muscle with wortmannin, a PI3-K inhibitor, has no impact on contraction-
mediated GLUT4 translocation (Lund et al., 1995).  Furthermore, electrically stimulated contraction of 
isolated skeletal muscle has no effect on the activity of IRS-1, PI3-K or Akt/PKB (Goodyear et al., 
1995; Wojtaszewski et al., 1996). 
 
During muscle contraction an increase in the AMP to ATP ratio leads to activation of AMP-activated 
protein kinase (AMPK) (Wojtaszewski et al., 2000b).  Importantly, AMPK activation by 5-
aminoimidazole-4-carboxamide-1-β-D-ribonucleoside (AICAR; an AMP analogue) also enhances 
GLUT4 translocation to the plasma membrane and glucose uptake (Kurth-Kraczek et al., 1999; Merrill 
et al., 1997), whereas AICAR-stimulated glucose uptake is not effected by incubation with wortmannin 
(Hayashi et al., 1998), indicating that AMPK activation, like muscle contractions, leads to GLUT4 
translocation independent of an effect on the proximal insulin signalling components.  However, it is 
important to acknowledge that 60% of contraction-mediated glucose uptake is maintained when AMPK 
is knocked out (Mu et al., 2001), suggesting that other intracellular factors, independent of AMPK, may 
also stimulate glucose uptake.  To this end, calcium (Ca2+) released from the sarcoplasmic reticulum 
during muscle contraction forms a complex with calmodulin (CaM) that subsequently binds to and 
activates Ca2+/CaM-activated kinase (CAMK).  CAMKII, which is the predominant isoform present in 
skeletal muscle, may provide a link between contraction-mediated Ca2+ release and GLUT4 
translocation, since blocking CAMK activation reduces glucose uptake (Wright et al., 2005; Wright et 
al., 2004).  In addition, increases in Ca2+ concentration in response to muscle contraction lead to 
activation of PKC which may play an important role in exercise-induced glucose uptake, since 
pharmacological inhibition of PKC (using calphostin C) reduces contraction-mediated glucose uptake 
(Ihlemann et al., 1999).  However, the lack of isoform specificity of calphostin C precludes 
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identification of the responsible PKC isoforms.  Subsequent studies demonstrated that PKC activity 
was increased in rat skeletal muscle in response to electrical stimulation, and this coincided with 
activation of conventional and novel PKC isoforms (Richter et al., 2003).  However, neither the 
conventional or novel PKC isoforms are activated during exercise in human skeletal muscle (Rose et 
al., 2004).  Consequently, it has been proposed that the increase in PKC activity in response to 
exercise is attributed to activation of atypical PKC (Perrini et al., 2004; Rose et al., 2004), although this 
may not be crucial for contraction-mediated glucose uptake (Sajan et al., 2010).  Rather, it is 
suggested that increased atypical PKC activation in response to exercise may potentially enhance the 
action of insulin (Maarbjerg et al., 2011).  It is also worth noting that several mitogen-activated protein 
kinase (MAPK) isoforms (extracellular related kinase 1/2 (ERK1/2), p38, and c-Jun N-terminal kinase 
(JNK)) are activated in response to muscle contraction (Sakamoto and Goodyear, 2002).  More 
specifically, the increase in atypical PKC activation in response to exercise is paralleled by increased 
ERK activity (Nielsen et al., 2003), although blocking ERK activation does not completely inhibit 
contraction-mediated glucose uptake (Wojtaszewski et al., 1999).  Phosphorylation of p38 MAPK is 
also increased concomitant with enhanced contraction-induced glucose uptake, and inhibition of p38 
MAPK blocks this increase (Chambers et al., 2009).  However, the p38 inhibitor used in this study has 
previously been reported to directly interact with and inhibit GLUT4 (Jensen and Richter, 2012), and 
therefore may not conclusively identify a role for p38 MAPK in contraction-mediated glucose uptake.  
Clearly, we do not have a complete understanding of how these intracellular signals ‘blend’ to provide 
a specific increase in the level of glucose transport in response to muscle contraction.        
 
One downstream target of AMPK and CAMKII is AS160/TBC1D4, providing a link by which these 
intracellular kinases may promote GLUT4 translocation independent of insulin action.  Importantly, 
AMPK has been shown to phosphorylate TBC1D4 (Kramer et al., 2006a; Treebak et al., 2006; 
Treebak et al., 2010), whereas expression of a mutant form of TBC1D4 reduces contraction-mediated 
glucose uptake (Kramer et al., 2006b).  In addition, it has been reported that TBC1D4 contains a 
calmodulin binding domain, and mutation of this domain reduces contraction-mediated glucose uptake 
(Kramer et al., 2007).  Furthermore, a single bout of resistance exercise enhances TBC1D4 
phosphorylation in the post exercise period (Dreyer et al., 2008), and TBC1D4 phosphorylation was 
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increased following 60 and 90 min of moderate-intensity endurance exercise (Treebak et al., 2007).  
TBC1D1 shares 50% of the identity of TBC1D4, but importantly, the GAP domains are 79% identical, 
suggesting that TBC1D1 also plays a role in regulating GLUT4 translocation (Sakamoto and Holman, 
2008).  Like TBC1D4, AMPK also phosphorylates TBC1D1 (Taylor et al., 2008), and TBC1D1 
phosphorylation is increased in response to exercise (Frosig et al., 2010; Jessen et al., 2011).  
Importantly, contraction-induced glucose uptake is impaired in skeletal muscle of TBC1D1-deficient 
mice (Szekeres et al., 2012), providing evidence that TBC1D1 plays a significant role in contraction-
mediated increases in glucose uptake.  It is clear that further work is needed in this area to fully 
understand the mechanism by which muscle contraction stimulates GLUT4 translocation, but it 
appears that TBC1D4 and TBC1D1 play a key role in this process. 
 
1.3 Lipid metabolism in skeletal muscle 
1.3.1 Lipid storage in the human body 
Subcutaneous and deep visceral adipose tissue depots are the predominant sites for the storage of fat 
as TAG in the human body.  More specifically, the average non-obese male (~70 kg) stores between 9 
and 15 kg (equating to an energy store of 80,000 to 140,000 kcal) of TAG in adipose tissue (van Loon, 
2004).  Adipose tissue TAG concentration is increased during periods of caloric excess resulting in 
expansion of adipose tissue mass.  In contrast, periods of starvation or famine lead to a reduction in 
adipose tissue TAG concentration and adipose tissue mass, due to the hydrolysis of TAG leading to 
fatty acid (FA) mobilisation, in order to meet the body’s energy requirements.  Consequently, it is 
appreciated that TAG stored within adipose tissue represents a dynamic pool of FAs. 
 
Although adipose tissue is the predominant site for TAG storage, nearly all cell types possess the 
capacity to store FAs as TAG in intracellular lipid droplets (LDs).  LDs are encased by a phospholipid 
monolayer, which also contains cholesterol and a large number of proteins, and in addition to TAG, 
LDs have the capacity to store diacylglycerol (DAG), retinyl esters, cholesterol esters, and free 
cholesterol (Meex et al., 2009).  Although their structure infers a prominent role in TAG storage, LDs 
also have a function in vesicle trafficking and cell signalling capabilities.  Furthermore, the 
physiological role of individual LDs is determined by a number of factors including morphology, 
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subcellular localisation, and the specific proteins associated with the LD.  For example, both cardiac 
and skeletal muscle tissue are oxidative tissues and contain a large number of small, discrete LDs 
(ranging from 100 nm up to 1 µm in size), whereas the cytoplasm of an individual adipocyte is 
occupied entirely by the LD (up to 100 µm).  Importantly, the balance between TAG synthesis and 
TAG breakdown determines the LD size and number, and therefore their intracellular concentration, 
which in turn is reflective of both nutritional and training status. 
 
The concentration of intramuscular triglyceride (IMTG) is generally in the range between 2 and 10 
mmol.kg-1 wet weight, equating to a mixed muscle TAG content of approximately 0.2 kg (an energy 
store of 1,850 kcal) (van Loon, 2004; Watt et al., 2002b; Wendling et al., 1996), and is predominantly 
influenced by energy intake, dietary composition and training status.  Indeed, the consumption of a 
high-fat diet, either short-term (<67 h) (Bachmann et al., 2001; Johnson et al., 2006; Zderic et al., 
2004) or for a more prolonged period (>7 days) (Schrauwen-Hinderling et al., 2005; Van Proeyen et 
al., 2011a; Van Proeyen et al., 2010), increases the concentration of IMTG.  In addition, directly 
increasing plasma free fatty acid (FFA) concentrations through a lipid and heparin infusion enhances 
IMTG storage (Boden et al., 2001).  A number of cross-sectional reports also demonstrate that one of 
the metabolic adaptations to a period of endurance training is greater IMTG storage (reviewed in 
(Shaw et al., 2010), which appears to parallel greater glycogen storage in the endurance-trained state.  
Furthermore, morphological evidence reveals that IMTG are predominantly located in close proximity 
to the mitochondria (Hoppeler, 1999; Shaw et al., 2008).  Given that FFAs liberated from IMTG via 
hydrolysis are metabolised in the mitochondria, this apparent morphology provides evidence that 
IMTG is a readily available pool of FA which can be used as an oxidative substrate source during 
exercise in active individuals. 
 
1.3.2 Intramuscular triglyceride as a substrate source during exercise 
Total fat oxidation rates are increased approximately 10-fold compared to resting values during 
moderate-intensity exercise in trained individuals (Romijn et al., 1993; van Loon et al., 2001), and it is 
therefore plausible that the IMTG pool provides a readily available source of FAs for mitochondrial β-
oxidation, especially considering the physical IMTG-mitochondria interactions mentioned previously 
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(Hoppeler, 1999; Shaw et al., 2008).  In order to estimate the contribution of the IMTG pool to total fat 
oxidation during an acute exercise bout a number of early studies employed indirect calorimetry 
measures in combination with the infusion of a 13C-labelled FA tracer (Romijn et al., 1993; van Loon et 
al., 2001; van Loon et al., 2003; van Loon et al., 2005b; Watt et al., 2002a).  Using this technique it is 
possible to measure total fat and plasma FFA oxidation and calculate the contribution of other fat 
sources (i.e. the sum of IMTG and lipoprotein-derived TAG) to total fat oxidation from the difference 
between the two.  However, this method makes the assumption that the contribution of lipoprotein-
derived TAG oxidation is relatively small (~5-10%) following an overnight fast under normal dietary 
conditions (van Loon, 2004; Watt et al., 2002b).  Stable isotope methodology has been employed to 
demonstrate that the rate of non-plasma FA oxidation (i.e. IMTG and lipoprotein-derived TG) is 
greatest during exercise between 40 and 65% VO2 max, and accounts for ~30-50% of total fat oxidation 
(Romijn et al., 1993; van Loon et al., 2001).  
 
Although the use of stable isotopes provides an indirect estimate of the contribution of the IMTG pool 
to total fat oxidation during exercise, it is essential to directly quantify net changes in IMTG 
concentration following an acute exercise bout.  This can be achieved non-invasively through the use 
of 1H magnetic resonance spectroscopy (1H-MRS), which permits the quantification of both IMTG and 
extramyocellular lipid (EMCL) concentrations.  More precisely, this technique is based on the 
observation that the resonance signal from methylene and methyl protons of TAG appear as multiple, 
but separate, peaks on the proton spectrum of skeletal muscle and are representative of either IMTG 
or EMCL (see van Loon, 2004).  Using this technique, it is consistently reported that IMTG 
concentration is significantly reduced (~20-40%) in response to moderate-intensity exercise (reviewed 
in van Loon, 2004), and therefore provides convincing evidence that the IMTG pool contributes to total 
fat oxidation during exercise in active individuals.  Using 1H-MRS it has also been established that a 
short-term (48 h) high-fat diet enhances IMTG utilisation during exercise, which was attributed to a 
greater pre-exercise IMTG concentration (Johnson et al., 2003; Zderic et al., 2004).  However, using 
this technique to quantify exercise-induced changes in IMTG content in sedentary, obese individuals 
and type 2 diabetes patients is difficult, due to the presence of a high EMCL signal which interferes 
with the quantification of the IMTG signal.     
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While both stable isotope and 1H-MRS methodology provide some evidence that the IMTG pool 
contributes to total fat oxidation during moderate-intensity exercise in active individuals, direct 
evidence obtained through the measurement of net changes in IMTG concentration using the 
biochemical extraction technique in skeletal muscle tissue are less clear.  In accordance, a significant 
net reduction in IMTG concentration following exercise is reported in a number of studies (Essen-
Gustavsson and Tesch, 1990; Phillips et al., 1996c; Sacchetti et al., 2002; Watt et al., 2002a), while 
others do not observe a significant decrease (Bergman et al., 1999; Kiens et al., 1993; Kiens and 
Richter, 1998; Wendling et al., 1996).  These inconsistent observations may be attributed to 
methodological issues, particularly a large between-biopsy variability (20-26%) (van Loon, 2004; Watt 
et al., 2002b), indicating that exercise-induced changes in IMTG concentration of less than ~25% do 
not always reach statistical significance.  It is postulated that the source of this variability is the 
presence of a variable amount of EMCL deposits in freeze-dried muscle samples, although whether 
significant pools of EMCL exist remains to be established (Guo, 2001; van Loon, 2004).  Nevertheless, 
failure to eliminate EMCL prior to performing biochemical IMTG extraction leading to contamination of 
the muscle sample will result in the overestimation of IMTG concentration.  Notably, the majority of 
reports that demonstrate a significant net decrease in IMTG content following exercise are performed 
in trained individuals who exhibit low EMCL concentrations (Szczepaniak et al., 1999).  Thus, data 
from studies employing the biochemical TAG extraction technique suggest that IMTG oxidation 
contributes significantly to total fat oxidation during exercise only in trained individuals. 
 
Using either 1H-MRS or biochemical TAG extraction only permits the quantification of mixed muscle 
TAG concentration and therefore does not allow an appreciation of fibre-specific differences and 
subcellular distribution of intramuscular lipid deposits.  Therefore, immunofluorescence microscopy 
methods have been developed which aim to discriminate between IMTG content in type I and type II 
fibres. By combining an antibody stain for slow myosin heavy chain type I with a lipid stain, such as oil 
red O, this method has been used to demonstrate that IMTG content is approximately 3-fold greater in 
type I compared to type II fibres (Koopman et al., 2001; van Loon et al., 2003).  Furthermore, use of 
immunofluorescence microscopy reveals that IMTG is deposited in greater abundance in 
subsarcolemmal regions of the individual muscle fibres (Shaw et al., 2008; Stellingwerff et al., 2007; 
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van Loon et al., 2004).  However, it is also worth noting that immunofluorescence microscopy only 
provides a semi-quantitative analysis of IMTG concentration, as the efficacy of the staining procedure 
and image-acquisition settings strongly determines the area fraction stained (i.e. the commonly 
reported unit of IMTG concentration).  Thus, analytical controls should be implemented to minimise 
variability in IMTG concentration which may confound ‘true’ intervention and/or population differences.  
When accurately controlled, this technique has been successfully employed to show 2 h of moderate-
intensity cycling induces a >60% net decline of the intramuscular lipid pool specific to type I fibres (van 
Loon et al., 2003).  Further studies have since demonstrated that IMTG concentration is significantly 
depleted in type I fibres following both endurance-type exercise (De Bock et al., 2008; De Bock et al., 
2007; De Bock et al., 2005; van Loon et al., 2005b; Van Proeyen et al., 2011a; Van Proeyen et al., 
2011b) and resistance exercise (Koopman et al., 2006).  IMTG utilisation during exercise is strongly 
determined by resting IMTG concentration (Stellingwerff et al., 2007), and type I fibres exhibit a 
greater oxidative capacity, due to a larger mitochondrial density.  Thus it is logical that utilisation of the 
intramuscular lipid pool during exercise is greatest in type I fibres.  Interestingly, mixed-muscle IMTG 
concentration determined through immunofluorescence microscopy correlates well with values 
obtained using biochemical TAG extraction (Stellingwerff et al., 2007).  However, this relationship 
disappears when used to quantify IMTG utilisation during exercise (Stellingwerff et al., 2007), as the 
rate of IMTG utilisation is higher in type I than in type II fibres. In summary, the use of 
immunofluorescence microscopy demonstrates the importance of considering fibre-specific responses 
in order to accurately determine the contribution of IMTG oxidation during exercise.  Importantly, when 
the data from studies employing different techniques to study IMTG concentration are pooled, it is 
consistently demonstrated that IMTG provides a readily available fuel source for trained athletes 
undertaking moderate-intensity exercise.   
 
1.3.3 Healthy individuals exhibit a high rate of IMTG turnover 
As well as demonstrating an ability to use IMTG as a fuel during moderate-intensity exercise, active 
individuals demonstrate high IMTG fractional synthetic rates compared to sedentary individuals 
(Bergman et al., 2010),  Thus, regular depletion of IMTG stores during exercise and subsequent 
replenishment during post-exercise recovery illustrates that the intramuscular lipid pool exhibits a high 
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rate of turnover in trained athletes.  Notably, in healthy active individuals complete turnover of the 
IMTG pool under resting conditions is estimated to take approximately 29 h (Sacchetti et al., 2004).  
Fundamentally, the turnover of IMTG is a constantly-occurring process, the rate of which will 
subsequently determine the IMTG concentration at any given time.  More specifically, IMTG turnover 
rate is a function of the relationship between FA uptake, esterification, hydrolysis and oxidation, and 
therefore an appreciation of the mechanisms that regulate the storage and oxidation of IMTG is 
important.              
 
(i) IMTG hydrolysis 
The hydrolysis of IMTG occurs in three consecutive steps and is dependent on the interaction of at 
least three different lipases in order to sequentially cleave a FA from the glycerol backbone (Fig. 1.2).  
Lipolysis is initially catalyzed by adipose triglyceride lipase (ATGL) which converts TAG to 
diacylglycerol (DAG).  Hormone-sensitive lipase (HSL) is the predominant lipase responsible for 
hydrolyzing DAG to monoacylglycerol (MAG), after which MAG lipase liberates the final FA.  HSL is a 
cytosolic protein, which is most abundantly expressed in adipose tissue, and to a lesser extent in 
skeletal muscle and cardiac tissue (Kraemer et al., 1993; Langfort et al., 1999).  Notably, HSL 
expression in skeletal muscle is greater in type I fibres compared to type II fibres (Langfort et al., 1999; 
Peters et al., 1998) and therefore correlates with the fibre-specific capacity for IMTG oxidation.  In 
addition, skeletal muscle HSL activity is increased in response to exercise at varying intensities (Watt 
et al., 2003a; Watt et al., 2003b), although this does not necessarily result in significant IMTG 
hydrolysis (Watt et al., 2004).  Nevertheless, HSL appears to be required for complete TAG hydrolysis 
since HSL-null mice demonstrate DAG accumulation (Haemmerle et al., 2002).  Furthermore, HSL 
demonstrates the greatest affinity for DAG, although hydrolase activity of HSL is not limited to DAG 
(Taschler et al., 2011; Zimmermann et al., 2004).  In skeletal muscle, the hydrolase activity of HSL 
accounts for ~60% of total neutral hydrolase activity at rest, whereas during exercise increased HSL 
activity has been reported to account for almost all of the total lipase activity (Watt et al., 2004), 
indicating the importance of HSL activation in the lipolytic process.  In general, HSL activation is a 
hormonal- and contraction-mediated process.  Firstly, adrenaline concentrations are increased during 
exercise which activates β-adrenergic receptors leading to protein kinase A (PKA) stimulation and 
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serine phosphorylation (S563 and S660) of HSL (Watt et al., 2006).  Upon phosphorylation, cytosolic 
HSL is redistributed to LDs, a process which appears to be crucial for complete hydrolase activity of 
HSL (Prats et al., 2006; Wang et al., 2009), and has been shown to occur in isolated rat soleus muscle 
following adrenaline incubation or electrically-stimulated muscle contraction (Prats et al., 2006).  
However, it is not known whether HSL translocation to LDs occurs in response to dynamic exercise in 
either rodent or human skeletal muscle.  Notably, muscle contraction also enhances AMPK activity 
leading to ser565 phosphorylation of HSL, which acts to reduce HSL activity.  In addition, the 
observation that fatty acyl-CoA accumulation occurs at high exercise intensities (>90% VO2 max) may 
also allosterically inhibit HSL activity (Kiens et al., 1999).  These opposing pathways appear to 
indicate the presence of a mechanism by which HSL activity can be adjusted relative to exercise 
intensity and duration (Meex et al., 2009; Watt et al., 2006). 
 
HSL knockout mice demonstrate unaltered basal TAG-hydrolase activity (Haemmerle et al., 2002), 
although ~40% of basal total neutral lipid hydrolase activity is not accounted for by HSL (Watt et al., 
2004).  In addition, given the high affinity of HSL for DAG hydrolysis, and that HSL knockout mice 
accumulate DAG in their muscles (Haemmerle et al., 2002), it is apparent that another lipase is 
responsible for the hydrolysis of TAG.  ATGL, first detected in adipose tissue, demonstrates a 
relatively high affinity for TAG hydrolysis (Zimmermann et al., 2004), and therefore appears the 
primary candidate for this role.  Although most abundantly expressed in adipose tissue, ATGL is also 
expressed in skeletal muscle and cardiac tissue (Zimmermann et al., 2004), and, like HSL, appears to 
be most abundant in type I compared to type II muscle fibres (Jocken et al., 2008).  Importantly, 
overexpression of ATGL in non-adipocyte cells enhances the degradation of TAG (Smirnova et al., 
2006), whereas ATGL knockout mice demonstrate reduced TAG lipolysis leading to IMTG 
accumulation (Haemmerle et al., 2006), underlining the importance of ATGL to the liberation of FA 
stored in intracellular LDs.  The regulation of ATGL activity is poorly understood in skeletal muscle. In 
adipose tissue the activity of ATGL is enhanced upon binding with its co-activator, comparative gene-
identification 58 (CGI-58) (Lass et al., 2006), and reduced by G(0)/G(1) switch gene 2 (G0S2) (Yang 
et al., 2010).  Notably, CGI-58 and G0S2 are both expressed in skeletal muscle (Lass et al., 2006; 
Yang et al., 2010), although their role in vivo is yet to be established.  However, the importance of 
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CGI-58 to ATGL activation in skeletal muscle is demonstrated by the fact that individuals who have a 
mutation of CGI-58 have an increased IMTG content in their muscle (Lass et al., 2006). 
 
Although the role and regulation of TAG and DAG hydrolases is relatively well-understood, at least in 
adipose tissue, little information is available regarding the lipase activity against MAG.  MAG 
hydrolases act to cleave the remaining FA from the glycerol backbone (Fig. 1.2), and would therefore 
presumably be important for complete TAG hydrolysis in skeletal muscle, as has been demonstrated 
in adipose tissue (Taschler et al., 2011).  Despite this gap in our knowledge, it is clear that efficient 
regulation of TAG hydrolysis is fundamental to increase lipolysis during exercise and preserve high 
rates of TAG turnover in trained individuals. 
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Figure 1.2 TAG synthesis and hydrolysis in skeletal muscle 
AGPAT 1-acylglycerol-3-phosphate acyltransferase, ATGL adipose triglyceride lipase, DAG 
diacylglycerol, DGAT diacylglycerol transferase, FA-CoA fatty acyl-CoA, FAS fatty acyl-CoA 
synthetase, FAT/CD36 fatty acid transporter, FFA free fatty acid, GPAT glycerol-3-phosphate 
acyltransferase, HSL hormone sensitive lipase, LPA lysophosphatidic acid, MAG monoacylglycerol, 
MGAT monoacylglycerol transferase, PAP phosphatidic acid phosphatase, TAG triacylglycerol.   
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(ii) Proteins associated with IMTG 
Intracellular LDs display a large number of proteins associated with their phospholipid monolayer 
(Zhang et al., 2011) surrounding the LD like a coat (Shaw et al., 2009). The most well-characterised 
family of these proteins are known as the PAT/perilipin proteins.  The nomenclature originates from 
the founding members perilipin, ADRP (adipose differentiation related protein/adipophilin) and TIP-47 
(tail interacting protein of 47kDa), and all present a common NH2-terminal motif.  Two other proteins, 
S3-12 and OXPAT, are also included in the PAT/perilipin family, as they demonstrate similar 
sequence homology and/or function to the original PAT/perilipin proteins.  In this thesis the PAT 
proteins will be referred to as perilipin (PLIN) 1 to 5 corresponding to perilipin, ADRP/adipophilin, TIP-
47, S3-12 and OXPAT, respectively, in line with a recent call for a unifying nomenclature (Kimmel et 
al., 2010).  Importantly, each PLIN protein possesses a unique tissue distribution and subcellular 
compartmentalization, indicating that they each play distinct roles in the regulation of LD metabolism. 
 
PLIN1 is the most well-characterised PLIN protein and is exclusively expressed in adipose tissue and 
steroidogenic cells (Londos et al., 1995), although PLIN1 mRNA have been detected at low levels in 
skeletal muscle (Gjelstad et al., 2012).  In adipocytes and steroidogenic cells PLIN1 appears to 
regulate the storage and hydrolysis of lipid stored in LDs.  Notably, PLIN1 knockout mice demonstrate 
enhanced basal TAG hydrolysis in isolated adipocytes, which appears to protect against diet-induced 
obesity (Tansey et al., 2001).  In addition, HSL-stimulated lipolysis in isolated adipocytes was reduced 
(Tansey et al., 2001), indicating that PLIN1 not only functions to reduce lipase activity under basal 
conditions, but also coordinates recruitment and/or activation of lipases under lipolytic conditions.  In 
support, PKA phosphorylates PLIN1 on serine residues leading to the translocation of HSL to PLIN1-
coated LDs in 3T3-L1 adipocytes (Granneman et al., 2007). Therefore, PLIN1 phosphorylation 
appears to permit HSL access to the stored TAG.  In addition, it has been established using COS-7 
cells that PLIN1 located at the LD binds and sequesters CGI-58 under basal conditions preventing 
ATGL activation; however, PKA phosphorylation of PLIN1 releases CGI-58 enabling its association 
with, and subsequent activation of ATGL (Granneman et al., 2009).  Thus, it appears that PLIN1 plays 
a fundamental role in regulating LD metabolism in adipocytes.  
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As PLIN1 protein expression does not extend to human skeletal muscle (Alsted et al., 2009; Phillips et 
al., 2005), this suggests that other perilipin proteins may be required to regulate TAG storage and 
hydrolysis in this tissue.  Two potential candidates are PLIN2 and PLIN3, since HSL redistribution to 
LDs coated with these proteins occurs in isolated rat soleus muscle following adrenaline incubation or 
electrically-stimulated muscle contraction (Prats et al., 2006).  However, the precise functional role of 
PLIN2 in skeletal muscle is yet to be established.  Interestingly, protein expression of PLIN2 closely 
correlates with IMTG concentration in Zucker diabetic fatty rats (Minnaard et al., 2009) and endurance 
trained athletes (Minnaard et al., 2009; Shaw et al., 2009), indicating that the relative expression of 
PLIN2 may determine the capacity for intracellular TAG storage.  In this respect, increasing the 
expression of PLIN2 enhances the TAG content of fibroblasts (Imamura et al., 2002), HEK 293 cells 
(Listenberger et al., 2007), hepatic stellate cells (Fukushima et al., 2005), and COS-7 cells (Gao and 
Serrero, 1999), whereas PLIN2-null mice demonstrate reduced hepatic TAG concentrations compared 
to their wild-type littermates (Chang et al., 2006). These observations suggest that PLIN2 may either 
promote TAG synthesis or reduce TAG lipolysis as both will lead to increases in TAG content.  Indeed, 
it has been reported that PLIN2 may limit the access of lipases, such as ATGL, to the stored TAG, 
thereby reducing the rate of TAG turnover (Bell et al., 2008; Listenberger et al., 2007).  Notably, only 
~two-thirds of LDs in skeletal muscle contain PLIN2 (Shaw et al., 2009), suggesting that other proteins 
may be associated with the remaining LD pool.  Two potential proteins, PLIN3 and PLIN4, are 
expressed in skeletal muscle, although to a much lesser degree than they are in adipose tissue 
(Wolins et al., 2001; Wolins et al., 2003).  In addition, they appear to translocate from a pre-existing 
cytosolic pool to nascent LDs, which form when FA availability is enhanced in adipocytes (Bulankina 
et al., 2009; Wolins et al., 2005).  Importantly, PLIN3 and PLIN4 are both stable in the cytosol, unlike 
PLIN2 which is degraded when TAG concentration is reduced in Chinese hamster ovary cells (Xu et 
al., 2005).  Furthermore, knock-down of PLIN3 in PLIN2-null fibroblasts reduces the number of LDs 
(Sztalryd et al., 2006), and it is therefore suggested that PLIN3 may also protect against lipolysis and 
promote TAG storage.  However, the precise role of PLIN3 and PLIN4 in skeletal muscle remains to 
be established.    
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PLIN5 is highly expressed in oxidative tissues, including skeletal muscle, cardiac tissue, brown 
adipose tissue and liver (Wolins et al., 2006b), and it appears from cell culture studies that PLIN5 may 
be important for the accumulation of TAG, since expression of PLIN5 in Chinese hamster ovary cells 
(Dalen et al., 2007) or COS-7 cells (Wolins et al., 2006b) increases TAG concentration.  In contrast, 
PLIN5-null mice demonstrate reduced TAG concentrations in the heart compared to wild-type controls 
(Kuramoto et al., 2012).  Similarly to PLIN2, these observations suggest that PLIN5 may either 
promote TAG synthesis or decrease TAG lipolysis, thereby leading to an increase in TAG 
concentration.  However, it is interesting to note that PKA-stimulation of alpha mouse liver 12 cells 
overexpressing PLIN5 promotes TAG hydrolysis, increasing the availability of FAs for β-oxidation 
(Wang et al., 2011b) Taken together, these findings suggest that PLIN5 may be a major regulator of 
intracellular TAG turnover.  More specifically, PLIN5 overexpression in COS-7 cells and Chinese 
hamster ovary (CHO) cells reveals that this protein may bind either CGI-58 or ATGL (but not both 
simultaneously) under basal conditions, reducing the TAG hydrolase activity of ATGL, and therefore 
limiting lipolysis (Granneman et al., 2011; Wang et al., 2011a).  However, phosphorylation of PLIN5 
under PKA-stimulating conditions causes the release of ATGL and CGI-58 and is proposed to 
enhance TAG hydrolysis (Granneman et al., 2011; Wang et al., 2011a).  Notably, PLIN5 also mediates 
the physical interaction of LDs with the mitochondria (Bosma et al., 2011; Wang et al., 2011b), and 
therefore given the role of PLIN5 in controlling TAG hydrolysis, it is suggested that this PLIN protein 
channels FA released by lipolysis into the mitochondria for β-oxidation.  However, at the start of this 
project no information was available as to the exact role of PLIN5 in skeletal muscle. 
 
(iii) IMTG synthesis 
The exact process through which intracellular LDs are formed remains to be fully established, 
especially in skeletal muscle, although the prevailing model hypothesises that neutral lipid deposited 
between the leaflets of the endoplasmic reticulum (ER) forms an expanding lens of neutral lipid which 
is eventually budded into the cytoplasm as a nascent LD (reviewed by (Beller et al., 2010a; Brasaemle 
and Wolins, 2012; Ducharme and Bickel, 2008).  This model is derived from morphological evidence 
demonstrating that LDs are surrounded by the ER (Tauchi-Sato et al., 2002; Wolins et al., 2005), and 
that a number of lipid synthesising enzymes are associated with the ER fraction (see (Brasaemle and 
22 
 
Wolins, 2012; Takeuchi and Reue, 2009).  In addition, several enzymes involved in the initial 
esterification of FA moieties to TAG are associated with the mitochondrial fraction (Brasaemle and 
Wolins, 2012; Takeuchi and Reue, 2009).  Fatty acyl-CoA synthetase (FAS) resides in both the 
mitochondria and ER, and activates FAs for further metabolism through either β-oxidative pathways or 
TAG synthesis (Fig. 1.2) (Coleman et al., 2000).  Fatty acyl-CoA’s used for TAG synthesis are first 
attached to a glycerol-3-phosphate backbone to generate lysophosphatidic acid (LPA), a process 
which is catalyzed by a key lipogenic enzyme, glycerol-3-phosphate acyltransferase (GPAT).  Four 
GPAT isoforms exist, but differ by their subcellular distribution, such that GPAT1 and GPAT2 localise 
to the mitochondria, whereas GPAT3 and GPAT4 are observed at the ER (Gimeno and Cao, 2008).  
Notably ~90% of total GPAT activity in skeletal muscle is attributed to GPAT1 (Park et al., 2002).  A 
second fatty acyl-CoA is subsequently transferred to LPA by a 1-acylglycerol-3-phosphate 
acyltransferase (AGPAT) to generate phosphatidic acid (PA).  Next, the lipin family of enzymes, which 
confer phosphatase activity, convert PA to DAG.  This reaction is reversible through the action of a 
DAG kinase, which is important as PA is a precursor for phospholipid biosynthesis.  Thus, the 
production of DAG serves as a key point for determining the use of FAs for either TAG storage, growth 
(phospholipid biosynthesis) or energy production (β-oxidation) (Brasaemle and Wolins, 2012).  In the 
fed state, TAG synthesis proceeds through the action of diacylglycerol transferase (DGAT) catalyzing 
the addition of the final fatty acyl-CoA to DAG.  Two DGAT isoforms exist and both are expressed in 
skeletal muscle although they demonstrate different subcellular distributions, such that DGAT1 is 
localised to the ER, whereas DGAT2 is observed at the ER, mitochondria and LD (Bosma et al., 
2012b).  Importantly, DGAT1 is the predominant isoform expressed in skeletal muscle (Cases et al., 
1998; Cases et al., 2001), suggesting that TAG synthesis in this tissue occurs primarily within the ER.  
To summarise, this brief overview demonstrates that LD formation and storage of TAG is highly 
dependent on a number of lipogenic enzymes, whose coordinated interaction is a key determinant of 
the rate of IMTG turnover (Fig. 1.2). 
 
1.3.4 Cellular energetics as a regulator of IMTG use during exercise 
As described in the previous section, IMTG utilisation (and whole body fat oxidation) is greatest during 
an acute bout of moderate-intensity exercise.  However, it is important to address the question of how 
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the proportion that IMTG contribute to total fat oxidation is regulated during moderate-intensity 
exercise.  A number of lines of evidence point at plasma FFA availability as being an important 
determinant.  Indeed, Watt et al. (2002) reported that IMTG utilisation was greatest during the first 2 h 
of a 4 h exercise bout performed at 57% VO2max, whereas the contribution of plasma FFA to total fat 
oxidation increased during the second half of the exercise bout.  Notably, the decrease in IMTG 
utilisation after 2 h of exercise coincided with an increase in plasma FFA concentration (Watt et al., 
2002a).  This observation has since been replicated during 2 h of exercise at 50% of maximum 
aerobic workload (Wmax) (van Loon et al., 2003).  In another study performed by van Loon et al. (van 
Loon et al., 2005b), reducing plasma FFA availability through administration of a nicotinic acid analog 
(acipimox; inhibitor of adipose tissue lipolysis) enhanced the utilisation of IMTG during 2 h of exercise 
at 50% of maximum aerobic workload.  Unfortunately, van Loon et al. (2005) failed to observe any 
changes in AMPK activation, acetyl-CoA carboxylase (ACC) phosphorylation, or HSL serine 
phosphorylation between normal and low plasma FFA availability trials, which may otherwise have 
explained the increase in IMTG utilisation.  Nevertheless, these studies do provide evidence to 
suggest that plasma FFA availability is a key factor determining the contribution of IMTG utilisation to 
total fat oxidation during low to moderate intensity exercise. 
 
An important observation from the study of van Loon et al. (2005) was that although acipimox 
administration increased the relative contribution of IMTG utilisation to total fat oxidation during 
exercise, absolute rates of fat oxidation were actually reduced (the energy deficit being accounted for 
by an increase in glycogen use).  Therefore, it appears that plasma FFA availability may regulate the 
relative contribution of carbohydrate and fat oxidation to total energy expenditure during exercise.  The 
‘glucose-FFA cycle’, first proposed by Randle et al (Randle et al., 1963), aimed to explain the 
reduction in the rate of muscle carbohydrate oxidation when plasma FFA availability was high.  
Specifically, this theory proposed that increased plasma FFA availability could enhance the rate of fat 
oxidation and reduce the rate of carbohydrate oxidation by suppressing pyruvate dehydrogenase 
complex (PDC) activity, via an increase in the acetyl-CoA/free CoA (CoASH) ratio and NADH/NAD+ 
ratio.  Furthermore, an increase in the cytosolic citrate concentration was proposed to suppress the 
activity of phosphofructokinase (PFK), resulting in an increase in glucose-6-phosphate, which would 
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subsequently suppress the activity of hexokinase and glycogen phosphorylase.  Therefore, this theory 
proposed that plasma FFA availability was the key factor determining the relative utilisation of 
carbohydrate and fat during exercise. 
 
In support of the ‘glucose-FFA cycle’ (Randle et al., 1963) it has been shown that increasing plasma 
FFA availability through an intralipid-heparin infusion increases the rate of fat oxidation during exercise 
(Hawley et al., 2000; Horowitz et al., 1997).  However, no significant reductions in plasma FFA 
concentrations are observed when moving from moderate to high intensity exercise (Romijn et al., 
1993; van Loon et al., 2001), as would be expected if plasma FFA availability was the determining 
factor regulating an increase in carbohydrate oxidation during high intensity exercise.  Indeed, it is 
likely that blood flow is actually greatest during high intensity exercise, suggesting that FFA supply to 
skeletal muscle would also be greatest during high intensity exercise.  It is important to note that 
Romijn et al. (Romijn et al., 1995) did observe a decrease in palmitate rate of appearance (a measure 
of plasma FFA availability) during exercise performed at ~85% VO2 max; however, an intralipid 
infusion to increase plasma FFA availability only partially rescued the rate of fat oxidation during 
exercise.  Taken together, these data suggest that plasma FFA availability does not regulate the 
relative contribution of carbohydrate and fat oxidation to total energy expenditure during high intensity 
exercise. 
 
Although plasma FFA availability is not significantly altered when moving from moderate to high 
intensity exercise, and FFA delivery to skeletal muscle may actually be greater due to an increase in 
blood flow, this may not necessarily lead to an increase in FA uptake.  Indeed, it is logical that a 
reduced FA uptake would limit the availability of FA for oxidation in the mitochondria.  FA uptake into 
skeletal muscle requires transporter proteins (i.e. FAT/CD36, FABP) that reside at endosomal 
membranes at rest, and translocate to the plasma membrane upon muscle contraction (Bonen et al., 
2000; Bradley et al., 2012).  Recently, it has been reported that FA uptake in FAT/CD36 knockout 
mice is reduced at rest and during exercise compared to their wild-type counterparts, and that this 
occurs concomitant with a decrease in fat oxidation (McFarlan et al., 2012), suggesting that fat 
oxidation rates are highly dependent on FA uptake into skeletal muscle.  However, plasma membrane 
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FAT/CD36 concentration was increased concomitant with enhanced FA uptake in giant vesicles 
prepared from contracting muscle in an intensity-dependent manner (Bonen et al., 2000), suggesting 
that FA entry into skeletal muscle is not limited as exercise intensity increases.  In support, Kiens et al. 
(Kiens et al., 1999) reported that skeletal muscle long chain fatty acid (LCFA) concentrations were 
increased in response to exercise performed at 90% VO2 max compared to 65% VO2 max.  Taken 
together, these data demonstrate that the decrease in fat oxidation observed during high intensity, 
submaximal exercise is not due to a reduction in the intramyocellular FA availability. 
 
Given that the oxidation of FA’s (through β-oxidation) occurs within the mitochondria, it is possible that 
limiting the entry of FA into the mitochondria may explain how fat oxidation is regulated.  Importantly, 
medium chain fatty acids (MCFA) can enter the mitochondria directly, whereas LCFA require a 
transport mechanism in order to cross through the outer and inner mitochondrial membranes.  Based 
on this characteristic, two studies have investigated the oxidation of MCFA and LCFA under conditions 
of high glycolytic flux, either by pre-exercise glucose feeding (Coyle et al., 1997) or by moving from a 
low (40% VO2 max) to a high (80% VO2 max) exercise intensity (Sidossis et al., 1997).  Infusion of a 
14C-labeled MCFA (octanoate) and a 13C-labeled LCFA (oleate) allowed quantification of the 
proportion of MCFA and LCFA taken up and oxidised during exercise.  During exercise at 80% VO2 
max LCFA oxidation was reduced, whereas MCFA oxidation, which does not rely on a mitochondrial 
transport mechanism, was unchanged compared to exercise at 40% VO2 max (Sidossis et al., 1997).  
The authors concluded that LCFA oxidation was limited by the mitochondrial transport mechanism for 
LCFA, which involves the enzyme carnitine palmitoyl transferase-1 (CPT-1).  Therefore, increasing 
concentrations of malonyl-CoA during high intensity exercise would inhibit CPT-1 activity, thereby 
reducing LCFA transport into the mitochondria.  However, no evidence is available to support the 
notion that malonyl-CoA concentrations are increased in human skeletal muscle as exercise intensity 
increases (Odland et al., 1998); rather, malonyl-CoA concentrations may actually decrease during 
exercise in an intensity-dependent manner (Dean et al., 2000).  Thus, while it appears that LCFA 
transport into the mitochondria may limit fat oxidation during high intensity exercise this cannot be 
attributed to the suppression of CPT-1 activity by an increase in malonyl-CoA concentrations.  In 
addition, H+ accumulation as a result of high glycolytic flux during high intensity exercise may 
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contribute to the reduction in fat oxidation through a pH-mediated downregulation in CPT-1 activity 
(Starritt et al., 2000).  
 
It is important to consider that performing high intensity, submaximal exercise is associated with an 
increase in the ratios of AMP/ATP and ADP/ATP, and that these metabolic disturbances stimulate 
glycolytic flux.  Specifically, an increase in AMP and ADP will lead to allosteric activation of the key 
glycolytic enzymes glycogen phosphorylase, PFK and PDHa.  Thus, during high intensity exercise, the 
flux through PDC will be in excess of the flux through the tri-carboxylic acid (TCA) cycle leading to an 
accumulation of acetyl-CoA (van Loon et al., 2001).  As acetyl-CoA is a precursor for malonyl-CoA, an 
increase in acetyl-CoA concentration could theoretically lead to greater malonyl-CoA production; 
however, it has already been concluded that malonyl-CoA concentrations are not increased during 
high intensity exercise.  An alternative fate for the excess acetyl-CoA is the formation of 
acetylcarnitine, a reaction catalysed by the enzyme carnitine acetyltransferase (CAT).  In this way, free 
carnitine provides a buffer for the excess acetyl-CoA, and ensures that a viable pool of CoASH is 
maintained which is important for the continuation of PDC and TCA flux.  However, as a consequence 
of this buffering mechanism for acetyl-CoA, the free carnitine pool is significantly reduced.  Therefore, 
it is proposed that a reduction in the availability of carnitine through the process of acetyl group 
buffering limits the capacity for carnitine to participate in the transport of LCFA into the mitochondria 
through CPT-1.  In support, it has been shown that acetylcarnitine concentrations are increased during 
high intensity, submaximal exercise concomitant with a reduction in free carnitine and a decrease in 
fat oxidation (van Loon et al., 2001).  In contrast, acetylcarnitine and free carnitine concentrations are 
significantly lower and higher, respectively, during moderate-intensity exercise, suggesting that the 
flux through PDC is similar or only marginally greater than the flux through the TCA cycle (van Loon et 
al., 2001).  Accordingly, total fat oxidation (and the contribution of IMTG utilisation) is greatest during 
moderate-intensity exercise when there is sufficient carnitine available to participate in LCFA transport 
into the mitochondria.  Overall, current evidence suggests that the contribution of fat oxidation (and 
IMTG utilisation) to total energy expenditure during exercise is regulated primarily by the glycolytic and 
PDC flux.  
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1.4 Physical inactivity – a major contributor to chronic disease 
The present-day lifestyle is far removed from that in which our “physically active genotype” originated.  
In accordance, recent advances in technology have increased the use of motorised transport, and an 
occupational shift from labour-intensive work (e.g. farming, construction, and mining) to sedentary 
office-based jobs has occurred.  Further, pressure in the workplace has increased, such that less time 
is prioritised for physical activity concomitant with greater consumption of energy-dense foods with 
poor nutritional value.  In fact, in 2008, only 39% of men and 29% of women met the current physical 
activity guidelines which suggest that individuals should perform at least 150 min of exercise per week 
(Health Survey for England, (2010).  Therefore, at least ~65% of the UK population do not achieve the 
levels of physical activity that are required to remain free of chronic disease.  Interestingly, a recent 
report by the World Health Organisation (WHO) stated that physical inactivity was a leading cause of 
mortality worldwide (WHO, 2010). 
 
Leading a physically inactive lifestyle is associated with the development of a number of metabolic 
disorders including obesity, insulin resistance, metabolic syndrome, type 2 diabetes and 
cardiovascular disease.  Obesity is the result of an imbalance between energy intake and expenditure, 
and is therefore considered a consequence of physical inactivity coupled with the consumption of an 
energy dense diet.  Physical inactivity is also associated with insulin resistance, which is characterised 
by an inability of tissues to respond to a physiological increase in plasma insulin concentration.  In 
healthy individuals, insulin is secreted from the pancreas in response to carbohydrate ingestion, and is 
responsible for the clearance of glucose from the plasma into peripheral tissues, such as skeletal 
muscle.  However, in the insulin resistant state physiological insulin secretion becomes insufficient to 
stimulate glucose uptake into skeletal muscle, resulting in greater insulin secretion in order to return to 
a state of euglycaemia.  Further progression of insulin resistance to type 2 diabetes is characterised 
by prolonged periods of postprandial hyperglycaemia and hyperinsulinaemia, where high levels of 
insulin are inadequate to reduce plasma glucose concentrations following a meal.  Notably, the 
progression to type 2 diabetes correlates strongly with BMI (Edelstein et al., 1997), indicating that 
obesity (and physical inactivity) is a primary risk factor for the development of type 2 diabetes. 
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1.5 Lipid-induced insulin resistance of skeletal muscle 
Experimentally, a shift from a state of high physical activity to a sedentary condition decreases insulin-
stimulated glucose disposal into skeletal muscle and promotes greater abdominal fat storage, as 
evidenced from studies in rodents (Kump and Booth, 2005) and humans (see (Booth et al., 2008).  As 
skeletal muscle accounts for ~50% of glucose disposal following ingestion of a mixed meal (Capaldo 
et al., 1999), skeletal muscle glucose uptake is a key determinant of whole-body insulin sensitivity.  
Since physical inactivity is also associated with increased adiposity, it is likely that greater lipid storage 
may also contribute to reduced insulin sensitivity.  
   
1.5.1 Lipid ‘overflow’ hypothesis 
Adipose tissue is the primary organ controlling the plasma concentrations of FFA and TAG in the 
fasted and postprandial states, and plasma FFA concentrations are greatest following an overnight 
fast (typically 0.3 to 0.6 mmol.l-1).  Ingestion of a mixed meal increases the plasma glucose 
concentration resulting in insulin secretion from pancreatic β-cells.  The subsequent increase in 
plasma insulin concentrations has three predominant effects: 1) suppression of adipose tissue 
hormone sensitive lipase (HSL) activity reducing FFA release into the circulation, 2) activation of 
lipoprotein lipase (LPL) in the capillaries of adipose tissue, thereby stimulating hydrolysis of 
chylomicron-TAG, releasing FA that are subsequently taken up by adipocytes for storage as TAG, and 
3) suppression of LPL activity in the capillary bed of skeletal muscle.  It is important to note that a 
proportion of FA liberated from chylomicron-TAG always escape esterification into adipose tissue and 
contribute to the plasma FFA pool, which is termed ‘spillover’.   Fundamentally, through its ability to 
buffer the lipid flux adipose tissue is suggested to be important in protecting non-adipose tissues, such 
as the liver, skeletal muscle, heart and pancreatic β-cells, from the potentially damaging effects of 
elevated plasma concentrations of FFA and TAG (Frayn, 2002). 
 
In obese subjects displaying large visceral adipose tissue stores, there is considerable evidence to 
suggest that the ability of adipose tissue to buffer the lipid flux is compromised, an observation that is 
commonly associated with insulin resistance (Bays et al., 2004; Frayn, 2002; Lewis et al., 2002).  In 
particular, the obese phenotype is reported to exhibit impaired insulin-mediated suppression of 
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adipose tissue lipolysis, resulting in greater appearance of FFA liberated from adipocytes in the 
circulation (Coppack et al., 1992; Hickner et al., 1999).  This increase in FFA appearance in the 
plasma has been linked to insulin resistance, since high-fat feeding for 56-67 h enhances plasma FFA 
concentrations concomitant with reduced insulin sensitivity (Johnson et al., 2006; Pehleman et al., 
2005).  Furthermore, elevating plasma FFA concentrations through infusion of an intralipid/heparin 
emulsion in humans decreases insulin-stimulated glucose uptake in skeletal muscle (Bachmann et al., 
2001; Boden and Chen, 1995; Itani et al., 2002; Kelley et al., 1993; Roden et al., 1999).  However, 
rates of insulin-stimulated glucose disposal were only reduced after 2 hours of lipid infusion, 
suggesting that plasma FFA per se do not directly interfere with insulin action.  This is consistent with 
the observation that rates of adipose tissue FFA release in obese individuals are normal when 
adjusted relative to total fat mass (Bickerton et al., 2008; Campbell et al., 1994; Fabbrini et al., 2009; 
McQuaid et al., 2011; Robinson et al., 1998).  Consequently, plasma FFA concentrations may not 
differ between lean and obese individuals (Bickerton et al., 2008; McQuaid et al., 2011; Reeds et al., 
2006), indicating that the elevated plasma insulin concentrations observed in insulin-resistant 
individuals may actually be sufficient to suppress FFA release from adipose tissue.  Rather, it appears 
that the capacity of adipose tissue to store plasma-derived TAG is impaired in obese individuals 
(McQuaid et al., 2011), which may be due to a reduced LPL rate of action (per unit of fat tissue) in the 
capillary bed of adipose tissue (Frayn, 2002; Karpe et al., 2011).  As a result, there is an increase in 
TAG which has not undergone lipolysis in the plasma, and it is suggested that the elevated plasma 
TAG concentrations are more closely related to insulin resistance than increased FFA concentrations 
(Bickerton et al., 2008; Karpe et al., 2011).  In this respect, TAG remnants of chylomicron-TAG are 
deposited in the liver and provide substrate for the production of very low-density lipoproteins 
containing TAG (VLDL-TAG), and increased assembly and secretion of VLDL-TAG is a common 
feature of obesity and insulin resistance (Karpe et al., 2011; Reilly and Rader, 2003).  Accordingly, 
increased plasma TAG and FFA concentrations during an intralipid/heparin infusion are associated 
with insulin resistance (Bachmann et al., 2001), and it is postulated that FFAs ‘spillover’ into non-
adipose tissues in order to maintain plasma lipid homeostasis.  In particular, an increase in 
intracellular TAG concentration is observed in the liver and skeletal muscle.  Consequently, the obese 
insulin resistant state is characterised by reduced insulin-stimulated suppression of hepatic glucose 
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output and glucose uptake into skeletal muscle.  Accordingly, a link between lipid accumulation in non-
adipose tissues in obesity and hyperglycaemia in insulin resistance has been identified. 
 
Several lines of evidence are available to support the notion that lipid accumulation in non-adipose 
tissues is an important event in the development of insulin resistance.  Firstly, lipodystrophy is a 
condition that is characterized by partial or complete loss of adipose tissue.  As a result, excess 
calorie ingestion in lipodystrophic mice or humans promotes lipid storage in non-adipose tissues, such 
as skeletal muscle and liver, concomitant with reduced insulin sensitivity (Gavrilova et al., 2000; Kim et 
al., 2000a).  A-ZIP/F-1 mice exhibit a severe form of lipoatrophic diabetes, but transplantation of 
adipose tissue from wild-type mice into these mice reverses hyperglycaemia, reduces insulin 
concentrations and improves skeletal muscle insulin sensitivity (Gavrilova et al., 2000; Kim et al., 
2000a).  Significantly, these adaptations occurred concomitant with a decrease in lipid storage in 
skeletal muscle and liver tissue (Kim et al., 2000a), underlining the importance of adipose tissue to 
maintain skeletal muscle insulin sensitivity.  Secondly, thiazolidinedione (TZD) treatment of obese 
Zucker rats activates peroxisome proliferator γ (PPARγ) receptors in adipocytes, leading to adipocyte 
differentiation.  As a consequence, lipid stored in both skeletal muscle and liver is redistributed to 
adipocytes, concomitant with improved insulin sensitivity (Hallakou et al., 1997).  Further evidence is 
available from human studies in both healthy individuals and type 2 diabetic patients, whereby 
supplementation of the TZD, Pioglitazone, improves insulin sensitivity in line with a reduction in muscle 
lipid concentration (Rasouli et al., 2005; Teranishi et al., 2007).  Together, these reports demonstrate 
that the accumulation of lipid in non-adipose tissues, such as liver and skeletal muscle, contributes to 
the development of insulin resistance. 
 
1.5.2 IMTG accumulation, per se, is not responsible for insulin resistance 
IMTG concentration is negatively associated with insulin-stimulated glucose uptake in rodents 
(Storlien et al., 1991) and humans (Pan et al., 1997), in as much as elevated IMTG content provides a 
risk factor for the development of insulin resistance and/or type 2 diabetes.  Accordingly, greater IMTG 
concentrations are observed in insulin-resistant obese individuals and obese type 2 diabetes patients 
when compared to lean, insulin-sensitive controls (Goodpaster et al., 2001; van Loon et al., 2004).  
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However, this relationship becomes distorted when endurance-trained athletes are included in the 
comparison as they also demonstrate elevated IMTG concentrations, yet remain exquisitely insulin 
sensitive, in a phenomenon known as the “athlete’s paradox” (Goodpaster et al., 2001; van Loon et 
al., 2004).  Therefore, only when comparing individuals who are sedentary does IMTG content 
negatively correlate with insulin sensitivity.  In fact, elevated IMTG content in endurance-trained 
athletes may actually predict greater insulin sensitivity (Thamer et al., 2003).  Thus it appears that the 
quantity of FA stored within intramuscular LDs, per se, does not directly impair insulin sensitivity. 
 
The relationship between IMTG concentration and insulin sensitivity may be partly explained by the 
fibre type composition of skeletal muscle.  Type I muscle fibres are reported to exhibit a three to four-
fold greater IMTG content than type II fibres (He et al., 2001; van Loon et al., 2003; van Loon et al., 
2004).  This may be an important observation given that skeletal muscle of obese individuals and/or 
type 2 diabetes patients demonstrates a reduced proportion of type I fibres when compared to lean 
individuals or BMI-matched controls (Nyholm et al., 1997; Tanner et al., 2002), although this is not a 
universal finding (van Loon et al., 2004).  Nevertheless, it is well-documented that endurance-trained 
athletes exhibit a large proportion of type I fibres (Andersson et al., 2000).  Therefore, fibre type 
composition combined with fibre-specific lipid content may partly explain the paradoxical relationship 
between IMTG concentration and insulin sensitivity in trained athletes, obese individuals and type 2 
diabetes patients.  In this respect, it was reported that mixed muscle IMTG content was ~78% greater 
in trained athletes compared to type 2 diabetes patients (van Loon et al., 2004).  However, when 
corrected for fibre type composition, ~43% of the difference in IMTG content between groups was 
explained by the greater proportion of type I fibres observed in trained athletes, with the remainder 
attributed to greater IMTG content in type I fibres in athletes.  Therefore, muscle fibre composition only 
partly explains the differences between groups in the relationship between IMTG content and insulin 
sensitivity.  It is also worth considering that IMTG concentration is a function of both the number and 
volume of TAG-containing LDs.  In this respect, it appears that the elevated IMTG concentration in 
trained athletes is attributable to a greater number of LDs, whereas no difference in LD volume was 
observed when compared to obese individuals or type 2 diabetes patients (van Loon et al., 2004). 
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1.5.3 IMTG metabolism as a determinant of insulin sensitivity 
(i) An imbalance in IMTG turnover leads to IMTG accumulation 
Elevated IMTG storage in endurance-trained individuals appears to represent one of a number of 
metabolic adaptations to endurance training (Amati et al., 2011; Goodpaster et al., 2001; van Loon et 
al., 2004), increasing the capacity to use IMTG as a substrate source during exercise.  Accordingly, 
longitudinal training studies (De Bock et al., 2008; Phillips et al., 1996b; Schrauwen et al., 2002; Van 
Proeyen et al., 2011a; Van Proeyen et al., 2011b) and cross-sectional comparisons between trained 
and untrained individuals (Coggan et al., 2000; Klein et al., 1994) demonstrate that the IMTG pool 
makes a significant contribution to total substrate oxidation during exercise following endurance 
training.  On the other hand, it appears that IMTG does not provide a readily available fuel source 
during exercise in sedentary, obese and/or type 2 diabetes patients (Blaak et al., 2000; Schrauwen et 
al., 2002).  This finding appears logical given that elevated plasma FFA concentrations, as observed in 
obese individuals and/or type 2 diabetes patients, may inhibit IMTG utilisation during exercise (van 
Loon et al., 2005b).  Notably, administration of acipimox to inhibit adipose tissue lipolysis thereby 
reducing plasma FFA concentrations enhanced the utilisation of IMTG during exercise (van Loon et 
al., 2005b).  Therefore, in obese individuals and/or type 2 diabetes patients the elevated plasma FFA 
availability and FA uptake inhibit the capacity for IMTG utilisation, and as a result IMTG accumulation 
occurs.  In trained individuals a harmonious relationship between FA uptake, esterification, hydrolysis 
and oxidation is apparent resulting in high rates of IMTG turnover.  However, in obese individuals 
and/or type 2 diabetes patients FA uptake is greater than the rate of FA oxidation, implying that the 
rate of IMTG turnover is low as well.  
 
Not only is a low rate of IMTG turnover associated with an increase in IMTG content, but the functional 
imbalance between IMTG storage, lipolysis and FA oxidation may also result in the accumulation of 
FA metabolites.  These metabolites possess signalling properties that appear to downregulate the 
insulin signalling cascade.  The most well-studied FA metabolites thought to possess the capacity to 
negatively impact insulin signalling include DAGs, long chain fatty acyl-CoAs (LCFA-CoA) and 
ceramides.  DAG is an intermediate in both IMTG synthesis and hydrolysis, and is increased in 
obesity-induced insulin resistance in animals (Turinsky et al., 1990a) and lipid-induced insulin 
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resistance in humans (Itani et al., 2002).  However, cross-sectional studies comparing lean and obese 
individuals (Jocken et al., 2010; Thrush et al., 2009) or normal glucose tolerant and obese insulin 
resistant individuals (Coen et al., 2010; Perreault et al., 2010) do not report significant differences in 
skeletal muscle DAG concentration.  Nevertheless, DAG concentration may be an important predictor 
of insulin resistance (Bergman et al., 2012; Moro et al., 2009; Straczkowski et al., 2007).  More 
precisely, DAG saturation is greater in sedentary lean and obese individuals or those with insulin 
resistance compared to athletes or normal glucose tolerant controls (Bergman et al., 2012; Bergman 
et al., 2010; van Hees et al., 2011), although observations to the contrary are also reported (Amati et 
al., 2011).  Most recently it has been reported that the degree of FA saturation in the DAG fraction 
extracted from the muscle plasma membrane fraction of individuals with obesity and type 2 diabetes 
was greater than of trained athletes, and that it showed a negative association with insulin sensitivity 
(Bergman et al., 2012).  Thus, while total DAG is not consistently increased in the insulin resistant 
state, insulin resistance induced by FA metabolites may be dependent on the accumulation of certain 
DAG species at specific intracellular locations, in this case the compartment in which the proximal 
insulin signalling intermediates reside. 
 
Ceramides provide structural support for biological membranes, and require long chain saturated FA 
for their biosynthesis.  Furthermore, ceramide accumulation is reported in obese individuals and type 2 
diabetes patients compared with lean controls (Adams et al., 2004; Coen et al., 2010; Moro et al., 
2009; Straczkowski et al., 2007; Thrush et al., 2009), although reports to the contrary also exist 
(Skovbro et al., 2008).  Interestingly, ceramide content is reported to be greater in type I compared to 
type II fibres in healthy lean individuals (Nordby et al., 2010) and obese subjects with or without type 2 
diabetes (Kristensen et al., 2012).  However, as with DAG, ceramide FA saturation may be more 
important than total ceramide content, as this is increased in obese compared to lean individuals 
(Adams et al., 2004; Moro et al., 2009; Thrush et al., 2009).  Furthermore, 4-6 h intralipid infusion, 
which mainly consists of unsaturated lipid, induces insulin resistance without significant elevations in 
ceramide content (Hoeg et al., 2011; Itani et al., 2002; Vistisen et al., 2008).  Thus, a high degree of 
FA saturation appears to be an important factor in the mechanism by which ceramide accumulation 
leads to skeletal muscle insulin resistance.  Much less is known about the effects of long-chain fatty 
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acyl-CoAs.  If the rate of IMTG synthesis or FA β-oxidation is not matched to FA uptake then fatty 
acyl-CoA accumulation occurs in either the cytosolic or membrane fraction.  Notably, rats fed a high-
fat compared to a standard chow diet (Ellis et al., 2000), or obese compared to lean humans (Hulver 
et al., 2003) demonstrate long chain fatty acyl-CoA accumulation.  In addition, insulin-sensitising 
interventions reduced intramuscular long chain fatty acyl-CoA concentrations (Bajaj et al., 2010; Bajaj 
et al., 2005; Houmard et al., 2002).  However, contrary to these reports, no differences in long chain 
fatty acyl-CoA concentrations were observed between obese individuals, type 2 diabetes patients or 
trained athletes (Bruce et al., 2003).  Taken together, further studies are required to elucidate the 
exact role that lipid metabolite species play in the development of skeletal muscle insulin resistance.     
 
It is clear that further investigations are required in order to determine the species, saturation status 
and subcellular localisation of the exact lipid species responsible for inducing obesity-related insulin 
resistance in skeletal muscle. Nevertheless, it is logical that their accumulation may be a function of a 
mismatch between FFA uptake and IMTG synthesis, or an increased rate of IMTG hydrolysis which is 
not matched by an increased FA oxidation rate.  Therefore, further understanding of the mechanistic 
processes underlying LD synthesis, hydrolysis and oxidation, including the role of LD-associated 
proteins will help provide an explanation for the underlying cause of lipid-induced insulin resistance. 
 
(ii) Control of FA uptake, IMTG synthesis and hydrolysis, and FA oxidation in insulin resistance 
The expression of the lipid transporter, fatty acid translocase (FAT/CD36), appears to be similar in 
obese individuals and lean controls, at least when assessed using whole muscle homogenates (Aguer 
et al., 2010; Bonen et al., 2004; Holloway et al., 2007).  Like the glucose transporter, GLUT4, 
FAT/CD36 is able to cycle between intracellular depots and the plasma membrane in response to 
muscle contraction and insulin (Bonen et al., 2000; Luiken et al., 2002).  However, under conditions of 
chronically elevated plasma FFA concentrations, as in obesity, it has been shown that permanent 
relocation of FAT/CD36 to the plasma membrane fraction occurs (Aguer et al., 2010; Bonen et al., 
2004).  As a result, the capacity for plasma-derived FA uptake may be enhanced in the insulin 
resistant state. 
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Despite plasma FFA availability and FA uptake being elevated in obese individuals and/or type 2 
diabetes patients, an enhanced capacity for IMTG synthesis would direct FA towards storage, 
reducing their potential to negatively impact insulin signalling.  Notably, rodent studies report improved 
insulin sensitivity when DGAT1, a key rate-limiting enzyme in IMTG synthesis, is overexpressed in 
skeletal muscle (Liu et al., 2009; Liu et al., 2007; Timmers et al., 2011).  However, reports comparing 
lean and obese individuals do not demonstrate significant differences in the expression of GPAT1 or 
DGAT1 (Li et al., 2011; Thrush et al., 2009).  Furthermore, DGAT1 mRNA or protein expression does 
not differ between trained athletes and sedentary controls (Amati et al., 2011; Bergman et al., 2010; 
Schmitt et al., 2003), and subsequently it has been reported that 8-16 weeks of endurance training 
does not significantly alter DGAT1 protein expression in lean (Alsted et al., 2009) or obese individuals 
(Dubé et al., 2011).  In contrast, acute exercise increases protein expression of both GPAT1 and 
DGAT1 while preventing insulin resistance induced by an overnight lipid-heparin infusion (Schenk and 
Horowitz, 2007).  Thus, GPAT1 and DGAT1 protein expression appears to respond to changes in 
plasma FFA availability when preceded by exercise-induced increases in IMTG lipolysis leading to 
transient decreases in IMTG content.  However, obese individuals and/or type 2 diabetes patients 
exhibit chronically elevated plasma FFA concentrations, yet GPAT1 and DGAT1 protein expression is 
not significantly different when compared to lean, healthy individuals.  Accordingly, it is speculated that 
a failure to upregulate IMTG synthesis when plasma FFA availability and uptake is increased may 
negatively impact insulin sensitivity.  Indeed, DGAT1 knockout mice demonstrate reduced insulin 
sensitivity concomitant with a greater concentration of lipid metabolites (Liu et al., 2007).  However, 
whether an impaired capacity for IMTG synthesis (relative to FA availability) plays a causative role in 
the development of lipid-induced insulin resistance requires further investigation. 
 
The rate of IMTG turnover is not only determined by the capacity for IMTG synthesis, but also IMTG 
lipolysis.  Direct evidence obtained in vivo using microdialysis suggests that skeletal muscle lipolysis is 
impaired in obese individuals (Blaak et al., 2004).  However, IMTG lipolysis is largely under the control 
of two lipases, ATGL and HSL, which differ in their affinity for TAG and DAG, respectively (Zechner et 
al., 2012).  As such, a mismatch in the activity of HSL relative to ATGL will result in the accumulation 
of FA metabolites.  In accordance, ATGL protein expression is increased in insulin resistant obese 
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individuals relative to lean controls, whereas a proportionate increase in HSL protein expression is not 
observed (Badin et al., 2011; Jocken et al., 2010).  As a result, DAG hydrolase activity is reduced 
relative to TAG hydrolase activity (Jocken et al., 2010; Moro et al., 2009), a factor which is estimated 
to explain 54% and 38% of the increase in DAG and ceramide accumulation in obesity, respectively 
(Moro et al., 2009).  However, DAG accumulation is not always associated with a reduced DAG to 
TAG hydrolase ratio (Jocken et al., 2010), and skeletal muscle ATGL and HSL protein expression is 
not consistently different between insulin resistant and insulin sensitive individuals (Coen et al., 2010; 
Li et al., 2011).  Thus, whether impairments in IMTG lipolysis promote the accumulation of lipid 
metabolites that contribute to lipid-induced insulin resistance remains to be determined.    
 
The activation of ATGL and HSL requires a number of other proteins, at least in cell culture studies, 
such as CGI-58, G0S2, and the perilipin proteins (Granneman et al., 2009; Granneman et al., 2011; 
Wang et al., 2011a; Wang et al., 2011b).  As such, a reduced DAG to TAG hydrolase ratio may be 
attributable to a disproportionate activation of ATGL or HSL.  However, CGI-58 protein expression 
does not differ in skeletal muscle of lean and obese individuals (Jocken et al., 2010), and skeletal 
muscle expression of G0S2 is yet to be investigated.  The predominant role of the PLIN proteins 
appears to be as a protective coat for stored TAG against the action of intracellular lipases, such as 
ATGL or HSL.  Specifically, expression of PLIN2 in human embryonic kidney cells or AML12 cells 
limits the interaction of ATGL with TAG-containing LDs, thereby reducing the rate of TAG hydrolysis 
(Bell et al., 2008; Listenberger et al., 2007).  In addition, using COS-7 cells it was observed that PLIN5 
binds either CGI-58 or ATGL (but not both simultaneously) under basal conditions, which may reduce 
the activation of ATGL by CGI-58 (and therefore the TAG hydrolase capacity of ATGL), thus limiting 
the rate of lipolysis (Granneman et al., 2011; Wang et al., 2011a).  Taken together these observations 
suggest that the PLIN proteins appear to be important in protecting stored TAG from unregulated 
lipolysis, which may generate insulin resistance-inducing lipid metabolites.  In line with this proposal, 
downregulation of PLIN2 in AML12 liver cells decreases insulin sensitivity, as evidenced by reduced 
insulin stimulated Akt phosphorylation (Bell et al., 2008).  In humans, limited evidence is available to 
discern a relationship between PLIN protein expression and insulin sensitivity.  Indeed, PLIN2 protein 
expression has been reported to be similar between type 2 diabetes patients and BMI-matched 
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controls, although pharmacological treatment with insulin-sensitizing drugs may increase (Phillips et 
al., 2005) or decrease perilipin 2 expression (Minnaard et al., 2009).  Interestingly, PLIN3 expression 
is reported to be greater in obese individuals compared to lean controls, when corrected for IMTG 
concentration (Li et al., 2011).  Furthermore, PLIN5 protein expression was enhanced in trained 
athletes compared to sedentary lean and obese controls, and PLIN5 expression correlated with IMTG 
concentration (Amati et al., 2011).  Thus, the expression of PLIN proteins might represent an adaptive 
response to altered intramuscular lipid content.  However, given that PLIN5 is present on the LD and 
mitochondria (Bosma et al., 2011; Wang et al., 2011b), this suggests that PLIN5 may be a key 
regulator of IMTG-derived FA delivery to the mitochondria for oxidation.  
 
A reduced capacity to oxidise FA liberated from IMTG-containing LDs may also contribute to lipid 
metabolite accumulation and impaired insulin signalling.  Importantly, a reduced skeletal muscle 
oxidative capacity, as assessed through measurements of the common mitochondrial markers citrate 
synthase (CS), β-hydroxyacyl-CoA dehydrogenase (β-HAD) and cytochrome c oxidase (COX), 
correlates with a decrease in the capacity for FA oxidation (Simoneau et al., 1999).  In accordance, 
cross-sectional studies report that obese individuals and/or type 2 diabetes patients exhibit a reduced 
oxidative capacity (Amati et al., 2011; Bruce et al., 2003; Goodpaster et al., 2001).  However, whether 
the reduced oxidative capacity is due to intrinsic defect in the mitochondrial oxidative machinery or 
simply the result of a decrease in mitochondrial density requires further investigation.  Indeed, a 
number of reports implicate the latter as the underlying cause of a reduced capacity for FA oxidation 
(He et al., 2001; Holloway et al., 2007; Kelley et al., 2002; Kim et al., 2000b; Ritov et al., 2005), while 
other reports suggest that there is an intrinsic defect in the mitochondrial oxidative machinery (Liang et 
al., 1997; Petersen et al., 2004).  In addition, it is suggested that mitochondrial density within the 
subsarcolemmal region of the muscle fibre is where the greatest reduction is observed, compared to 
lean controls (Ritov et al., 2005), although other studies attribute the reduction in mitochondrial content 
to the intermyofibrillar region of the muscle fibre (Chomentowski et al., 2011; Holloway et al., 2007).  
Nevertheless, substantial evidence exists to indicate that obese individuals have a reduced oxidative 
capacity, presumably due to a lack of regular physical activity, and this may be a more important 
determinant of insulin sensitivity than an increased IMTG concentration (Bruce et al., 2003). 
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In summary, an imbalance between the processes liberating FA (IMTG lipolysis and FA uptake) and 
those processes that consume FA (IMTG synthesis and mitochondrial β-oxidation) may lead to an 
increase in the concentration of FA metabolite species, thereby contributing to the development of 
skeletal muscle insulin resistance.  It appears that in trained athletes, who exhibit regular depletion 
and resynthesis of the IMTG pool, this balance is maintained to a greater extent than in sedentary 
obese individuals and type 2 diabetes patients and therefore trained athletes remain highly insulin 
sensitive.  However, the mechanisms regulating the efficient balance between FA liberation and 
consumption in trained individuals are not well understood.    
 
1.5.4 Lipid-induced impairments of insulin signalling in skeletal muscle 
As already described, it is generally accepted that lipid-induced insulin resistance is associated with 
the accumulation of FA metabolites, which include long chain fatty-acyl CoAs, DAG, and ceramides 
(Samuel et al., 2010).  Although controversy still exists as to whether absolute intracellular DAG 
concentration, saturation, or subcellular localisation (or a combination of all three) is the key factor in 
determining insulin sensitivity in skeletal muscle, DAG is implicated in the development of insulin 
resistance due to its ability to activate novel protein kinase C (PKC) isoforms (δ, ε, ζ, θ, and µ).  
Accordingly, high fat feeding in rodents (Schmitz-Peiffer et al., 1997) and lipid infusion studies 
conducted in humans (Itani et al., 2002) suggest that PKC activation, as measured through PKC 
translocation to the plasma membrane, is increased concomitant with elevated DAG concentrations 
and a reduced rate of glucose disposal.  Notably, PKC-θ knockout mice are protected against the 
detrimental effects of a lipid infusion, indicating the importance of PKC activation in the development 
of lipid-induced insulin resistance (Kim et al., 2004).  Furthermore, PKC-θ is increased in the muscle 
plasma membrane fraction of obese individuals (Itani et al., 2000) and type 2 diabetes patients (Itani 
et al., 2001).  Moreover, a recent study has reported that PKC-ε activation is positively associated with 
the plasma membrane concentration of DAG, which itself is negatively associated with insulin 
sensitivity (Bergman et al., 2012).  Taken together, these reports suggest that DAG-induced 
translocation of PKC to the plasma membrane is an important feature of insulin resistance, 
presumably by increasing the proximity of PKC to components of the insulin signalling cascade.  In 
accordance, it appears that DAG-activated novel PKCs target the IRS proteins (Fig. 1.3), either 
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directly or through upstream activation of the stress kinases IκBα kinaseβ (IKKβ) and c-Jun NH2-
terminal kinase (JNK).  Importantly, enhanced PKC-θ activation is associated with reduced tyrosine 
phosphorylation and increased serine phosphorylation of IRS-1 in response to a lipid infusion in 
humans (Yu et al., 2002).  A plethora of studies have now established the predominant serine 
phosphorylation sites which are targeted by novel PKCs and stress kinases which include ser307, 
ser636/639, and ser1101 (reviewed in (Boura-Halfon and Zick, 2009; Gual et al., 2005).  Given that serine 
phosphorylation of IRS-1 generally inhibits IRS1 tyrosine phosphorylation and subsequent 
downstream activation of PI3-K and Akt/PKB, it is postulated that insulin-stimulated GLUT4 
translocation is consequently reduced (Fig. 1.3). 
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Figure 1.3 Lipid-induced insulin resistance in skeletal muscle 
Akt/PKB protein kinase B, DAG diacylglycerol, DGAT1 diacylglycerol acyltransferase, FAT/CD36 fatty 
acid transporter, FFA free fatty acid, GLUT4 glucose transporter 4, GPAT1 glycerol-3-phosphate 
acyltransferase, IR insulin receptor, IRS-1 insulin receptor substrate-1, LCFA-CoA long chain fatty acyl 
CoA, nPKC novel protein kinases C, PDK phosphoinositide-dependent kinase 1, PI3-K 
phosphoinositide 3-kinase, PIP2 phosphatidylinositol 4,5-bisphosphate, PIP3 phosphatidylinositol-
3,4,5-triphosphate, Rab-GDP Rab guanosine disphosphate, Rab-GDP Rab guanosine triphosphate, 
TAG triacylglycerol, TBC1D4 TBC 1 domain family member 4. 
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Ceramide accumulation is also reported to inhibit insulin signalling as it initiates a signal that leads to 
dephosphorylation and inactivation of Akt/PKB.  Indeed, incubation of C2C12 skeletal muscle cells or 
L6 myotubes with the saturated FA palmitate leads to elevated ceramide concentrations concomitant 
with an impaired capacity for Akt/PKB activation (Pickersgill et al., 2007; Schmitz-Peiffer et al., 1999; 
Watson et al., 2009).  It is now established that ceramide directly activates protein phosphatase 2A 
(PP2A) leading to dephosphorylation of Akt/PKB already phosphorylated at thr308 and ser473 residues, 
resulting in inactivation of Akt/PKB (reviewed in (Lipina and Hundal, 2011; Summers, 2006).  
Furthermore, ceramide can activate the aPKC isoforms ζ and λ, leading to serine phosphorylation of 
the Akt/PKB pleckstrin homology, thus reducing its affinity towards PIP3 and ultimately preventing 
Akt/PKB translocation to the plasma membrane (reviewed in (Lipina and Hundal, 2011; Summers, 
2006).  As a result of these defects in insulin signalling at IRS-1 and Akt/PKB, GLUT4 translocation 
from its intracellular vesicles is reduced, and insulin-stimulated glucose uptake is subsequently 
decreased.  In accordance, GLUT4 translocation to the plasma membrane fraction was not increased 
following insulin stimulation in skeletal muscle obtained from type 2 diabetic patients (Zierath et al., 
1996). 
 
1.6 Exercise training 
1.6.1 Exercise as a therapeutic agent to combat insulin resistance 
Booth and colleagues have proposed that the current human genotype originates from a physically 
active lifestyle (Booth et al., 2002; Booth et al., 2008; Booth and Lees, 2006; Chakravarthy and Booth, 
2004), although the environmental pressures which formed our current genotype are absent from 
present day living, and as such, our lifestyle is relatively sedentary by comparison.  Most notably, a 
sedentary, ‘physically inactive’ lifestyle is estimated to cause 13% of the burden of disease from type 2 
diabetes and 11% from coronary heart disease (Lee et al., 2012).  Therefore, increasing the quantity 
of physical activity that we perform will significantly improve metabolic health. 
 
Large-scale lifestyle intervention studies provide some insight as to the impact of physical activity for 
reducing the risk of developing type 2 diabetes.  Lifestyle intervention studies generally invite 
individuals to incorporate at least 30 minutes of exercise into their day, decrease body mass by 
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around 7%, and reduce total and saturated dietary fat intake.  A review of the literature by Sigal and 
colleagues (2004) reveals that lifestyle interventions reduce the risk of developing type 2 diabetes by 
~50%.  However, it must be acknowledged that lifestyle intervention studies do not allow the relative 
importance of either physical activity or diet to be determined.  Accordingly, large-scale physical 
activity intervention studies provide some indication of the effect of incorporating regular physical 
activity into daily living on the risk of developing metabolic disease (reviewed in (Bassuk and Manson, 
2005).  For example, walking briskly for 30 minutes per day, 5 days per week, reduced the risk of 
developing type 2 diabetes by 25% over 8 years of follow up in a group of more than 70,000 initially 
healthy US women (Hu et al., 1999), or by 34% over 7 years of follow up in a group of 38,000 US 
female health professionals (Weinstein et al., 2004).  Similarly, of 897 Finnish men, those who 
performed at least 40 minutes of moderate-to-vigorous intensity activity per week were 56% less likely 
to develop type 2 diabetes over 4 years of follow up (Lynch et al., 1996).  Importantly, regular physical 
activity may also be beneficial for individuals who already demonstrate symptoms of metabolic 
disease, such as type 2 diabetes patients (reviewed in (Gordon et al., 2009; Sigal et al., 2004).  Taken 
together, these observations provide strong support for undertaking regular physical activity, 
preferably performed as part of a structured exercise training programme, as a viable therapeutic 
intervention to enhance metabolic health and reduce the risk of developing metabolic and 
cardiovascular disease. 
 
It is important to acknowledge that the rate of insulin-stimulated glucose clearance, a measure of 
insulin sensitivity, is improved following a single bout of endurance exercise (Brestoff et al., 2009; 
Wojtaszewski et al., 2000a; Wojtaszewski et al., 1997).  Similarly, an acute bout of resistance exercise 
has been reported to improve glucose tolerance and insulin sensitivity in both insulin-sensitive and 
insulin-resistant individuals (Fenicchia et al., 2004; Koopman et al., 2005; Venables et al., 2007).  
Notably, improvements in insulin sensitivity following an acute bout of exercise appear to persist for up 
to 48 h (Mikines et al., 1988; Perseghin et al., 1996).  However, following a period of chronic exercise 
training, improvements in insulin sensitivity are observed beyond those detected following a single 
bout of exercise (Perseghin et al., 1996), thereby supporting epidemiological reports of the beneficial 
health effects of performing regular exercise.  
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1.6.2 Exercise training-induced improvements in insulin signalling     
Regular exercise training in the form of prolonged bouts of aerobic exercise or resistance-type 
exercise have both been shown to directly improve insulin signalling capacity.  Importantly, both 
endurance and resistance training is associated with an enhanced capacity for skeletal muscle 
glucose uptake (Frosig et al., 2007; Holten et al., 2004), and it appears that this adaptation is highly 
dependent on the capacity for GLUT4 translocation to the plasma membrane (Frosig and Richter, 
2009).  In this regard both endurance and resistance training increase the protein expression of 
GLUT4 (Frosig et al., 2007; Holten et al., 2004; Ivy, 2004; Stuart et al., 2010).  However, insulin-
stimulated GLUT4 translocation, and therefore glucose uptake, is also dependent on a number of 
insulin signalling intermediates.  Interestingly, IRS-1 protein expression does not seem to be 
enhanced with exercise training in humans (Frosig et al., 2007; Holten et al., 2004; Yu et al., 2001).  
Rather, it appears that serine phosphorylation of IRS-1 is reduced in response to regular exercise 
training (Glynn et al., 2008; Langlais et al., 2011), therefore increasing the capacity for insulin-
stimulated IRS-1 tyrosine phosphorylation.  In addition, PI3K protein expression is unchanged 
following exercise training (Frosig et al., 2007; Holten et al., 2004), although PI3K activity was 
increased in response to 7 days of endurance training in sedentary males (Houmard et al., 1999), and 
greater in trained compared to untrained males (Kirwan et al., 2000).  In contrast, insulin-stimulated 
IRS-1 associated PI3K activity was reduced following 3 weeks of knee extensor exercise training 
(Frosig et al., 2007).  Taken together, these results demonstrate that improved proximal insulin 
signalling is predominantly attributed to enhanced activity and/or phosphorylation of IRS-1 and PI3K, 
rather than changes in protein expression. 
 
As previously stated, Akt/PKB is a critical node in insulin signalling as it can affect many cellular 
processes, including protein synthesis, glucose uptake and glycogen storage.  Both endurance and 
resistance training stimulate increased protein expression and insulin-stimulated activity of Akt/PKB in 
parallel to enhanced glucose uptake (Frosig et al., 2007; Holten et al., 2004; Vind et al., 2011).  In 
addition, TBC1D4 protein expression and phosphorylation is increased in response to endurance 
training (Frosig et al., 2007; Vind et al., 2011).  Thus, exercise training appears to enhance both the 
expression and activation of the distal insulin signalling intermediates, leading to an increase in 
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GLUT4 translocation and a greater capacity for glucose uptake.  The capacity for glycogen synthesis 
is also enhanced following both endurance and resistance training, as glycogen synthase protein 
expression and activity are elevated (Holten et al., 2004; Vind et al., 2011).  Increased intramuscular 
glycogen storage is a key adaptation to exercise training, as incorporating glucose taken up from the 
circulation into glycogen stores maintains the cellular gradient for subsequent glucose disposal, and is 
therefore associated with insulin sensitivity.    
 
1.6.3 Exercise training-induced changes in lipid metabolism 
(i) Changes to IMTG utilisation during exercise following exercise training 
One of the most common adaptations to endurance exercise training is an increased capacity to 
oxidise fat as a substrate source during exercise, thereby reducing the reliance on carbohydrate 
oxidation to meet the energy demands (see (van Loon, 2004).  Furthermore, it is well established that 
IMTG provides a readily available substrate source during moderate-intensity exercise in trained 
individuals (see (van Loon, 2004).  Studies using FA tracer methodology have reported that 12 weeks 
of endurance training in lean, sedentary individuals increases the use of TAG (sum of muscle plus 
lipoprotein-derived TAG) during 1 h of moderate-intensity exercise (Schrauwen et al., 2002).  Of 
additional importance was the observation that the increase in total fat oxidation following endurance 
training was predominantly attributed to the enhanced oxidation of TAG (sum of muscle plus-
lipoprotein-derived TAG), while plasma FA oxidation rates did not change (Schrauwen et al., 2002).  In 
addition, several other studies employing FA tracer methodology are available to substantiate the 
observation that IMTG use during exercise is enhanced following exercise training (Martin et al., 1993; 
Phillips et al., 1996b).  Studies that directly measure IMTG content in muscle biopsies obtained before 
and after exercise also demonstrate that IMTG use during moderate intensity exercise is greater 
following 6 to 12 weeks endurance training (De Bock et al., 2008; Hurley et al., 1986; Van Proeyen et 
al., 2011a; Van Proeyen et al., 2011b), although this is not a universal finding (Bergman et al., 1999; 
Kiens et al., 1993).    In addition, when assessed in a fibre type specific manner, the increase in IMTG 
use appears to be specific to type I fibres, especially when training in the fasted state (De Bock et al., 
2008; Van Proeyen et al., 2011a; Van Proeyen et al., 2011b). However, the consumption of a high-fat 
diet during training may also increase IMTG use in type IIa fibres (Van Proeyen et al., 2011a).  Thus, 
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longitudinal training studies are consistent with acute reports from trained individuals suggesting that 
IMTG use during exercise is enhanced following exercise training.     
 
Enhanced IMTG utilisation during exercise following exercise training may be explained by greater 
expression of enzymes responsible for IMTG hydrolysis and/or an increased capacity for and/or 
efficiency for oxidation of FA liberated from IMTG stores.  In accordance, endurance exercise training 
is associated with an increased expression of ATGL in human skeletal muscle (Alsted et al., 2009; 
Yao-Borengasser et al., 2010), although HSL expression does not appear to be enhanced following 
exercise training in either rats (Enevoldsen et al., 2001) or humans (Alsted et al., 2009).  Probably the 
most well-established adaptation to exercise training is an enhanced skeletal muscle oxidative 
capacity.  This is a logical adaptation to exercise training, given that skeletal muscle oxidative capacity 
correlates with the ability to oxidise fat (Simoneau et al., 1999) and exercise training increases fat 
oxidation (see van Loon, 2004).  Notably, the training-induced increase in oxidative capacity has been 
determined using a number of markers, including the activity of mitochondrial enzymes such as citrate 
synthase and 3-hydroxyacyl-CoA dehydrogenase, protein expression of mitochondrial proteins such 
as cytochrome c oxidase, ex vivo respiration capacity of isolated mitochondria, or point-counting of 
mitochondria from electron microscopy images.  In accordance, protein expression or activity assays 
of mitochondrial enzymes provide a relatively robust measure of oxidative capacity, although they do 
not provide data on the morphology or cellular distribution of mitochondria.  Using electron microscopy 
it is reported that following 10 weeks of endurance training in type 2 diabetes patients and BMI-
matched controls the increase in mitochondrial density occurred predominantly in the subsarcolemmal 
region of the muscle fibre (Nielsen et al., 2010).  Furthermore, endurance training may increase the 
volume of individual mitochondria, and also their proximity to LDs (Tarnopolsky et al., 2007).  This 
adaptation would presumably provide an efficient system in which FA liberated from intracellular LDs 
are efficiently shuttled to the mitochondria to undergo β-oxidation.  Indeed, evidence is available to 
suggest that in trained individuals the mitochondria becomes a ‘reticulum’, such that a number of 
mitochondria form a functional network (Hood, 2001), enabling efficient generation of ATP at all 
cellular locations requiring energy.  Through this mechanism, an increase in mitochondrial density and 
formation of a mitochondrial reticulum reduces the ‘energy stress’ (AMP and ADP production) that is 
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generated at the same exercise intensity, reducing the inhibition placed on the capacity to oxidise fat 
by the glycolytic flux (through the mechanisms discussed in 1.3.3). 
 
Although endurance training consistently enhances skeletal muscle oxidative capacity, mitochondrial 
adaptations to resistance training are less clear.  In accordance, some studies report an increase in 
oxidative capacity following a period of resistance training (Balakrishnan et al., 2010; Pesta et al., 
2011; Tang et al., 2006), whereas others observe no change (Bell et al., 2000; Green et al., 1999), or 
even a decrease (Chilibeck et al., 1999; MacDougall et al., 1979).  The variable findings may be 
attributed to the population studied, training protocol employed, frequency and duration of training, or 
the degree of hypertrophy observed, with less hypertrophy occurring in short interventions and 
interventions with a lighter workload. 
 
(ii) Changes in IMTG concentration following exercise training   
Cross-sectional studies consistently report that endurance trained individuals demonstrate significantly 
higher IMTG concentrations than untrained controls (Amati et al., 2011; Bergman et al., 2010; 
Goodpaster et al., 2001; van Loon et al., 2004).  Furthermore, IMTG use during exercise strongly 
correlates with resting IMTG concentration (Stellingwerff et al., 2007; van Loon et al., 2003).  
Therefore, as endurance training enhances the rate of IMTG utilisation during exercise, the elevated 
IMTG concentration observed in endurance trained athletes should be regarded as a key metabolic 
adaptation to endurance training.  Although the data obtained from cross-sectional studies are clear, 
longitudinal studies employing endurance training interventions are less consistent.  Interestingly, 
some studies report significant increases in IMTG content (Dubé et al., 2008; Dubé et al., 2011; Kiens 
et al., 1993; Phillips et al., 1996b; Pruchnic et al., 2004; Schrauwen-Hinderling et al., 2003; 
Tarnopolsky et al., 2007; Van Proeyen et al., 2011a; Van Proeyen et al., 2010), whereas others report 
either a decrease (Alsted et al., 2009; Bergman et al., 1999; Bruce et al., 2004; Bruce et al., 2006; 
Solomon et al., 2008) or no change (De Bock et al., 2008; Hurley et al., 1986; Meex et al., 2010; Van 
Proeyen et al., 2011b) in IMTG concentration, in both lean and obese insulin-resistant individuals.  
The discrepant findings may be attributed to the population studied, training protocol, diet, and the 
method used for IMTG analysis.   
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Despite the inconsistent findings obtained from longitudinal studies, it is clear that endurance trained 
athletes exhibit large IMTG stores.  However, the expression of IMTG synthesising enzymes, such as 
DGAT1 or GPAT1, does not seem to be upregulated when comparing trained and untrained 
individuals (Amati et al., 2011; Bergman et al., 2010) or following a period of endurance training 
(Alsted et al., 2009).  Interestingly, DGAT1 and GPAT1 protein expression is increased in the period 
following exercise (Schenk and Horowitz, 2007), suggesting that acute upregulation of the IMTG 
synthesising enzymes could at least enhance the maximal capacity for IMTG synthesis in the post-
exercise period, and therefore partly explain the enhanced IMTG concentration associated with 
regular exercise training.  It is also important to acknowledge that an increase in the protein content of 
FAT/CD36 following exercise training (Perry et al., 2008; Talanian et al., 2010) could enhance the 
maximal capacity for uptake of FA into skeletal muscle, thereby delivering FA for an increase in IMTG 
synthesis.  However, as FAT/CD36 mediates passive diffusion of FA into skeletal muscle, the rate of 
FA uptake will also depend on the FA concentration gradient between arterial blood and skeletal 
muscle.  Taken together, these observations demonstrate that an increase in IMTG concentration will 
only occur when substrate concentration and enzyme activation is optimal. 
   
It is also worth noting that ET enhances the expression of the rate-limiting enzyme responsible for the 
conversion of saturated FAs into monounsaturated FAs, known as steroyl-CoA desaturase-1 (SCD-1).  
Indeed, 6 weeks of ET increased both the mRNA and protein expression of SCD-1 in soleus muscle of 
rodents (Dobrzyn et al., 2010).  In human skeletal muscle, SCD-1 protein expression is upregulated 
following an acute bout of exercise (Schenk and Horowitz, 2007), suggesting that desaturation of 
incoming FAs is a key process during post-exercise IMTG resynthesis.  Furthermore, endurance 
trained athletes demonstrate elevated SCD-1 mRNA expression compared to sedentary controls 
(Bergman, 2010).  Given that saturated FA metabolites have recently been proposed to be important 
in the development of insulin resistance (Bergman et al., 2012; Bergman et al., 2010; van Hees et al., 
2011), enhancing SCD-1 expression may play a key role in maintaining lower concentrations of 
saturated FA metabolites.  
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(iii) Improved insulin sensitivity following exercise training is associated with an enhanced rate 
of IMTG turnover 
An increased rate of IMTG turnover is proposed to be associated with improved insulin sensitivity 
following exercise training.  Notably, ET increases the protein expression and/or activity of the lipolytic 
enzymes (ATGL and HSL), thereby facilitating greater rates of IMTG lipolysis (Alsted et al., 2009; Yao-
Borengasser et al., 2010).  Furthermore, ET enhances skeletal muscle mitochondrial density, 
providing a greater capacity to oxidise FAs liberated from IMTG as a substrate source during 
moderate-intensity exercise (see van Loon, 2004).  In addition, ET increases the capacity for FA 
uptake by augmenting FAT/CD36 protein expression (Perry et al., 2008; Talanian et al., 2010), and in 
the period following a bout of exercise the protein expression and/or activity of the lipogenic enzymes 
(DGAT1 and GPAT1) is increased (Schenk and Horowitz, 2007), leading to replenishment of the IMTG 
stores.  Therefore, during a period of prolonged ET involving repeated bouts of endurance-type 
exercise, it is likely that the activity of the processes liberating FA (IMTG lipolysis and FA uptake) and 
the activity of those processes that consume FA (IMTG synthesis and mitochondrial β-oxidation) 
remain continuously elevated.  Consequently, the concentration of FA metabolites, such as DAGs and 
ceramides, remains low and therefore it is postulated that a high IMTG turnover rate contributes to the 
ET-induced improvement in insulin sensitivity (Moro et al., 2008; Shaw et al., 2010; van Loon and 
Goodpaster, 2006).  This hypothesis is supported by the observation that 16 weeks ET in overweight 
non-diabetic individuals improves insulin sensitivity in line with a reduction in the concentration of DAG 
and ceramide (Dubé et al., 2008; Dubé et al., 2011).  In lean sedentary individuals, a common 
adaptation to short term ET (< 12 weeks) is an increase in IMTG content concomitant with improved 
insulin sensitivity (Phillips et al., 1996b; Van Proeyen et al., 2010).  It should be noted, however, that 
improved insulin sensitivity following exercise training is not always accompanied by significant IMTG 
accretion.  In this regard, 12 weeks of exercise training in type 2 diabetes patients did not increase 
IMTG concentration, although insulin sensitivity was enhanced (Meex et al., 2010).  Thus, it is 
postulated that in sedentary populations who exhibit large pre-training IMTG concentrations, exercise 
training resets the balance between IMTG synthesis and IMTG hydrolysis, leading to a decrease in FA 
metabolites at a higher range of IMTG concentrations (Shaw et al., 2010; van Loon and Goodpaster, 
2006). 
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1.6.4 Use of high intensity interval training to improve metabolic health 
High intensity interval training (HIT) is defined as brief, intermittent bursts of vigorous exercise, 
interspersed by periods of rest or active recovery (low intensity exercise).  Interestingly, when work- or 
energy expenditure-matched to traditional endurance-type exercise it has been reported that HIT can 
induce similar, if not superior, improvements in performance and metabolic health parameters in both 
healthy and diseased populations (Tjonna et al., 2009; Wisloff et al., 2007).  Furthermore, HIT is 
perceived to be more enjoyable than traditional endurance training at least in young active males  
(Bartlett et al., 2011), and therefore taken together it appears that HIT provides a viable alternative to 
more traditional forms of exercise training. 
 
The physiological and metabolic benefits of HIT have been reported in studies employing a number of 
different forms of HIT.  In this respect, high intensity aerobic interval training, which requires subjects 
to perform 10 x 4 min exercise at 90% VO2 max interspersed with 2 min rest, is reported to improve 
oxidative capacity, protein expression of the fat and glucose transporter proteins, and rates of fat 
oxidation during steady state exercise in untrained males and females (Perry et al., 2008; Talanian et 
al., 2007).  A different method of high intensity aerobic interval training was pioneered by Wisløff and 
colleagues, in which subjects performed ~4 x 4 min exercise at 90-95% HRmax interspersed with 3 min 
active recovery,
 
and has been extensively applied to a variety of patient populations (Moholdt et al., 
2009; Rognmo et al., 2004; Schjerve et al., 2008; Tjonna et al., 2008; Tjonna et al., 2009; Wisloff et 
al., 2007).  This approach practiced for 4 to 12 weeks led to improvements in aerobic capacity, 
endothelial function, body composition, blood pressure, and insulin sensitivity, and reversed left 
ventricular remodelling in overweight and obese individuals, as well as those recovering from heart 
failure or coronary artery bypass (Moholdt et al., 2009; Rognmo et al., 2004; Schjerve et al., 2008; 
Tjonna et al., 2008; Tjonna et al., 2009; Wisloff et al., 2007).  Furthermore, the beneficial adaptations 
to high intensity aerobic interval training were often more pronounced and longer-lasting than those 
observed using more traditional exercise approaches (Moholdt et al., 2009; Tjonna et al., 2009).   
 
Gibala and colleagues established an alternative approach to HIT (known as sprint interval training, 
SIT) which was based on a Wingate test, and requires subjects to perform repeated 30 s ‘all out’ effort 
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cycling exercise against a supra-maximal resistance.  During one session subjects perform 4-6 
Wingate tests, separated by ~4 min rest, which equates to 2-3 min exercise over a 20-30 min period.  
This research group initially demonstrated that just 6 sessions of SIT over a 2 week period improved 
skeletal muscle oxidative capacity, as measured by enhanced activity and/or protein expression of 
mitochondrial enzymes (Burgomaster et al., 2005; Gibala et al., 2006), a finding that has since been 
replicated over 6 weeks of HIT (Burgomaster et al., 2007; Burgomaster et al., 2006; Burgomaster et 
al., 2008).  Most notably, when compared to traditional endurance training consisting of moderate-
intensity cycling for 40-60 min, 5 times per week for 6 weeks, it appears that the magnitude of 
improvement in skeletal muscle oxidative capacity is similar to that observed following 6 weeks of SIT 
(Burgomaster et al., 2008).  In addition, similar increases in resting glycogen content, whole-body fat 
oxidation during steady state exercise, and time trial performance were also observed (Burgomaster et 
al., 2008).  Furthermore, several studies have reported improvements in insulin sensitivity following 2 
weeks of SIT in sedentary lean or overweight individuals (Babraj et al., 2009; Richards et al., 2010; 
Whyte et al., 2010).  Importantly, this form of HIT requires one fifth of the time commitment, and a 
~90% lower weekly training volume, compared to traditional endurance training.  Given that the most 
commonly cited barrier to participating in regular exercise is a “lack of time” (Stutts, 2002), the 
observation that SIT and ET induce similar physiological and metabolic adaptations has clear 
implications for exercise prescription.  
 
Despite the potency of Wingate-based SIT to stimulate beneficial metabolic adaptations, it does 
require specialized equipment, high levels of motivation and may induce nausea during the initial 
sessions of the training programme, suggesting that it may not be tolerable or appealing for all people.  
Consequently, Gibala and colleagues established a new ‘constant-load’ HIT protocol, which requires 
subjects to perform 8-12 60s bouts of cycling at a constant workload which equates to ~90% HRmax, 
interspersed with 60s rest (Little et al., 2010).  Notably, 2 weeks of ‘constant-load’ HIT induced 
significant improvements in skeletal muscle oxidative capacity (Little et al., 2010).  This adaptation 
may be, in part, due to greater mRNA and protein expression of peroxisome-proliferator activated 
receptor γ coactivator (PGC)-1α, which is considered the ‘master regulator’ of mitochondrial 
biogenesis, following HIT (Little et al., 2011a; Little et al., 2011b; Little et al., 2010).  Improvements in 
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insulin sensitivity have also been reported following 2 weeks of ‘constant-load’ HIT in overweight 
individuals (Hood et al., 2011).  In addition, a recent study has reported that 2 weeks of ‘constant-load’ 
HIT in type 2 diabetes patients significantly reduced postprandial glucose excursions and 24 h 
average blood glucose concentrations, as assessed using continuous glucose monitoring (Little et al., 
2011a).  Furthermore, HIT improved skeletal muscle oxidative capacity and increased GLUT4 protein 
expression (Little et al., 2011a).  Taken together, it appears that HIT provides a practical alternative to 
traditional ET to improve physiological and metabolic health in both a healthy and a diseased 
population. 
 
Although it is becoming clear that HIT enhances insulin sensitivity in a number of populations, how this 
compares to ET remains to be examined.  Furthermore, HIT studies have so far focused on glucose 
metabolism to explain how this training mode enhances insulin sensitivity, although it is clear that lipid 
metabolism is also a key determinant of insulin action in skeletal muscle.  Therefore, further research 
is required to elucidate the impact of HIT on the relationship between skeletal muscle lipid metabolism 
and insulin sensitivity. 
 
1.7 Thesis overview 
Chapter 1 provides an overview of how a sedentary lifestyle leads to the development of insulin 
resistance and other metabolic disorders, and outlines the effectiveness of regular exercise training as 
a therapeutic tool to improve skeletal muscle insulin sensitivity and reduce the risk of developing type 
2 diabetes.  In addition, the introductory chapter identifies a number of gaps in our knowledge which 
require further investigation and have been chosen as the topics of the experimental chapters.  To this 
end, the studies in this thesis were designed to generate new knowledge on the role of PLIN2 and 
PLIN5 in skeletal muscle, and also to investigate the effect of acute exercise or various exercise 
training modes on IMTG metabolism and insulin sensitivity. 
 
Section 1.3.3 of the introduction concluded that PLIN2 is reported to play a regulatory role in TAG 
lipolysis in cultured cells, although the precise role of PLIN2 in skeletal muscle remains to be 
elucidated.  Chapter 2 therefore aimed to generate novel data to support the theory that PLIN2 also 
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plays a regulatory role in IMTG lipolysis.  To this end, Chapter 2 investigated the hypothesis that 
PLIN2-containing LDs are preferentially targeted for breakdown during exercise.  To test this 
hypothesis, the effect of a single bout of moderate-intensity cycling exercise on the colocalisation 
between PLIN2 and IMTG using immunofluorescence microscopy methods was investigated. 
 
In section 1.6.3 it was explained that ET alters the balance between IMTG synthesis and hydrolysis 
such that a net increase in IMTG concentration occurs concomitant with improved insulin sensitivity.  
However, at this time no studies had examined the impact of prolonged ET on PLIN2 protein 
expression in skeletal muscle.  Chapter 3 therefore investigated the hypothesis that ET in type 2 
diabetes patients would preferentially augment PLIN2 protein expression in type I muscle fibres.  
Given that the results of Chapter 2 suggest the PLIN2 association with IMTG plays a role in the 
utilisation of IMTG during endurance-type exercise, it was expected that PLIN2 expression would be 
enhanced following ET. 
 
Like PLIN2, PLIN5 has also been implicated in the regulation of TAG hydrolysis in cultured cells in 
vitro (Wang et al., 2011a; Wang et al., 2011b), although whether a similar function exists in skeletal 
muscle remains to be elucidated.  Furthermore, the use of sprint interval training (SIT) as a time-
efficient training strategy to induce positive metabolic adaptations has recently received much interest, 
although whether changes in IMTG metabolism occur following SIT remains unknown.  Therefore, 
Chapter 4 first investigated the hypothesis that both PLIN2 and PLIN5 play a role in the well-
established increase in IMTG breakdown during exercise following ET in sedentary young men.  
Chapter 4 also aimed to establish whether SIT also enhances IMTG breakdown during moderate-
intensity exercise and increases the protein expression of PLIN2 and PLIN5. 
Chronic resistance training induced qualitative changes in skeletal muscle that are responsible for the 
observed improvements in insulin sensitivity.  However, whether the improvements in IMTG 
metabolism that contribute to ET-induced increases in insulin sensitivity also occur following RT has 
not yet been investigated.  Chapter 5 therefore investigated whether RT augments IMTG content and 
mitochondrial density, and enhances IMTG breakdown during endurance-type exercise concomitant 
with improvements in insulin sensitivity.  It was hypothesised that repeated bouts of resistance 
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exercise undertaken during a RT programme would result in a net increase in IMTG content and 
enhance the capacity for IMTG breakdown during exercise. 
 
In Chapter 4 it was shown that SIT was an effective training mode to enhance IMTG content and 
IMTG breakdown during exercise concomitant with improved insulin sensitivity.  In Chapter 6, a pilot 
study was conducted to investigate the effects of a new, more practical and time-efficient constant-
workload SIT strategy.  The effect of this protocol was investigated with regards to IMTG content, 
PLIN2 and PLIN5 protein expression, and oxidative capacity, and whether changes in these variables 
translated in an improved aerobic capacity, insulin sensitivity, and cardiovascular risk profile, in a 
group of young, previously sedentary obese males.  It was hypothesised that 4 weeks constant-load 
SIT would elicit an enhanced IMTG content, PLIN2 and PLIN5 protein expression, and oxidative 
capacity, and that these changes would mirror improvements in insulin sensitivity and cardiovascular 
risk profile. 
 
Chapter 7 (general discussion) summarises the main findings and conclusions generated by the 
experimental chapters.  Based on these findings, and together with data reported in the most recent 
literature, a number of future experiments aiming to generate new information on the mechanisms 
underlying the improvements metabolic health following exercise training are suggested. 
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Chapter 2 
 
Preferential utilisation of perilipin 2 associated 
intramuscular triglycerides during one hour of 
moderate intensity endurance-type exercise 
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2.1 Abstract 
The lipid droplet (LD)-associated protein perilipin 2 (PLIN2) appears to colocalise with LDs in human 
skeletal muscle fibres, although the function of PLIN2 in the regulation of intramuscular triglyceride 
(IMTG) metabolism is currently unknown. Here we investigated the hypothesis that the presence of 
PLIN2 in skeletal muscle LDs helps to increase lipolysis during exercise. We, therefore, measured 
exercise-induced changes in IMTG and PLIN2 distribution and changes in their colocalisation. Muscle 
biopsies from the vastus lateralis were obtained from 7 lean, untrained males (22±2 years, BMI 
24.2±0.9 kg.m-2, VO2peak 3.35±0.13 L.min-1) before and after 1 h of moderate intensity cycling at ~65% 
VO2peak. Cryosections were stained for perilipin 2, IMTG, and myosin heavy chain type I and viewed 
using widefield and confocal fluorescence microscopy. Exercise induced a 50±7% decrease in IMTG 
content in type I fibres only (P<0.05) but no change in PLIN2 content. Colocalisation analysis showed 
that the fraction of PLIN2 associated with IMTG was 0.67±0.03 before exercise, which was reduced to 
0.51±0.01 post-exercise (P<0.05). Further analysis revealed that the number of PLIN2-associated LDs 
was reduced by 31±10% after exercise (P<0.05), whereas the number of PLIN2-null LDs was 
unchanged. No such changes were seen in type II fibres. In conclusion, this study shows that PLIN2 
content in skeletal muscle is unchanged in response to a single bout of endurance exercise. 
Furthermore, the PLIN2 and IMTG association is reduced post-exercise, apparently due to preferential 
utilisation of PLIN2-associated LDs. These results confirm the hypothesis that the PLIN2 association 
with IMTG is related to the utilisation of IMTG as a fuel during exercise. 
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2.2 Introduction   
Lipid droplets (LDs) are storage depots for sequestered fatty acids and are important in maintaining 
energy homeostasis within cells, especially when energy provisions are low or an increase in energy 
consumption occurs. The current view suggests that LDs are a dynamic cellular organelle with a 
variety of functions (for recent reviews see (Beller et al., 2010b; Ducharme and Bickel, 2008; Fujimoto 
et al., 2008; Guo et al., 2009), due to the distinct array of proteins that have been found to be 
associated with the phospholipid monolayer of the LD. The most well recognised are the PAT proteins 
(Perilipin, ADRP/adipophilin, TIP-47, S3-12 and OXPAT, referred to in this paper as perilipin 1, 2, 3, 4, 
and 5, (Kimmel et al., 2010). Perilipin 1 is the most well-characterized protein and is reported to be 
exclusively expressed in adipocytes and steroidogenic cells (Londos et al., 1995). Its expression is 
linked to triacylglycerol (TAG) accumulation, with suggestions made that it regulates the activity of 
lipolytic enzymes, such as hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) 
(Granneman et al., 2007; Wang et al., 2009). Perilipin 2 (PLIN2) was originally discovered as an early 
marker of adipocyte differentiation, although it is now known to be expressed in other tissues, 
including skeletal muscle (Brasaemle et al., 1997). It is suggested that PLIN2, like perilipin 1, serves to 
increase the storage of TAG, decreasing TAG turnover through a reduction of lipolytic rates, which is 
supported by evidence from PLIN2 overexpression in murine fibroblasts and PLIN2 loss of function 
studies in AML12 cells (Bell et al., 2008; Imamura et al., 2002). In particular, PLIN2 expression has 
been shown to decrease the association of ATGL with LDs in non-adipose cell lines leading to 
reduced rates of lipolysis under basal conditions (Listenberger et al., 2007; Wang et al., 2011a). In 
skeletal muscle, little is known about the function of PLIN2 with regards to the regulation of IMTG 
metabolism, both at rest and during exercise. 
 
LDs in skeletal muscle provide a readily available store of energy during exercise in endurance-trained 
athletes, a view that is supported by studies measuring IMTG turnover using metabolic tracers 
(Sacchetti et al., 2002; van Loon et al., 2003). In addition, reductions in IMTG content during 
prolonged (~2 h duration) endurance exercise have consistently been observed using magnetic 
resonance spectroscopy (~30% decrease) (Brechtel et al., 2001; Decombaz et al., 2000; Decombaz et 
al., 2001) and fluorescence microscopy techniques (~60%) (De Bock et al., 2005; van Loon et al., 
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2003). Fluorescence microscopy permits fibre type-specific observations to be made, and studies 
employing this technique have demonstrated that the reduction in IMTG after an acute exercise bout 
occurs exclusively in type I muscle fibres (De Bock et al., 2005; van Loon et al., 2003). 
 
A recent study from our laboratory has described a fibre type-specific distribution of PLIN2, where 
there is a two-fold greater concentration of PLIN2 in type I muscle fibres of trained individuals (Shaw 
et al., 2009). This observation underlines the importance of acknowledging fibre type when 
investigating IMTG metabolism (van Loon et al., 2003; Watt et al., 2002b). In addition, approximately 
60% of IMTG are found to colocalise with PLIN2 (Shaw et al., 2009), suggesting that the IMTG pool is 
heterogenous with regard to their protein composition. These observations offer a unique opportunity 
to investigate the role of PLIN2 content and LD association in the regulation of IMTG metabolism in 
skeletal muscle during exercise. In this study we therefore aim to investigate the hypothesis that the 
PLIN2 association with IMTG is related to IMTG utilisation during an acute bout of endurance 
exercise.  
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2.3 Methods 
 
Subjects and pre-experimental testing 
Seven lean, untrained males (22 ± 2 years, BMI 24.2 ± 0.9 kg.m-2) (see Table 2.1 for characteristics) 
volunteered to take part in the study, which was approved by the Black Country NHS Research Ethics 
Committee (West Midlands, UK) and conformed with the Declaration of Helsinki. Written, informed 
consent was obtained from volunteers following a verbal and written explanation of the nature and 
risks involved in the experimental procedure. A general health questionnaire assessed all participants 
as healthy but all engaged in less than two 30 min sessions of physical activity per week in the 
preceding year. At least one week prior to the experimental trial all participants performed a 
progressive exercise test to exhaustion on an electronically braked cycle ergometer in order to 
determine peak oxygen uptake (VO2 peak) using an on-line gas collection system (Oxycon Pro, Jaeger, 
Germany). Briefly, subjects initially cycled at 95 W for 3 minutes after which the workload was 
increased by 35 W every 3 minutes until subjects could not maintain a cadence of > 50 rpm, at which 
point the test was terminated. VO2peak was taken as the highest value obtained in the last 30-seconds 
of the test. A workload equivalent to 65% VO2peak was calculated and used during the experimental 
trial. Body composition was analysed using Dual X-ray Absorptiometry (DXA). QDR software (Hologic 
Inc., Beford, MA) was used to analyse fat mass and fat-free mass. Relative fat mass was calculated 
using absolute fat mass as a proportion of total mass. 
 
Study protocol 
On the day of the experimental trial, subjects arrived at the laboratory after an overnight fast (> 10 h) 
to complete a 60 min cycle ride at ~65% VO2peak. Prior to and immediately following the exercise bout 
a muscle biopsy was taken from the vastus lateralis. Briefly, 1% lidocaine (~5 ml) was applied to the 
skin and fascia of the muscle, after which two small incisions were made approximately 2 cm apart. A 
muscle biopsy (~100 mg) was taken from the distal incision using the Bergström needle technique. 
The leg from which the biopsy was taken was randomised in order to counter any bias of the dominant 
limb. A portion of the muscle sample was immediately dissected free of any fat and connective tissue, 
embedded in Tissue-Tek OCT Compound (Sakura Finetek Europe, The Netherlands) and frozen in 
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liquid nitrogen-cooled isopentane. The remaining muscle tissue (~40mg) was immediately snap-frozen 
in liquid nitrogen.  Subjects cycled on an electronically braked cycle ergometer for 60 min (at ~65% 
VO2peak) maintaining a constant cadence throughout. Heart rate was recorded every 5 minutes, and 
gas collection (5 min collection period) was performed at 15 minute intervals (t = 15, 30, 45, 60 min) 
using an on-line gas collection system (Oxycon Pro, Jaeger, Germany), in order to determine rates of 
carbohydrate and fat oxidation. A second muscle biopsy was taken immediately post-exercise from 
the proximal incision.  Whole body rates of carbohydrate and fat oxidation were estimated from VO2 
and VCO2 values, using the equations used by Jeukendrup and Wallis (Jeukendrup and Wallis, 2005). 
 
Three days prior to the experimental trial, all subjects were requested to refrain from vigorous physical 
activity, as well as avoid excessive alcohol or caffeine intake. In addition, subjects were provided with 
all food and drinks to be consumed in the 24 h preceding the experimental trial. The diet was of a 
standard macronutrient composition (50% CHO, 35% fat, 15% protein), but adjusted for each 
individuals habitual caloric intake, assessed through the completion of a 3 day weighed-intake diet 
diary. 
 
Muscle samples analysis 
Immunofluorescence staining: Serial 5 µm sections were cut at -30°C on to plain glass slides and left 
for a maximum of 1 h to air dry prior to treatment. Sections of 5 µm thickness were chosen in order to 
reduce the background signal from out of focus light which improves the quality of image analysis. 
Paired samples (pre and post-exercise) were mounted on to the same slide to reduce the variation in 
staining intensity between sections. Slides were fixed in 3.7% formaldehyde for 1 h, rinsed 3x30 s in 
deionised water, followed by permeabilisation in 0.5% Triton-X 100 for 5 min. After washing slides in 
PBS for 3x5 min, sections were incubated with appropriate primary antibodies for 45 min. Following a 
further 3x5 min PBS wash, sections were incubated with appropriately targeted secondary fluorescent 
conjugated antibodies for 30 min. To visualise IMTG, the well-established neutral lipid dye oil red O 
staining protocol in combination with immunofluorescence was used (Koopman et al., 2001). In this 
respect, oil red O solution was applied to washed (3x5 min PBS) sections for 30 min following 
secondary antibody incubation. Slides were finally rinsed 3x30 s in deionised water followed by a 10 
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min rinse with slow running tap water, after which coverslips were mounted with a glycerol and mowiol 
4-88 solution in 0.2 M Tris buffer (pH 8.5) (including 0.1% DABCO anti-fade medium). 
 
Fibre type determination was undertaken through incubation of muscle sections with mouse anti-
myosin for slow twitch fibres (A4.840-c, DSHB, University of Iowa, US, developed by Dr. Blau) 
followed by the application of Alexa Fluor goat-anti mouse IgM 488. Positively stained fibres were 
classified as type I fibres, and those with no staining were classified as type II fibres. As a marker of 
the cell border, the basal lamina was visualised by first incubating sections with a mouse anti-collagen 
type IV antibody (M3F7, DSHB, University of Iowa, US, developed by Dr. Furthmayr), followed by 
treatment with Alexa Fluor goat anti-mouse IgG1 350. A working solution of oil red O was freshly 
produced for each staining procedure and consisted of 100 mg oil red O in 20 ml 60% 
triethylphosphate (Sigma-Aldrich, UK). Twelve ml of working solution was added to 8 ml deionised 
water and filtered twice to remove any oil red O crystals. PLIN2 was visualised using a monoclonal 
mouse anti-ADRP antibody (American Research Products, USA), followed by treatment with either 
Alexa Fluor GAMIgG1 488 (for co-staining with IMTG) or Alexa Fluor GAMIgG1 594 (for co-staining 
with MHC I). Control slides were included where the appropriate secondary antibody for PLIN2 (Alexa 
Fluor GAMIgG1 488) or oil red O was omitted in order to confirm the absence of non-specific staining 
and/or bleed through into the opposing channel (Scriven et al., 2008). The specificity of the PLIN2 
antibody was confirmed in a competition experiment where a PLIN2 recombinant peptide (Genway 
Biotech, Inc, CA, USA) was incubated with the primary antibody, and subsequently the positive 
fluorescent signal for PLIN2 was removed (Fig. 2G and H). In addition, immunoblot analysis of human 
skeletal muscle using the PLIN2 antibody revealed a band at ~50 kDa (Fig. 2I), in accordance with the 
previously identified molecular weight (Brasaemle et al., 1997). 
 
Image capture, processing and data analysis: Images of cross-sectional orientated fibres for the fibre 
type-specific determination of IMTG and PLIN2 content were captured using a widefield Nikon E600 
microscope with a 40x 0.75 NA objective, coupled to a SPOT RT KE colour 3 shot CCD camera 
(Diagnostic Instruments Inc., MI, USA). Both DAPI UV (340-380 nm) and FITC (465-495 nm) 
excitation filters were used to view the Alexa Fluor 350 and 488 fluorophores, respectively. In addition, 
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a Texas red (540-580 nm) excitation filter was used to view sections stained with oil red O or the Alexa 
Fluor 594 fluorophore. The use of 3 excitation filters and I dichroic and 1 emission filter (“Pinkel” Triple 
Set, Semrock, Kettering, UK) allowed for semi-automated sequential image capture. Digital images to 
specifically assess the size of IMTG and PLIN2 containing droplets, as well as the colocalisation of 
IMTG and PLIN2, were obtained using an inverted confocal microscope (Leica DMIRE2, Leica 
Microsystems) using a 63x 1.4 NA oil immersion objective. An argon laser was used to excite the 
Alexa Fluor 488 fluorophore, while both the Alexa Fluor 594 fluorophore and oil red O was excited 
using a Helium-Neon laser.   
 
Image processing was undertaken using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA).  
An intensity threshold was uniformly selected to represent positive signal for IMTG and PLIN2 
identification. Widefield images were used to assess fibre-type specific content of both IMTG and 
PLIN2.  Accordingly, between 6 and 10 widefield images were used per muscle section, resulting in a 
total of 98 ± 8 fibres analysed per muscle cross-section (39 ± 6 type I fibres, 59 ± 9 type II fibres). 
IMTG and PLIN2 content was expressed as the percentage of the total fibre area positively stained. 
Images captured using confocal microscopy were used to identify changes in mean LD size and 
density.  Mean LD size was calculated by dividing the total number of objects by the total area stained.  
As there were no detectable changes in the relative lipid area stained in type II fibres, only type I fibres 
were used when assessing changes in LD area. Images of PLIN2 were also captured in the texas red 
channel (when using the Alexa Fluor GAMIgG1 488 secondary antibody) in order to confirm there was 
no bleed through of the positive signal for PLIN2.  
 
For colocalisation analysis of PLIN2 and IMTG, sequential images captured using confocal 
microscopy at 8x digital magnification were used. Positive signal for IMTG and PLIN2 was identified 
through the selection of a uniform intensity threshold. Based on these thresholds, binary images were 
generated for both IMTG and PLIN2, which were subsequently used for colocalisation analysis using 
Image-Pro Plus 5.1 software. A binary image was created to define the overlapping area between the 
IMTG and PLIN2 images. The total number of overlapping objects was expressed relative to the total 
number of PLIN2 objects, as a measure of colocalisation (Fig. 3). No signal above the threshold was 
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detected in the opposing channel for each negative control. In order to determine whether the degree 
of colocalisation observed was statistically different from that expected for a random distribution, we 
generated a series of randomized images from non-corresponding images of IMTG and PLIN2. In this 
respect, each PLIN2 image was randomly assigned to an IMTG image under the same experimental 
conditions, thus preserving the spatial and intensity distribution of the objects, but removing the 
correlation between the green and red images (Fig. 3).  Consequently it was found that the degree of 
colocalisation occurring by chance (random distribution) was far less than that observed when using 
actual images (Fig. 4).   
 
Western blot analysis: Snap frozen muscle tissue was powdered in liquid nitrogen and mixed on ice 
for 2 hours in eppendorf tubes containing lysis buffer (1x RIPA buffer, Cell Signalling, including 1 
complete mini protease inhibitor tablet, Roche Diagnostics, Germany) followed by homogenization for 
~30 s at slow speed (Polytron) and centrifugation for 20 min at 4°C and 10,000 G.  The supernatant 
was removed and a small portion used to determine protein concentration (Pierce BCA assay kit).  
Samples were subsequently diluted to a final concentration of 3 µg.µl-1, and equal quantities of protein 
(45 µg) were separated by electrophoresis on 12% SDS-polyacrylamide gels and transferred to 
nitrocellulose membranes at 25 V for 1.5 hours.  Ponceau S staining was performed to assess transfer 
efficacy and subsequently imaged using a ChemiDoc XRS+ system (Bio-Rad, UK).  This image was 
used to quantify the total protein stain of each lane, and this was used as a measure of equal loading 
when the inter-lane variation was less than 10%.  Membranes were subsequently blocked for 1 h in 
5% non-fat dried milk (NFDM) in phosphate-buffered saline with 0.1% Tween (PBST) followed by 
incubation overnight at room temperature with an anti-adipophilin (American Research Products, MA, 
USA) antibody diluted in 3% NFDM in PBST.  The membranes were then washed (3 x 5 min PBST), 
blocked in 5% NFDM for 1 h, followed by incubation for 1 h at room temperature with appropriate 
horseradish peroxidase-conjugated IgG secondary antibodies diluted in 3% NFDM in PBST.  Antibody 
binding was detected using enhanced chemiluminescence HRP detection reagent (GE Healthcare, 
UK) and imaging and band quantification was performed using a ChemiDoc XRS+ system (Bio-Rad, 
UK). 
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Statistics 
All data are expressed as means ± S.E. To identify significant fibre type and time differences for IMTG 
and PLIN2, we applied a repeated measures analysis of variance (ANOVA), with the within subject 
factors as fibre type and time. This analysis was also applied to measure significant changes in IMTG 
and PLIN2 colocalisation, but also included the between subject factor as image type (i.e. actual or 
randomised). A paired t-test was applied to measure significant differences between IMTG and PLIN2 
object density and size, before and after exercise. In order to investigate specific relationships 
between variables, a simple linear regression analysis was used.  Significance was set at the 0.05 
level of confidence. 
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Table 2.1. Subject Characteristics 
Age (yrs) 22 ± 2 
Height (m) 1.78 ± 0.01 
Body mass (kg) 76.7 ± 3.1 
BMI (kg.m-2) 24.2 ± 0.9 
VO2 peak (l.min-1) 3.35 ± 0.13 
Wmax (W) 235 ± 13 
Basal plasma glucose (mmol.1-1) 5.4 ± 0.2 
2h OGTT glucose (mmol.l-1) 6.4 ± 0.6 
FFM (kg) 54.3 ± 1.8 
FM (kg) 13.3 ± 1.4 
 
 
Data provided are means ± S.E. (n = 7).  BMI body mass index, Wmax maximum workload, OGTT oral 
glucose tolerance test, FFM free fat mass, FM fat mass. 
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2.4 Results 
 
Substrate Oxidation 
Carbohydrate and fat oxidation rates during the 60 min constant load cycle at 66 ± 2% VO2 peak (53 ± 
3% Wmax) are shown in Table 2.2. Fat oxidation increased over the cycling bout, such that absolute fat 
oxidation was significantly increased at 30, 45 (P < 0.05), and 60 min (P < 0.01) compared to the 
value obtained at 15 min, while no changes in absolute carbohydrate oxidation were observed. In 
addition, RER was significantly reduced at 45 (P < 0.05) and 60 min (P < 0.01) compared to RER at 
15 min.   
 
IMTG and PLIN2 content 
Pre-exercise, IMTG content (expressed as the % of the total fibre area positively stained) was greater 
in type I fibres compared to type II fibres (type I 3.80 ± 0.41, type II 0.74 ± 0.10, P < 0.001, Fig. 2.1G). 
Similarly, an approximately two-fold greater concentration of PLIN2 was found in type I fibres relative 
to type II fibres (type I 1.92 ± 0.20, type II 0.87 ± 0.02, P = 0.005, Fig. 2E). 
 
Cycling at ~65% VO2peak for 60 min induced a 50 ± 7% decrease in IMTG content in type I fibres only 
(pre 3.80 ± 0.41%, post 1.90 ± 0.39%, P < 0.001, Fig. 2.1G). Using confocal images, it was 
determined that the reduction was accounted for by both a 50 ± 9% decrease in LD density (pre 0.043 
± 0.010, post 0.022 ± 0.006 LDs.µm-2, P = 0.042) and an 11 ± 4% decrease in LD size (pre 0.58 ± 
0.02, post 0.52 ± 0.03 µm2, P = 0.012). No significant change in IMTG content was observed in type II 
fibres post-exercise (P = 0.331).  PLIN2 content was unchanged after 60 min steady state cycling in 
both type I fibres (pre 1.92 ± 0.20%, post 1.78 ± 0.18%, P = 0.192, Fig. 2.2E) and type II fibres (pre 
0.87 ± 0.02%, post 0.74 ± 0.07%, P = 0.228). Accordingly, no significant changes in PLIN2 density 
(pre 0.032 ± 0.003, post 0.033 ± 0.006 PLIN2.µm-2, P = 0.736) were observed.  PLIN2 content, 
quantified through immunoblotting of whole muscle homogenates, also remained unchanged following 
exercise, and showed a strong positive correlation with mixed muscle PLIN2 content (when type I and 
type II fibres were pooled) determined from immunofluorescence images (R = 0.61, P = 0.018, Fig. 
2.2F). The IMTG content at rest positively correlated with IMTG breakdown during exercise (R = 0.86, 
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P < 0.001).  In addition, a positive correlation was observed between resting IMTG content and PLIN2 
content (R = 0.69, P = 0.01).  As a result, PLIN2 content was positively associated with IMTG 
breakdown during exercise (R = 0.55, P = 0.044) when type I and type II fibres were pooled. 
 
IMTG and PLIN2 association 
In the first instance, colocalisation was measured by expressing the number of overlapping objects 
relative to the total number of PLIN2 objects. Pre-exercise, the fraction of PLIN2 associated with IMTG 
was similar in type I and type II fibres (0.67 ± 0.03, 0.59 ± 0.04, respectively; P = 0.906), and this was 
significantly different from the fraction obtained between randomised images (0.10 ± 0.02, P < 0.001). 
To this end, the fraction of IMTG associated with PLIN2 prior to exercise was 0.71 ± 0.02 and 0.67 ± 
0.05 in type I and type II fibres respectively (P = 0.673, Figs. 2.3A-D and 2.4). In response to exercise, 
the association of PLIN2 and IMTG in type I fibres was reduced by 24 ± 4% (P = 0.001, Fig. 2.3E-H 
and 2.4), whereas no significant changes were observed in type II fibres. Thus, post-exercise the 
fraction of PLIN2 associated with IMTG was 0.51 ± 0.01. Furthermore, a significant difference between 
actual and randomised images was obtained (P < 0.001, Fig. 2.4A), indicating that any changes 
occurring in response to the exercise were ‘true’ changes, and did not occur by chance. As a change 
in PLIN2 association with IMTG was observed in response to exercise, we next investigated the 
number of LDs either associated (PLIN2-LD) or not associated (PLIN2-null-LD) with PLIN2, both 
before and after exercise. Pre-exercise, there was a significant difference between the number of 
PLIN2-LD (0.165 ± 0.012 LD.µm-2) compared to the number of PLIN2-null-LD in type I fibres (0.110 ± 
0.012 LD.µm-2, P = 0.001, Fig. 2.5A). Post-exercise, the number of PLIN2-LD was reduced by 31 ± 
10% (P = 0.02), while the number of PLIN2-null-LD was unchanged in type I fibres (P = 0.621, Fig. 
2.5A).  In accordance, the quantity of PLIN2 not associated with IMTG was increased post-exercise in 
type I fibres (P = 0.023, Fig. 2.5B). The number of PLIN2-LD, PLIN2-null-LD and the quantity of PLIN2 
not associated with IMTG was significantly different between type I and type II fibres (P < 0.001), but 
no change was observed in response to exercise for any of these variables in type II fibres (Fig. 2.5C 
and D). As before, there was a significant difference between the values obtained for PLIN2-LD and 
PLIN2-null-LD across actual and randomized images (P < 0.001). 
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Table 2.2. Substrate utilization during 60 min of moderate-intensity cycling 
 Time (min) 
 15 30 45 60 Mean 
VO2 (l.min-1)  2.03 ± 0.17 2.29 ± 0.09 2.32 ± 0.09 2.40 ± 0.08 2.26 ± 0.09 
VCO2 (l.min-1)  1.85 ± 0.14 2.06 ± 0.08 2.06 ± 0.08 2.08 ± 0.07 2.01 ± 0.06 
RER  0.92 ± 0.01 0.89 ± 0.02 0.88 ± 0.01* 0.87 ± 0.02† 0.89 ± 0.01 
CHO oxidation (g.min-1)  1.78 ± 0.13 1.81 ± 0.16 1.71 ± 0.08 1.65 ± 0.16 1.75 ± 0.09 
Fat oxidation (g.min-1)  0.29 ± 0.07 0.42 ± 0.07* 0.44 ± 0.06* 0.53 ± 0.07† 0.41 ± 0.06 
 
 
Values obtained during 60 min of moderate-intensity cycling at ~65% VO2 peak.  Data provided are 
means ± S.E. (n = 7).  RER respiratory exchange ratio, CHO carbohydrate.  * P < 0.05, † P < 0.01 
versus value at 15 min. 
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Fig. 2.1. Fibre specific IMTG content visualized through immunofluorescence microscopy and 
quantified before and immediately after exercise.  
  
 
 
 
 
 
 
 
 
 
Representative immunofluorescence images of IMTG (pre A, post D), the ORO signal obtained after 
the intensity threshold was applied during quantitation (showing the LDs in white) (pre B, post E) and 
myosin heavy chain type I combined with collagen IV (pre C, post F) from one participant pre- and 
post-exercise. Type I muscle fibres are indicated with “I” in images A and D, all other fibres are 
assumed type II fibres. White bar = 50µm. Fibre type specific IMTG (G) content quantified from 
immunofluorescence images before and after 1 hr constant load cycling at ~65% VO2 peak. Closed bars 
represent type I fibres, open bars represent type II fibres. Values are presented as means ± S.E (n=7). 
* P < 0.01 versus type I fibres, † P < 0.01 versus pre-exercise.  
A B C
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Fig. 2.2 Fibre specific PLIN2 content visualized through immunofluorescence microscopy and 
quantified before and immediately after exercise.  
 
Representative immunofluorescence images of PLIN2 (pre A, post B) and myosin heavy chain type I 
combined with collagen IV (pre C, post D) from one participant pre- and post-exercise. Type I muscle 
fibres are indicated with “I” in images A and B, all other fibres are assumed type II fibres. White bar = 
50µm.  Fibre type specific PLIN2 (E) content quantified from immunofluorescence images before and 
after 1 hr constant load cycling at ~65% VO2 peak. Closed bars represent type I fibres, open bars 
represent type II fibres. Values are presented as means ± S.E (n=7). * P < 0.01 versus type I fibres.  
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(F) PLIN2 content in pre and post exercise samples was also determined using immunoblotting, and 
correlated well with PLIN2 content (when type I and type II fibres were pooled) determined using 
fluorescence microscopy. (G) The specificity of the PLIN2 antibody was confirmed in a competition 
experiment where a PLIN2 recombinant peptide (Genway Biotech, Inc, CA, USA) was incubated with 
the antibody, and subsequently the punctate pattern typical of PLIN2 positive staining was removed 
HI).  Immunoblot analysis of human skeletal muscle using the PLIN2 antibody revealed a band at ~50 
kDa (I). 
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Fig. 2.3. IMTG and PLIN2 colocalisation images visualized using immunofluorescence 
microscopy before and immediately after exercise. 
 
 
Representative confocal microscopy images of IMTG (A pre, E post), PLIN2 (B pre, F post), and the 
subsequent merged images (C pre, G post) used to calculate colocalisation, obtained from one 
participant.  Images D and H (pre and post exercise, respectively) show the overlaying areas from 
both IMTG and PLIN2 images, used to identify the relative association of PLIN2 with IMTG. White bar 
= 5µm. 
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Fig. 2.4. Fraction of PLIN2 associated with IMTG before and after exercise.   
 
 
 
 
 
 
 
 
 
Relative association of PLIN2 with IMTG pre- and post-exercise. Colocalisation analysis was 
performed in actual images in type I fibres (closed bars) and type II fibres (open bars), and statistically 
compared to randomized images (grey bars) where colocalisation would occur by chance. Values are 
presented as means ± S.E (n=7). * P < 0.001 versus actual images, † P < 0.05 versus pre-exercise.   
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Fig. 2.5. PLIN2 and IMTG association before and after exercise.   
 
 
The number of LDs associated (PLIN2-LD) (closed bars) or not associated (PLIN2-null-LD) (open 
bars) with PLIN2 before and after exercise in type I fibres (A) and type II fibres (C). The quantity of 
PLIN2 that is not associated with LDs (grey bars) in type I (B) and type II fibres (D) before and after 
exercise. Values are presented as means ± S.E (n=7). * P < 0.05 versus pre-exercise, † P < 0.05 
versus PLIN2-null-LD. 
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2.5 Discussion 
 
In this study we investigated the hypothesis that the PLIN2 association with IMTG is related to IMTG 
utilisation during an acute bout of endurance exercise. Accordingly, we demonstrate for the first time 
that although PLIN2 content is unchanged immediately post-exercise, the reduction in IMTG results in 
a decrease in the PLIN2 association with IMTG in type I muscle fibres. In addition, the data suggest 
that PLIN2-associated LDs are preferentially depleted over those LDs not associated with PLIN2.  
 
PLIN2 presents a fibre type-specific distribution in skeletal muscle obtained from humans in the 
rested, fasted state, with a two-fold greater concentration observed in  type I fibres (Shaw et al., 2009), 
a finding confirmed in the current study. The observation of IMTG colocalisation with PLIN2 
demonstrates that PLIN2 is contained on the LD surface as reported previously in adipocytes 
(Brasaemle et al., 1997) and skeletal muscle (Prats et al., 2006; Shaw et al., 2009).  The fraction of 
IMTG associated with PLIN2 (~0.67 in type I fibres and ~0.58 in type II fibres) indicates that the 
majority, but not all, IMTG contains PLIN2. Therefore, it appears that different subpopulations of LDs 
with a particular perilipin protein composition exist in muscle. This is in agreement with several in vitro 
observations that suggest that the protein composition of the LD could influence its function 
(Ducharme & Bickel, 2008; Fujimoto et al., 2008; Wolins et al., 2006). Using the techniques described 
in the present study it is not possible to discount the possibility that small, undetectable levels of 
PLIN2 are present on all LDs.  Nevertheless, in our model two pools of IMTG can be described: 1) 
PLIN2-associated LDs (PLIN2-LD), and 2) LDs where no PLIN2 was detected (PLIN2-null-LD). This 
apparent heterogeneity of LD protein composition in skeletal muscle corroborates a previous report 
from our lab (Shaw et al., 2009). 
 
Endurance exercise in trained individuals stimulates a reduction in IMTG content, which is specific to 
type I muscle fibres (De Bock et al., 2005; Stellingwerff et al., 2007; van Loon et al., 2003). We report 
that 60 min steady state cycling induced a significant (~50%) fibre-specific decrease in IMTG content, 
which is consistent with previous reports using fluorescence microscopy demonstrating an 
approximate 60% reduction following 2-3 h of endurance exercise (De Bock et al., 2005; Stellingwerff 
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et al., 2007; van Loon et al., 2003). In addition, our observation confirms that IMTG also contributes to 
total fat oxidation in untrained individuals (Coggan et al., 2000). As there was no change in PLIN2 
content in response to exercise, the fraction of PLIN2 associated with IMTG was significantly reduced 
~24% following exercise in type I fibres. Conversely, no change in either IMTG or PLIN2 content was 
observed in type II fibres in response to exercise, and therefore the fraction of PLIN2 associated with 
IMTG remained unchanged. Thus, from our data, we can suggest that the change in PLIN2 
association with IMTG in type I fibres is due to the decrease in PLIN2-associated IMTG containing LDs 
observed following exercise. In order to validate our finding, we compared the fraction of PLIN2 
associated with IMTG in ‘actual’ images to the fraction observed in a subset of randomized images, as 
previously described (Lachmanovich et al., 2003). The degree of colocalisation between the 
randomized images was only a fraction of that observed in the ‘actual’ images and provides evidence 
that the observed colocalisation in the basal and post exercise biopsies was not due to chance 
colocalisation.   
 
The degree of IMTG breakdown during exercise was related to basal IMTG concentrations, in 
agreement with previous  studies (Steffensen et al., 2002; Stellingwerff et al., 2007; van Loon et al., 
2003), and also basal PLIN2 content.  This suggests that the IMTG and PLIN2 content are related and 
that greater PLIN2 expression is related to enhanced IMTG utilisation during exercise.  To further 
investigate this relationship, we investigated the number of PLIN2-LD and PLIN2-null-LDs before and 
after exercise. Interestingly, in type I fibres 60 min steady state exercise induced a significant 
reduction in the number of PLIN2-LD, with no apparent change in the number of PLIN2-null-LD. 
Therefore, it appears that PLIN2-LD are preferentially utilised, compared to the PLIN2-null-LD, in 
response to moderate-intensity exercise in type I fibres. These data confirm the hypothesis that in 
skeletal muscle the PLIN2 association with IMTG may be a factor mediating IMTG utilisation during an 
acute bout of endurance exercise. The precise mechanisms regulating exercise-induced lipolysis in 
skeletal muscle are poorly understood, particularly in comparison to adipocytes (reviewed in (Lass et 
al., 2011). In isolated rat skeletal muscle, the colocalisation of HSL, a key lipolytic enzyme, with PLIN2 
was enhanced in response to muscle contraction and epinephrine (Prats et al., 2006), though this 
does not provide substantial evidence that PLIN2 is able to activate HSL. Nevertheless, in 
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combination with the results of the present study, it does suggest that PLIN2-associated LDs are 
targeted to undergo lipolysis and subsequent oxidation during exercise compared to the PLIN2-null-
LDs. In adipocytes or CHO cells expressing perilipin 1, it has been demonstrated that a key step in 
achieving maximal lipolysis is phosphorylation of perilipin 1, which recruits HSL to the LD and also 
releases CGI-58, the co-activator of ATGL (Sztalryd et al., 2003; Wang et al., 2009). However, perilipin 
1 is absent from skeletal muscle (Londos et al., 1999), and so far, PLIN2 phosphorylation has only 
been reported in HeLa cells (Bartz et al., 2007). Studies in CHO cells transfected with PLIN2 
demonstrate that HSL binds to PLIN2 in the basal state probably via its PAT-1 domain, the sequence 
that is common to most perilipins (Londos et al., 1995; Wang et al., 2009). There are also suggestions 
that PLIN2 can bind CGI-58 (Wang et al., 2011a) . These results suggest that the PLIN2-LD may be at 
an advantage, compared to the PLIN2-null-LD, when activation of lipolysis is required given the 
likelihood of HSL and CGI-58 localisation to those LDs. Thus, our results are compatible with a 
mechanism in which PLIN2 provides a structural function for HSL activation.  
 
As we have only considered PLIN2, we cannot discount the probability that other perilipin proteins 
which are expressed in skeletal muscle may be associated with either the PLIN2-LD or the PLIN2-null-
LD pools, as has been previously shown in rodent skeletal muscle (Ducharme and Bickel, 2008; 
Thiele and Spandl, 2008). Clearly the exact role of PLIN2 and the other perilipins in the regulation of 
skeletal muscle LD metabolism remains to be determined and warrants further investigation.  
 
In the pre exercise state the fraction of PLIN2 associated with IMTG was ~0.67 and ~0.58 in type I and 
type II fibres, respectively, indicating that a proportion of PLIN2 is not bound to IMTG, which appears 
contrary to the general notion that PLIN2 is found predominantly at the LD surface (Bell et al., 2008; 
Prats et al., 2006; Wolins et al., 2006b). Nevertheless, a recent study has proposed that PLIN2 may 
cycle between the cytosolic and LD fraction (Wang et al., 2009), and PLIN2 has also been observed at 
the endoplasmic reticulum membrane (Robenek et al., 2006). Furthermore, as exercise induced a 
reduction in the number of LD only (in type I fibres) and no change in PLIN2, it is worth noting that as 
a result a larger proportion of PLIN2 is not associated with the LD after exercise. As our data only 
concerns PLIN2 content immediately following exercise, we cannot establish how the exercise-
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induced IMTG decrease influences PLIN2 content in the period following exercise. In vitro data from 
CHO cells suggests that a decrease in TAG concentration promotes PLIN2 ubiquitination and 
degradation through proteolysis (Xu et al., 2005). Our data suggest that this process was not 
detectable during the first hour of exercise using immunofluorescence microscopy.  
 
In conclusion, the reduction in IMTG during moderate intensity exercise in type I muscle fibres is due 
to the preferential utilisation of LDs associated with PLIN2. This adds to the evidence that perilipin 
proteins regulate IMTG metabolism in skeletal muscle, and suggests that the perilipin composition of 
the LDs in skeletal muscle is important in determining the utilisation of IMTG during exercise. 
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Chapter 3 
 
Prolonged exercise training increases 
intramuscular lipid content and perilipin 2 
expression in type I muscle fibres of patients 
with type 2 diabetes 
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3.1 Abstract 
The aim of the present study was to investigate changes in intramuscular triglyceride (IMTG) content 
and perilipin 2 (PLIN2) expression in skeletal muscle tissue following 6 months of endurance type 
exercise training in type 2 diabetes patients. 10 obese, male type 2 diabetes patients (age 62±1 y, BMI 
31±1 kg/m2) completed 3 exercise sessions per week, consisting of 40 min of continuous endurance 
type exercise at 75% VO2 peak, for a period of 6 months. Muscle biopsies collected at baseline and 
after 2 and 6 months of intervention were analysed for IMTG content and PLIN2 expression using fibre 
type specific immunofluorescence microscopy. Endurance type exercise training reduced trunk body 
fat by 6±2% and increased whole-body oxygen uptake capacity by 13±7% (P<0.05). IMTG content 
increased two-fold in response to the 6 months exercise training in both type I and type II muscle 
fibres (P<0.05). A three-fold increase in PLIN2 expression was observed from baseline to 2 and 6 
months of intervention in the type I muscle fibres only (1.1±0.3, 3.4±0.6, and 3.6±0.6% fibre stained, 
respectively; P<0.05). Exercise training induced a 1.6-fold increase in mitochondrial content after 6 
months of training in both type I and type II muscle fibres (P<0.05). In conclusion, this is the first study 
to report that prolonged endurance type exercise training increases the expression of PLIN2 alongside 
increases in IMTG content in a type I muscle fiber type specific manner in type 2 diabetes patients.  
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3.2 Introduction 
Skeletal muscle insulin resistance is a defining characteristic of type 2 diabetes and is associated with 
intramuscular triglyceride (IMTG) accumulation. The concept of lipid-induced insulin resistance was 
initially derived from cross-sectional studies which demonstrated a correlation between high IMTG 
concentrations and insulin resistance (Pan et al., 1997). However, trained endurance athletes are 
generally highly insulin sensitive despite having substantially elevated IMTG levels (Goodpaster et al., 
2001; van Loon et al., 2004). Consequently, IMTG accumulation appears to relate to insulin resistance 
when accompanied by a sedentary lifestyle and low oxidative capacity (Bruce et al., 2003). It is 
postulated that a low turnover of the intramuscular lipid pool and a resultant elevation in the 
concentration of lipid metabolites, such as diacylglycerol and ceramides, mediates impairments in the 
insulin signaling pathway which are responsible for reduced insulin sensitivity (Moro et al., 2008).  
 
The benefits of prolonged endurance type exercise training on cardiovascular and metabolic health 
have been well established (Hansen et al., 2010), and provide a basis for prescribing exercise in the 
prevention and treatment of type 2 diabetes (Praet and van Loon, 2007). Exercise training 
interventions that enhance oxidative capacity and improve the storage and packaging of IMTG are 
likely to facilitate the improvement in skeletal muscle insulin sensitivity. In accordance, recent studies 
demonstrate an increase in mitochondrial density and intrinsic mitochondrial function in response to 
prolonged endurance type exercise training in type 2 diabetes patients (Hey-Mogensen et al., 2010; 
Phielix et al., 2010). The impact of endurance type exercise training on IMTG content is less clear, 
with studies showing an increase (Dubé et al., 2008; Pruchnic et al., 2004), no change (Bruce et al., 
2006), or a decrease (Bruce et al., 2004; Solomon et al., 2008) in muscle lipid storage in older obese 
individuals and obese type 2 diabetes patients. Changes in IMTG deposition can be assessed by the 
use of biochemical TG extraction of muscle tissue as well as immunohistochemical analyses of oil red 
O-stained muscle cross sections (Stellingwerff et al., 2007). The latter approach has shown a 3-4 fold 
greater lipid content in type I versus type II muscle fibres (van Loon, 2004). This method has been 
applied frequently to evaluate fibre type specific differences in IMTG content across different 
populations and in response to exercise (van Loon et al., 2003; van Loon et al., 2004). Therefore it is 
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important to utilize techniques that allow IMTG content and associated proteins to be analysed in a 
muscle fibre type specific manner.  
 
Lipid droplets (LDs) containing IMTG are viewed as a dynamic organelle which play a role in a variety 
of cellular functions including lipid homeostasis and cell signaling (for recent reviews see (Farese and 
Walther, 2009; Goodman, 2008). This notion is supported by the discovery of a family of proteins 
associated with the phospholipid monolayer of LDs, referred to as the perilipin proteins (numbered 1 to 
5; (Kimmel et al., 2010). Perilipin 1 is relatively well-characterized and appears to regulate lipolysis 
through its interaction with lipases and co-activators at the surface of the LD (Granneman et al., 2009; 
Wang et al., 2009), however its expression is reported to be limited to adipocytes and steroidogenic 
cells (Londos et al., 1999). Perilipin 2 (formerly known as adipocyte differentiation-related protein; 
ADRP or adipophilin) (PLIN2) on the other hand is ubiquitously expressed and present in skeletal 
muscle tissue. PLIN2 content is closely related to IMTG concentrations and is more abundantly 
expressed in the type I muscle fibres (Brasaemle et al., 1997; Minnaard et al., 2009; Shaw et al., 
2009). Although the exact function of PLIN2 remains to be established, in vitro data suggest that its 
presence on the lipid droplet surface can limit the LD-association with adipose triglyceride lipase 
(ATGL) (Bell et al., 2008; Listenberger et al., 2007). Therefore, TG accumulation in cells expressing 
PLIN2 has been attributed to the subsequent lowering of basal lipolytic rates which also promotes 
tissue insulin sensitivity (Bell et al., 2008). In agreement, human studies demonstrate that PLIN2 gene 
expression is higher in insulin sensitive versus insulin resistant individuals (Coen et al., 2010) and 
improvements in insulin mediated glucose disposal in response to weight loss and the 
pharmacological treatment of type 2 diabetes alters the expression of PLIN2 in skeletal muscle 
(Minnaard et al., 2009; Phillips et al., 2005). However, the impact of prolonged endurance type 
exercise training on fibre type specific PLIN2 protein expression remains to be assessed.  
 
We hypothesized that prolonged endurance type exercise training increases muscle lipid storage and 
upregulates the expression of PLIN2. Given the importance of considering muscle fibre type when 
investigating IMTG and related proteins, we applied immunofluorescence microscopy techniques to 
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investigate muscle fibre type specific changes in IMTG, PLIN2 and cytochrome c oxidase (COX) 
content following 2 and 6 months of endurance type exercise training in type 2 diabetes patients. 
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3.3 Methods 
 
Participants 
Ten type 2 diabetes patients participated in the current study (62 ± 1 y, BMI 31.2 ± 0.9 kg.m-2). 
Participants had been diagnosed for at least 12 months, were all being treated with oral blood-
glucose-lowering medication and were sedentary. The study was approved by the medical ethics 
committee of the Virga Jesse Hospital, Belgium and written informed consent was obtained from all 
participants. The patients in the current study were part of a larger project (clinical trial registration: 
ISRCTN32206301) investigating the impact of prolonged endurance type exercise training in a cohort 
of fifty type 2 diabetes patients, described in detail elsewhere (Hansen et al., 2009).  
 
Study design 
Participants completed a 6 month endurance type exercise training program. Prior to commencement 
of the study, and after 2 and 6 months of the intervention, oxidative capacity, body composition and 
oral glucose tolerance were assessed as described previously (Hansen et al., 2009). Muscle biopsies 
were taken from the vastus lateralis in the morning and following an overnight fast and were analysed 
for mitochondrial content, IMTG, and PLIN2 expression. The measurements at 2 and 6 months were 
performed at least 4 d after the last exercise session. Oral blood glucose and/or lipid-lowering 
medication were stopped 3 d prior to these measurements.  
 
Training intervention  
Participants undertook 3 supervised training sessions per week in the rehabilitation centre of the 
hospital. Each exercise session consisted of walking, cycling, and cross-country ski-type exercise and 
was performed for 40 min at a heart rate corresponding to exercise performed at 75% of VO2 peak. The 
relationship between VO2 peak and heart rate was reassessed after 2 months, and training intensity was 
adjusted accordingly.  
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Immunohistochemistry 
Muscle samples were dissected free of fat and connective tissue, before being embedded in Tissue-
Tek OCT Compound (Sakura Finetek Europe, The Netherlands) and frozen in liquid nitrogen-cooled 
isopentane.  Cryosections of 5 µm thickness were fixed in 3.7% formaldehyde and permeabilised for 5 
min in 0.5% Triton-X 100. Sections were then incubated for 1 h with a mouse monoclonal anti-
ADRP/perilipin2 antibody (Progen, Germany) as described previously (Shaw et al., 2008; Shaw et al., 
2009). As a key protein in the electron transport chain, identification of cytochrome C oxidase using a 
mouse monoclonal anti-OxPhos Complex IV (COX) antibody (Invitrogen, UK) was also used as a 
marker of the mitochondrial network of skeletal muscle. Fibre type determination was achieved 
through incubation of muscle sections with mouse anti-myosin heavy chain type I (A4.840-c, DSHB, 
developed by Dr. Blau). Sections were then incubated with either an Alexa Fluor goat anti-mouse 
IgG2a 594 (for OxPhos Complex IV) or an Alex Fluor goat anti-mouse IgG1 594 (for PLIN2) in 
combination with an Alexa Fluor goat anti-mouse IgM 488 (for MHC I) (Invitrogen, UK) for 30 min. 
Coverslips were mounted with a glycerol and mowiol 4-88 solution in 0.2 M Tris buffer (pH 8.5) 
(including 0.1% DABCO anti-fade medium). When IMTG visualisation was undertaken, the neutral lipid 
dye oil red O staining protocol in combination with immunofluorescence was used (van Loon et al., 
2003). In this respect, oil red O was applied to sections for 30 min following incubation with antibodies 
for fibre type determination.   
 
Image capture, processing and data analysis 
Image capture was performed in a blinded fashion on a widefield Nikon E600 microscope with a 40x 
0.75 NA objective, coupled to a SPOT RT KE colour 3 shot CCD camera (Diagnostic Instruments Inc., 
USA) for the fibre type-specific determination of IMTG and PLIN2. FITC (465-495 nm) and Texas Red 
(540-580 nm) excitation filters were used to view the Alexa Fluor 488 and 594 fluorophores, 
respectively. The Texas Red excitation filter was also used to view sections stained with oil red O. An 
inverted confocal laser scanning microscope (Leica DMIRE2, Leica Microsystems) with a 63x 1.4 NA 
oil immersion objective was used to obtain digital images of mitochondria, IMTG and PLIN2. A Helium-
Neon laser was used to excite the Alexa Fluor 594 fluorophore and oil red O, and an argon laser was 
used to excite the Alexa Fluor 488 fluorophore. 
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Image processing was undertaken using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA). 
Widefield images were used to assess fibre-type specific content of IMTG and PLIN2. Confocal 
images were used to assess COX content, LD size and to visualize the subcellular distribution of 
PLIN2. Fibres positively stained for MHC I were considered type I muscle fibres and non-stained fibres 
were considered type II muscle fibres. Identification of COX, IMTG and PLIN2 was achieved through 
the selection of an intensity threshold that was used uniformly for all images in that series. COX, IMTG 
and PLIN2 content was expressed as the percentage fibre area positively stained. IMTG and PLIN2 
density were expressed as number of positively stained ‘spots’ corrected for fibre area (µm2). Mean LD 
size was calculated by dividing the total number of objects by the total area stained. A total of 100 ± 
12, 72 ± 6 and 86 ± 7 fibres were analysed per muscle cross-section for COX, IMTG and PLIN2 
analysis respectively.  
 
Statistics 
All data are expressed as means±SEM. Significance was set at the 0.05 level of confidence.  Changes 
in whole-body characteristics, exercise capacity, body composition and insulin sensitivity were 
analysed were using a one-way repeated measures ANOVA, with the within-subject factor as ‘time’ (0 
vs 2 vs 6 months). Changes in COX, IMTG and PLIN2 were assessed using a two-way repeated 
measures ANOVA, with two within-subject factors ‘fibre’ (type I vs type II fibres) and ‘time’ (0 vs 2 vs 6 
months). Significant main effects or interactions were assessed using Bonferroni adjustment post hoc 
analysis.  
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3.4 Results 
 
Participants 
Participant characteristics are displayed in Table 3.1.  Significant reductions in body mass and BMI 
were observed with training (P < 0.05; Table 3.1) which were accompanied by a reduction in relative 
trunk fat and leg fat percentage of 6±2% and 5±2% post-training, respectively (P < 0.05). Maximal 
oxygen uptake demonstrated a significant increase over time (P < 0.05) and was 16 ± 3% higher after 
2 months of training (from 23.4 ± 1.5 to 27.1 ± 1.7 mL.kg-1.min-1, P < 0.01), and remained 13 ± 7% 
higher compared to baseline values after 6 months of intervention (26.5 ± 1.9 mL.kg-1.min-1, P = 0.08). 
Although the total cohort showed significant improvements in glycemic control, as shown by reduced 
levels of HbA1c (Hansen et al., 2009), in this small subcohort of 10 subjects the decrease in HbA1c 
following training failed to reach significance (7.0 ± 0.4, 6.7 ± 0.3 and 6.5 ± 0.2%, for 0, 2 and 6 
months respectively; P = 0.20). No significant changes in fasting plasma glucose and insulin 
concentrations, 2 h post-OGTT glucose concentrations or HOMA index of insulin sensitivity were 
observed in response to training (P > 0.05). 
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Table 3.1 Subject characteristics 
 
Time   
Variable Baseline 2 months 6 months 
Effect of time  
(P value) 
Age (years) 62 ± 1 - -  
Height (m) 1.72 ± 0.02 - -  
Body weight (kg) 92.9 ± 3.4 91.7 ± 3.4 91.3 ± 3.4 <0.05 
Body mass index (kg.m-2) 31.2 ± 0.9 30.8 ± 0.9 30.7 ± 0.9 <0.05 
Insulin sensitivity 
    
Fasting glucose (mmol.L-1) 9.2 ± 0.7 9.0 ± 0.7 8.7 ± 0.7 0.632 
2 h glucose (mmol.L-1) 17.9 ± 1.6 16.5 ± 1.6 15.5 ± 1.7 0.367 
Fasting insulin (µIU.mL-1) 17.8 ± 2.3 16.8 ± 2.3 17.7 ± 2.1 0.855 
HOMA index  7.5 ± 1.4 7.0 ± 1.5 7.1 ± 1.2 0.865 
HbA1c (%) 7.0 ± 0.4 6.7 ± 0.3 6.5 ± 0.2 0.200 
Exercise capacity 
    
VO2 peak (L.min-1)  2.15 ± 0.14 2.46 ± 0.15* 2.41 ± 0.19 <0.05 
VO2 peak (mL.kg-1.min-1)  23.4 ± 1.5 27.1 ± 1.7* 26.5 ± 1.9 <0.05 
Wmax (W) 180 ± 12 189 ± 11 189 ± 11 0.134 
Body composition 
    
% Trunk fat  38.4 ± 1.4 37.3 ± 1.7 35.8 ± 1.3* <0.01 
% Leg fat  23.2 ± 1.6 22.4 ± 1.5 21.8 ± 1.3 <0.05 
 
Data provided represent means ± S.E. (n=10). * P<0.05 vs. baseline. 
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Immunohistochemical analysis 
Cytochrome c oxidase:  Muscle fibre type specific COX expression was significantly greater in type I 
compared with type II muscle fibres at all time points (P < 0.01; Fig. 3.1). Six months of endurance 
type exercise training induced a time-dependent increase in COX expression in both type I and type II 
fibres (P < 0.01). Following 6 months of exercise training, COX expression was higher than baseline in 
both type I (8.9 ± 2.1 vs. 14.0 ± 2.9% fibre stained) and type II muscle fibres (5.4 ± 1.8 vs. 8.8 ± 2.4% 
fibre stained). The confocal micrographs of COX stained muscle fibres at baseline, 2 months and 6 
months are presented in Fig. 3.1D-I. These images demonstrate greater COX density in both 
intermyofibrillar and subsarcolemmal regions of the muscle fibres after 6 months of training, and are 
most prominent in the subsarcolemmal regions.  
 
Intramuscular triglyceride:  IMTG content, expressed as the area fraction stained, differed between 
type I and type II muscle fibres at each time point (Fig. 3.2C; P < 0.01).  Six months of endurance type 
exercise training induced a time dependent increase in IMTG content in both type I and II muscle 
fibres. IMTG content had increased ~1.9-fold in type I fibres (2.3 ± 0.4 vs 4.3 ± 0.5%; P < 0.01) and 
type II fibres (0.9 ± 0.1 vs 1.7 ± 0.3%; P<0.01) following 6 months of training. The increase in IMTG 
content was mirrored by significant increases in IMTG density after 6 months of training in type I fibres 
(0.051 ± 0.007 and 0.079 ± 0.008 LDs/µm2 for 0 and 6 months, respectively; P < 0.01) but not in type 
II muscle fibres (0.022 ± 0.002 and 0.031 ± 0.003 LDs/µm2 for 0 and 6 months, respectively; P = 
0.056). No significant changes in IMTG content or density were apparent after 2 months of training in 
either fibre type (P > 0.05). There were no differences in lipid droplet size as determined by confocal 
microscopy between fibre types or in response to endurance type exercise training (P > 0.05).   
 
PLIN2 expression:  At baseline, PLIN2 expression calculated as the percentage area stained did not 
differ between type I and type II muscle fibres (Fig. 3.4; P > 0.05). Six months of exercise training 
induced a time dependent increase in PLIN2 expression in type I muscle fibres only (P < 0.05). In 
comparison to baseline, PLIN2 expression in type I muscle fibres had increased ~3-fold after 2 months 
of training (1.1 ± 0.3 vs 3.6 ± 0.6%, respectively; P < 0.05) with no further increase observed after 6 
months of training. This fibre type specific training response resulted in greater PLIN2 expression in 
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type I compared with type II muscle fibres after 2 and 6 months of training (P<0.05). Representative 
immunofluorescence images of PLIN2 expression in type I and type II muscle fibres at baseline and 
after 2 and 6 months of training are shown in figure 3. In comparison to baseline, PLIN2 density in 
type I fibres also increased ~2-fold after 2 and 6 months (0.018 ± 0.003, 0.033 ± 0.004 and 0.035 ± 
0.005 PLIN2 objects/µm2 for 0, 2 and 6 months respectively; P < 0.05) whereas PLIN2 density in type 
II muscle fibres did not change (P > 0.05). Therefore, PLIN2 density was higher in type I than type II 
muscle fibres after 2 and 6 months of training only. Higher magnification images of PLIN2 were 
obtained using confocal laser scanning microscopy and are shown in Fig. 3.3J-L. These images show 
a clear increase in PLIN2 expression after 6 months of training. These images also demonstrate that 
distinct rings of PLIN2 can frequently be observed and are more abundant after prolonged exercise 
training.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3.1. Effect of 6 months exercise training on fibre type-specific COX expression 
 
 
 
 
 
Representative confocal images of COX expression in skeletal muscle at baseline (A), and after 2 (B) and 6 months (C) of exercise training.  White bar 
= 50 µm.  Representative images of the intermyofibrillar (D, F, H) and subsarcolemmal (E, G, I) mitochondrial regions at baseline, and after 2 and 6 
months of exercise training, respectively.  White bar = 1 µm.  Fibre type-specific COX expression (expressed as % of fibre stained) at baseline, and 
after 2 and 6 months of exercise training, in type I (closed bars) and type II fibres (open bars).  Values are presented as means ± S.E.  * P < 0.05 vs. 
Baseline.  † P < 0.001 vs. type I fibres. 
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Fig. 3.2. Effect of 6 months exercise training on fibre type-specific IMTG content 
 
 
 
 
 
 
 
 
 
 
 
Representative immunofluorescence images of IMTG at baseline (A) and after 6 (B) of exercise 
training.  Type I fibres are indicated with “I”, all other fibres are assumed type II fibres.  White bar = 50 
µm.  (C) IMTG content was measured at baseline, and after 2 and 6 months of exercise training in 
type I (closed bars) and type II fibres (open bars).  Values are presented as means ± S.E.  * P < 0.05 
vs. Baseline.  † P < 0.001 vs. type I fibres. 
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Fig. 3.3. Immunofluorescence images of fibre type-specific PLIN2 protein expression.   
 
Representative images of PLIN2 at baseline (A), and after 2 (B) and 6 (C) months of exercise training, 
stained using anti-PLIN2 in combination with anti-myosin heavy chain type I (D, E, F, respectively) and 
wheat germ agglutinin 350 (WGA350) (G, H, I, respectively) and viewed and quantified with widefield 
immunofluorescence microscopy.  White bar = 50 µm. Representative confocal images of PLIN2 at 
baseline (A), and after 2 (B) and 6 (C) months of exercise training; rings of perilipin staining are clearly 
visible in all images. White bar = 10 µm. 
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Fig. 3.4. Effect of 6 months exercise training on PLIN2 protein expression 
 
 
 
 
 
 
 
 
 
 
Fibre type-specific COX expression (expressed as % of fibre stained) at baseline, and after 2 and 6 
months of exercise training, in type I (closed bars) and type II fibres (open bars).  Values are 
presented as means ± S.E.  * P < 0.05 vs. Baseline.  † P < 0.001 vs. type I fibres. 
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3.5 Discussion 
Prolonged endurance type exercise training is known to improve insulin-stimulated glucose uptake 
and glycaemic control in type 2 diabetes patients (Hansen et al., 2010). In this study we demonstrate 
that endurance type exercise training also increases both IMTG deposition and COX expression, 
which are higher in type I muscle fibres. In accordance, we show for the first time that training induces 
a greater expression of PLIN2 in type I muscle fibres. 
 
Insulin sensitivity is enhanced by regular physical activity which explains why significant improvements 
in glycaemic control were observed in the previous study after 6 months of endurance type exercise 
training in a large cohort of type 2 diabetes patients (Hansen et al., 2009). In the subset of participants 
used in this study there was no significant change in glycaemic control as evident from the HbA1c 
levels after 6 months of training (Table 3.1). Nevertheless a decline from 7.0 ± 0.4% down to 6.5 ± 
0.2% in HbA1c is of great clinical significance, as it would translate into a >10% reduction in the risk of 
premature death, a 5-10% reduction in the risk of myocardial infarction and a ~20% reduction in the 
risk of microvascular disease (Manley, 2003). 
 
Skeletal muscle oxidative capacity and whole body fatty acid oxidation are good predictors of muscle 
insulin sensitivity (Bruce et al., 2003; Goodpaster et al., 2001; Goodpaster et al., 2003; Kelley et al., 
1999). Obese individuals with insulin resistance and type 2 diabetes commonly display a reduced 
capacity for oxidative metabolism (Boushel et al., 2007; Kelley et al., 2002; Ritov et al., 2005).  Thus, it 
is likely that increased oxidative capacity following exercise interventions are mechanistically linked to 
improvements in metabolic health in this population. Accordingly, we observed a ~1.6-fold increase in 
COX expression in skeletal muscle following 6 months of endurance type exercise training (Fig. 3.1J). 
The increase in COX expression in this subset of patients is in agreement with the 50% increase in 
COX and citrate synthase activities observed in the full cohort of patients reported previously (Hansen 
et al., 2009). We extend on these previous data by the application of immunofluorescence microscopy, 
allowing us to assess oxidative capacity in a muscle fiber type specific manner. Furthermore, we also 
assessed subcellular localisation of the observed increases in oxidative capacity (Fig. 3.1D-I). The 
present work shows that increases in the content of the mitochondrial enzyme COX can be observed 
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in both the subsarcolemmal and intermyofibrillar region of the type I muscle fibres. In agreement with 
previous data investigating mitochondrial content following a 10 week training intervention in type 2 
diabetes patients using transmission electron microscopy (Nielsen et al., 2010), we show that 
increased COX expression is prominent in subsarcolemmal regions of type I fibres after prolonged 
endurance type exercise training.  
 
The exercise training-induced increase in skeletal muscle oxidative capacity was accompanied by a 
~2-fold elevation in skeletal muscle lipid deposition in both type I and type II muscle fibres (Fig. 3.2C). 
This is the first study to show a type I muscle fibre specific increase in IMTG content following 
prolonged exercise training in type 2 diabetes patients. These findings tend to be in line with several 
recent studies demonstrating IMTG accretion coupled to increased oxidative capacity in older, obese 
insulin resistant individuals following 12-16 weeks of exercise training (Dubé et al., 2008; Pruchnic et 
al., 2004). Although IMTG content is already elevated in obese type 2 diabetes patients, these levels 
still remain below those observed in endurance-trained athletes who are highly insulin sensitive 
(Goodpaster et al., 2001; van Loon et al., 2004). The high IMTG content in combination with a reduced 
oxidative capacity in type 2 diabetes patients likely mediates the reduction in muscle insulin sensitivity 
rather than merely elevated IMTG stores. Accordingly, exercise training-induced increases in 
mitochondrial content, coupled to IMTG accretion appear to enhance insulin sensitivity. For example, 
a recent study has demonstrated that training-induced increases in IMTG concentrations and 
improvements in insulin sensitivity are coupled to a reduction in the concentration of diacylglycerol and 
ceramide (Dubé et al., 2011). Therefore it has been hypothesized that the process of IMTG synthesis 
consumes the lipid metabolites that are precursors to IMTG and impair skeletal muscle insulin 
signaling. In further support, the high IMTG synthesis rates observed in the period after endurance 
type exercise protects against the development of insulin resistance during (intra)lipid infusion 
(Schenk and Horowitz, 2007). The present study adds to this growing body of evidence by 
demonstrating greater IMTG storage and improved glycaemic control in response to 6 months training 
in type 2 diabetes patients. Some studies employing a shorter training duration have failed to observe 
a significant increase in type 1 muscle fibre IMTG content following training in type 2 diabetic patients 
(Meex et al., 2010). Therefore, it is possible that a more prolonged intervention, such as the 6 month 
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endurance training programme applied in the current study, is required before increases in IMTG 
deposition are observed in type 2 diabetes patients. The duration of the training intervention, in 
addition to the method of IMTG analysis, may also explain the discrepancy across the many studies 
investigating changes in IMTG content.  
 
The increase in total IMTG content following training in the present study was accompanied by an 
increase in the number of LDs in type I fibres, whereas there was no change detected in LD size. This 
is in agreement with a previous electron microscopy study in young males and females, where the 
increase in total IMTG content with training was due to an increase in LD density while LD size 
remained unchanged (Tarnopolsky et al., 2007). IMTG expansion through an increase in the number 
of smaller LDs would befit a metabolic advantage as the surface area available for the interaction of 
lipolytic enzymes with the regulatory proteins contained on the LD surface would be enhanced. This 
would maximize the capacity for rapid LD turnover, allowing more efficient lipid mobilization and 
therefore oxidation during exercise.  
 
One of the regulatory proteins that reside on the surface of the LD monolayer is PLIN2. In the current 
study, despite observing a ~2-fold higher IMTG concentration in the type I muscle fibres, there was no 
difference in PLIN2 expression between type I and type II muscle fibres prior to endurance type 
exercise training (Fig. 3.4). However, training induced a significant increase in PLIN2 expression in 
type I muscle fibres. The perilipins are important in the packaging of lipid droplets and in vitro studies 
demonstrate that PLIN2 expression increases cellular TG and improves insulin sensitivity. The 
presence of PLIN2 at the LD surface appears to limit the association of ATGL with the LD surface, 
reduce basal lipolytic rates and therefore promote TG storage (Bell et al., 2008; Listenberger et al., 
2007).  
 
We show that when type 2 diabetes patients are physically active, type I muscle fibres exhibit a 
greater expression of PLIN2 than type II muscle fibres. This is in agreement with our previous 
observations of a greater PLIN2 expression in the type I muscle fibres of sedentary individuals and 
trained cyclists (Shaw et al., 2009; Shepherd et al., 2012). The increase in PLIN2 expression in type I 
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muscle fibres is likely to result in enhanced coverage of the LD surface with PLIN2. This adaptation 
would limit rates of basal lipolysis and promote IMTG storage in the basal state. Furthermore, 
hormone sensitive lipase translocates to PLIN2-coated LDs during muscle contraction and adrenaline 
stimulation (Prats et al., 2006) and PLIN2-associated LDs are depleted during exercise (Shepherd et 
al., 2012). We hypothesize that an increase in PLIN2 surface coverage of the LD, along with the 
greater total LD surface area available and the enhanced mitochondrial density, would aid the 
mobilization and oxidation of the IMTG pool during exercise. This proposed improvement in the 
regulation of IMTG turnover both at rest and during exercise may go some way to explaining why 
insulin sensitivity can be enhanced despite further accumulation of IMTG with training. However, it 
should be noted that neither intramuscular lipolysis nor lipid oxidation rates were assessed in the 
present study, therefore further research is required to fully explore the relationship between changes 
in PLIN2 expression and intramuscular lipid oxidation. 
 
A non-exercise control group was not included in the present study, however reductions in fat mass, 
and improvements in VO2max and muscle oxidative capacity are not seen in a similar time frame in 
non-exercising controls (Church et al., 2010; Short et al., 2003). Therefore we can be confident that 
the related changes in PLIN2 expression and IMTG storage in the present study are specific 
adaptations to the exercise intervention. As PLIN2 is one of four perilipin proteins present in skeletal 
muscle, additional investigations examining other perilipins are required to fully understand the role of 
IMTG metabolism in the development insulin resistance and the insulin sensitizing effect of endurance 
type training.  
 
In conclusion, prolonged endurance type exercise training increases intramuscular lipid storage in a 
muscle fibre type dependent manner in type 2 diabetes patients. Importantly, the increase in IMTG 
content is accompanied by a type I muscle fiber specific increase in PLIN2 expression. The greater 
PLIN2 expression following prolonged endurance type exercise training in combination with increased 
oxidative capacity may explain the improved turnover of the skeletal muscle lipid pool with regular 
physical activity, and likely contributes to the improvements in skeletal muscle insulin action and 
subsequent glycaemic control.   
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Chapter 4 
 
Sprint interval and traditional endurance 
training increase net intramuscular triglyceride 
breakdown and expression of perilipin 2 and 5 
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4.1 Abstract 
Intramuscular triglyceride (IMTG) utilization is enhanced by endurance training (ET) and is linked to 
improved insulin sensitivity. This study first investigated the hypothesis that ET-induced increases in 
net IMTG breakdown and insulin sensitivity are related to increased expression of perilipin 2 (PLIN2) 
and perilipin 5 (PLIN5). Secondly, we hypothesized that sprint interval training (SIT) also promotes 
increases in IMTG utilization and insulin sensitivity.  Sixteen sedentary males performed 6 weeks of 
either SIT (4-6, 30s Wingate tests per session, 3d.week-1) or ET (40-60 min moderate-intensity 
cycling, 5d.week-1). Training increased resting IMTG content (SIT 1.7-fold, ET 2.4-fold; P<0.05) 
concomitant with parallel increases in PLIN2 (SIT 2.3-fold, ET 2.8-fold; P<0.01) and PLIN5 expression 
(SIT 2.2-fold, ET 3.1-fold; P<0.01). Pre-training, 60 min cycling at ~65% pre-training VO2peak 
decreased IMTG content in type I fibres (SIT 17±10%, ET 15±12%; P<0.05). Following training, a 
significantly greater breakdown of IMTG in type I fibres occurred during exercise (SIT 27±13%, ET 
43±6%; P<0.05), with preferential breakdown of PLIN2- and particularly PLIN5-associated lipid 
droplets. Training increased the Matsuda insulin sensitivity index (SIT 56±15%, ET 29±12%, main 
effect P<0.05). No training x group interactions were observed for any variables. In conclusion, SIT 
and ET both increase net IMTG breakdown during exercise and similar increases in PLIN2 and PLIN5 
protein expression. The data are consistent with the hypothesis that increases in PLIN2 and PLIN5 are 
related to the mechanisms that promote increased IMTG utilization during exercise and improvements 
in insulin sensitivity following 6 weeks SIT and ET. 
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4.2 Introduction 
High intramuscular triglyceride (IMTG) concentrations are associated with insulin resistance in 
sedentary obese individuals and type 2 diabetes patients (Goodpaster et al., 2001; Pan et al., 1997; 
Phillips et al., 1996a). However, the athletes’ paradox describes a state of elevated IMTG storage 
alongside high levels of insulin sensitivity in endurance trained athletes (Goodpaster et al., 2001; van 
Loon et al., 2004). Endurance training also increases oxidative capacity and promotes a shift towards 
greater IMTG utilization during exercise (Schrauwen et al., 2002). Therefore, the capacity to oxidise 
IMTG as a fuel source is believed to be mechanistically important for the preservation of high insulin 
sensitivity in the face of elevated intramuscular lipid storage (Bruce et al., 2003; Goodpaster et al., 
2001; van Loon and Goodpaster, 2006). The overriding current hypothesis is that high rates of IMTG 
oxidation during exercise allows the regular turnover of the intramuscular lipid pool and prevents the 
accumulation of fatty acid metabolites, such as long-chain acyl-CoA, diacylglycerol and ceramides, 
which are believed to blunt insulin sensitivity (Moro et al., 2008; Shaw et al., 2010; van Loon and 
Goodpaster, 2006). Therefore, understanding the mechanisms regulating IMTG lipolysis and IMTG-
derived FA oxidation during exercise remain important.  
 
Recent attention has focused on the role of the perilipins (PLINs), a family of lipid droplet (LD) 
proteins, of which perilipin 2 (PLIN2) and 5 (PLIN5) are expressed in skeletal muscle, but who’s 
precise role is not fully understood. PLIN2 is ubiquitously expressed in the human body (Brasaemle et 
al., 1997) and its content is ~2-fold higher in type I muscle fibres compared to type II fibres, which 
mirrors the fibre type distribution of IMTG (Shaw et al., 2009). In non-muscle cells, PLIN2 expression 
regulates basal lipolytic rates in vitro by limiting the interaction of adipose triglyceride lipase (ATGL) 
with the LD (Bell et al., 2008; Listenberger et al., 2007). However, in intact rat skeletal muscle in 
response to lipolytic stimuli (electrically induced contractions and adrenaline) there is an increase in 
colocalisation of hormone sensitive lipase (HSL) with PLIN2 and of HSL with LDs (Prats et al., 2006). 
Furthermore, we recently reported that PLIN2-containing LDs are depleted in human skeletal muscle 
during moderate intensity exercise (Chapter 2). PLIN5, on the other hand, is highly expressed in 
oxidative tissues (Dalen et al., 2007; Wolins et al., 2006a; Yamaguchi et al., 2006). Cell culture studies 
demonstrate that PLIN5 expression limits basal lipolysis more effectively than PLIN2 (Wang et al., 
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2011a). Interestingly, these studies also show that PLIN5 expression (but not PLIN2) recruits ATGL 
and its coactivator, CGI-58, to the LD surface under basal conditions, and it is believed that PLIN5 
phosphorylation releases CGI-58 to bind ATGL to stimulate lipolysis in response to PKA-activation 
(Wang et al., 2011a). Skeletal muscle PLIN5 expression is higher in athletes (Amati et al., 2011) and 
increases following training in lean and obese individuals (Peters et al., 2012). Collectively, the results 
from the limited number of studies so far suggest that both PLIN2 and PLIN5 are important in 
regulating IMTG lipolytic rates, but that PLIN5 may be the key PLIN regulating IMTG lipolysis and net 
IMTG breakdown during exercise.  
 
Sprint interval training (SIT) promotes skeletal muscle adaptations and improvements in insulin 
sensitivity comparable to those induced by ET (Burgomaster et al., 2008; Gibala et al., 2012). In 
particular, skeletal muscle oxidative capacity is enhanced following SIT (Burgomaster et al., 2007; 
Burgomaster et al., 2008; Burgomaster et al., 2005; Hood et al., 2011; Little et al., 2011a; Little et al., 
2010), and may partly explain the SIT-induced improvements in whole-body insulin sensitivity (Babraj 
et al., 2009; Hood et al., 2011; Little et al., 2011a; Richards et al., 2010).  However, it has yet to be 
investigated whether such improvements in insulin sensitivity occur alongside increases in net IMTG 
breakdown during exercise and enhanced skeletal muscle expression of PLIN2 and PLIN5. 
  
Given the importance of studying IMTG metabolism in a fibre type specific manner (van Loon, 2004), 
in the current study we investigated IMTG metabolism and the content and localization of PLIN2 and 
PLIN5 following different training interventions using immunofluorescence microscopy. We 
hypothesized that increased expression of PLIN2 and PLIN5 plays a role in the well-established 
increase in net IMTG breakdown during exercise following ET. In addition, we investigated the 
hypothesis that SIT also increases the capacity to breakdown IMTG during moderate intensity 
exercise, the protein expression of PLIN2 and PLIN5 and insulin sensitivity. 
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4.3 Methods 
 
Ethical approval 
Sixteen healthy, sedentary males volunteered to take part in the study (for characteristics see Table 
1), which was approved by the Black Country NHS Research Ethics Committee (West Midlands, UK) 
and conformed with the Declaration of Helsinki. Written, informed consent was obtained from 
volunteers following a verbal and written explanation of the nature and risks involved in the 
experimental procedure. All subjects were healthy (free of any known metabolic or cardiovascular 
disease) and engaged in less than two 30 min sessions of physical activity per week in the preceding 
year. Percutaneous muscle biopsies taken in this study before and after each training mode, under 
basal conditions and after 60 min of moderate-intensity exercise have been used both for the 
measurements described in this manuscript and for measurements of endothelial eNOS content, 
eNOS serine1177 phosphorylation, NOX2 content and capillarization.  The latter are reported in a 
parallel manuscript (M. Cocks et al., under review).  Measures such as insulin sensitivity and VO2 peak 
also made in the volunteers are relevant for the interpretation of both studies and are presented in 
both manuscripts.  
 
Pre-experimental procedures 
At least 5 days prior to entering the study subjects performed a progressive exercise test to 
exhaustion on an electronically braked cycle ergometer (Lode BV, Groningen, The Netherlands) in 
order to determine peak oxygen uptake (VO2 peak) using an on-line gas collection system (Oxycon Pro, 
Jaeger, Germany). The test consisted of initially cycling at 95 W, followed by sequential increments of 
35 W every 3 minutes until cadence was reduced to < 50rpm, at which point the test was terminated. 
VO2 peak was taken as the highest value obtained in the last 30-seconds of the test. During this visit 
subjects were also allocated to their training intervention. The 16 subjects were divided into pairs, with 
the best possible match for age, BMI and VO2 peak, with one member from each pair randomly 
assigned to SIT and the other to the ET group. As none of the volunteers were familiar with SIT 
exercise, the subjects in the SIT group were familiarised to this exercise mode through the 
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performance of one 30 s all out effort (Wingate test, (Bar-Or, 1987)) on a cycle ergometer against a 
load equivalent to 0.075 kg per kg body mass.   
 
Experimental procedures 
Experimental procedures performed before (pre) and after (post) training were identical, and were 
undertaken across two consecutive days. Post-training experimental procedures were performed > 
48h after the final exercise training session in order to minimize any acute effects of the last exercise 
training bout. 
 
Day 1: All subjects reported to the laboratory after an overnight fast (> 10 h), having been instructed to 
refrain from performing vigorous exercise in the preceding 48 h period. On arrival, a 20G cannula was 
inserted into the antecubital vein of one arm and a 3-way stop cock attached to allow for multiple blood 
sampling and flushing of the cannula. After a 20 mL baseline sample was obtained, subjects 
consumed a beverage containing 75 g glucose (using 82.5g dextrose monohydrate obtained from 
Roquette, UK)  dissolved in water made up to 300 ml. Further 5 mL blood samples were obtained after 
30, 60, 90 and 120 minutes, and collected into EDTA-containing vacutainers. Isotonic saline (3 mL) (B 
Braun, UK) was used to keep the cannula patent every 15 minutes during the 2 h test. Plasma 
samples for each time point were obtained through centrifugation (10-minutes at 3500 rpm at 4°C) and 
stored at -80°C for subsequent analysis. Immediately following the oral glucose tolerance test (OGTT), 
body composition analysis was performed using Dual energy X-ray Absorptiometry (DXA). QDR 
software (Hologic Inc., MA, US) was used to analyse fat mass and fat-free mass in individual limbs 
and the trunk region of each subject. Relative fat mass was calculated using absolute fat mass as a 
proportion of total region mass. 
 
Day 2: On arrival at the laboratory after an overnight fast (> 10 h), the thigh of one leg was prepared 
for muscle biopsy collection. Subjects were randomised as to which leg they received the biopsy from 
pre-training; the contralateral leg was sampled post-training. Briefly, local anaesthetic (1% lidocaine, B 
Braun, UK) was administered under the skin and over the fascia of the vastus lateralis before two 
incisions were made approximately 2 cm apart. A muscle biopsy (~100mg) was taken using the 
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Bergstrӧm technique (Bergström, 1975) from the distal incision prior to exercise. Skeletal muscle 
samples were first blotted to remove excess blood, and visible fat and collagen were removed through 
dissection. A portion of the muscle tissue was then prepared for immunohistochemical analysis by 
embedding in Tissue-Tek OCT Compound (Sakura Finetek Europe, The Netherlands) and frozen in 
liquid nitrogen-cooled isopentane. The remaining muscle tissue (~40mg) was snap frozen in liquid 
nitrogen. Subsequently, subjects underwent 60 min of steady state exercise on an electronically 
braked cycle ergometer set at a workload equivalent to 65% pre-training VO2 peak. Heart rate and rate 
of perceived exertion (RPE) were recorded every 5 minutes, while gas collection (5 min collection 
period) was performed at 15 minute intervals (t = 15, 30, 45, 60 min) using an on-line gas collection 
system (Oxycon Pro, Jaeger, Germany), in order to determine rates of carbohydrate and fat oxidation. 
A second muscle biopsy was taken immediately post-exercise from the proximal incision. 
 
For all experimental trials, subjects were provided with all food and drinks to be consumed in the 
preceding 24 h period. The diet was of a standard macronutrient composition (50% carbohydrate, 35% 
fat, 15% protein), but adjusted for each individuals habitual energy intake, assessed through the 
completion of 3 day diet diary. When completing diet diaries, subjects were provided with electronic 
scales in order to increase the accuracy of portion size determination. All subjects were asked to 
continue their habitual dietary and physical activity patterns during the training period, again 
completing a 3 day diet diary post-training in order to assess any differences in energy or 
macronutrient intake over the training period. 
 
Training interventions 
Sprint Interval Training (SIT): The SIT training protocol was similar to the protocol used by 
Burgomaster et al (Burgomaster et al., 2008). Subjects performed 30 s ‘all out’ sprints (Wingate test) 
on a cycle ergometer against a load equivalent to 0.075 kg per kg body mass and with 4.5 minutes 
recovery between each test. During the recovery period subjects cycled against a small load (30 W) 
maintaining a cadence of below 50 rpm. All participants trained 3 times a week for 6 weeks, and were 
excluded from the study if they were absent from more than 2 sessions. Initially participants performed 
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4 Wingate tests per training session, increasing to 5 tests in weeks 3 and 4, and finishing with 6 tests 
per session in weeks 5 and 6. 
 
Endurance Training (ET): Subjects in the ET group trained 5 times a week over the 6 week training 
period, and were excluded from the study if they were absent from more than 3 training sessions. All 
subjects cycled at a workload equivalent to ~65% VO2 peak for 40 minutes in the first 2 weeks, 
increasing to 50 minutes in the following 2 weeks, and 60 minutes in the final 2 weeks. VO2 peak was 
reassessed after 3 weeks of training and workload adjusted accordingly. 
 
Muscle sample analysis 
Immunofluorescence staining: Serial 5 µm sections were cut at -30°C on to ethanol-cleaned glass 
slides.  Sections were fixed in 3.7% formaldehyde for 1 h, rinsed briefly in deionised water, and 
permeabilised in 0.5% Triton-X 100 for 5 min, followed by 3 x 5 min washes in PBS. Subsequently, 
slides underwent incubation with appropriate antibodies for 45 min, after which, a further 3 x 5 min 
PBS wash preceded incubation of sections with appropriately targeted secondary fluorescent 
conjugated antibodies for 30 min.  IMTG (lipid droplets) were visualised using neutral lipid dye oil red 
O staining (Koopman et al., 2001). As such, oil red O solution was applied to washed (3 x 5min PBS) 
sections for 30 min following secondary antibody incubation. Slides were then rinsed briefly in 
deionised water, followed by a 10 min rinse with slow running tap water, after which coverslips were 
mounted with a glycerol and mowiol 4-88 solution in 0.2 M Tris buffer (pH 8.5) (including 0.1% DABCO 
anti-fade medium). 
 
Cell border visualisation was achieved through incubation of sections with a wheat germ agglutinin 
Alexa Fluor 350 conjugate (Cat. #W11263, Invitrogen, Paisley, UK). Muscle fibre type was determined 
using a mouse anti-myosin antibody for slow twitch fibres (A4.840-c, DSHB, developed by Dr. Blau) 
followed by the application of Alexa Fluor goat anti-mouse IgM 488 or 350. Fibres containing positive 
staining were classified as type I fibres, while those with no staining were classified as type II fibres. 
The oil red O working solution was freshly produced for each staining procedure and consisted of 100 
mg oil red O in 20 ml 60% triethylphosphate (Sigma-Aldrich, UK). Twelve ml of working solution was 
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added to 8 ml deionised water and filtered twice to remove any oil red O crystals. Mitochondria were 
visualised using a mouse monoclonal anti-OxPhos Complex IV primary antibody (Cat. #459600, 
Invitrogen, Paisley, UK), followed by an Alexa Fluor goat anti-mouse IgG2a 594 secondary antibody. 
PLIN2 visualisation was achieved using a mouse monoclonal anti-adipophilin primary antibody (Cat. 
#03-610102, American Research Products, MA, USA), followed by an Alexa Fluor goat anti-mouse 
IgG1 594 secondary antibody. On occasions when IMTG staining with oil red O was undertaken in 
parallel with PLIN2, an Alexa Fluor goat-anti mouse IgG1 488 secondary antibody was used. PLIN5 
was visualised using a guinea pig polyclonal anti-OXPAT primary antibody (Cat. #GP31, Progen 
Biotechnik, Germany) followed by application of an Alexa Fluor goat-anti guinea pig IgG 488 
secondary antibody. All Alexa Fluor secondary antibodies were obtained from Invitrogen (Paisley, UK). 
The specificity of the PLIN5 antibody was confirmed in a competition experiment in which a PLIN5 
recombinant peptide (Cat. #NB110-60511PEP, Novus Biologicals, Cambridge, UK) was incubated 
with the PLIN5 primary antibody, subsequently resulting in removal of the positive fluorescent signal 
for PLIN5 (Supplementary fig. 1).   
 
Image capture, processing and data analysis: Images of cross-sectional orientated sections were used 
for the determination of fibre-type differences in the content of IMTG, mitochondria, and PLIN2 and 
PLIN5. Images were captured using a Nikon E600 microscope with a 40x 0.75 NA objective, coupled 
to a SPOT RT KE colour 3 shot CCD camera (Diagnostic Instruments Inc., MI, USA).  Both DAPI UV 
(340-380 nm) and FITC (465-495 nm) excitation filters were used to view the Alexa Fluor 350 and 488 
fluorophores, respectively. In addition, a Texas red (540-580 nm) excitation filter was used to view 
sections stained with oil red O or the Alexa Fluor 594 fluorophore. The use of 3 excitation filters and 1 
dichroic and 1 emission filter (“Pinkel” Triple Set, Semrock, Kettering, UK) allowed for semi-automated 
sequential image capture. Digital images to specifically assess the size and number of IMTG and 
PLIN2 and PLIN5 objects were obtained using an inverted confocal microscope (Leica DMIRE2, Leica 
Microsystems) using a 63x 1.4 NA oil immersion objective. An argon laser was used to excite the 
Alexa Fluor 488 fluorophore, while both the Alexa Fluor 594 fluorophore and oil red O was excited 
using a Helium-Neon laser. The same system was used to capture digital images and to assess IMTG 
and PLIN2 or PLIN5 colocalisation.  
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Image processing was undertaken using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA). 
Fibre-type distribution of IMTG, PLIN2 and PLIN5 and mitochondria was assessed using widefield 
images. To this end, between 6 and 10 widefield images were used per muscle section, resulting in 
104 ± 5 fibres analysed per muscle cross-section (42 ± 3 type I fibres, 62 ± 3 type II fibres). 
Mitochondrial fluorescence staining intensity was used to indicate changes in mitochondrial content 
after training. An intensity threshold was uniformly selected to represent a positive signal for IMTG, 
and PLIN2 and PLIN5. The content of IMTG and PLIN2 and PLIN5 were expressed as the positively 
stained area fraction relative to the total area of each muscle fibre. Images captured using confocal 
microscopy were used to identify changes in mean IMTG, PLIN2 and PLIN5 size and density. Density 
was calculated as the number of IMTG objects relative to area. The area of individual IMTG (lipid 
droplets), PLIN2 or PLIN5 objects was used as a measure of size.    
 
Colocalisation analysis was performed separately for PLIN2 or PLIN5 with IMTG. This analysis was 
restricted to type I fibres as a previous publication from our laboratory has shown that changes in 
colocalisation with IMTG do not occur in type II fibres in response to the exercise bout used in the 
present study (Shepherd et al., 2012). In this respect, sequential images of either PLIN2 or PLIN5 and 
IMTG were captured using confocal microscopy (as described) with 8x digital zoom. Positive signal for 
either PLIN protein and IMTG was obtained through the selection of a uniform intensity threshold. 
Binary images were created based on the selected threshold and subsequently used for colocalisation 
analysis. A colocalisation map was generated, displaying the merged images, with the overlapping 
area subsequently extracted to create a separate binary image. The total number of objects in this 
image was expressed relative to the total number of PLIN2 (or PLIN5) as a measure of colocalisation 
(Fig. 4).  The extracted objects were also used as a measure of the number of PLIN associated-LDs 
(PLIN-LDs), and the number of extracted objects were subsequently subtracted from the total number 
of LDs to quantify the number of LDs not associated with PLIN (PLIN-null-LDs). Several controls were 
performed to check for bleed through, non specific secondary antibody binding and autofluorescence 
before colocalisation analysis was performed. No positive staining was observed in the opposite 
channel when single staining (IMTG, PLIN2 and PLIN5) was performed and omission of the primary or 
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secondary antibody, and oil red O abolished all positive signal in the relevant channel discounting the 
influence of tissue autofluorescence or non-specific secondary antibody binding. In addition, we 
performed the same colocalisation analysis on a series of non-corresponding PLIN2 (or PLIN5) and 
IMTG images, in order to determine whether the level of random colocalisation was statistically 
different from that obtained for the true corresponding images, as previously described (Lachmanovich 
et al., 2003).   
 
Western blot analysis: Snap frozen muscle tissue was powdered in liquid nitrogen and transferred to 
eppendorf tubes containing lysis buffer (1x RIPA buffer, Cell Signalling, including 1 complete mini 
protease inhibitor tablet, Roche Diagnostics, Germany). Samples were mixed on ice for 2 hours and 
then homogenized on ice for ~30 s at slow speed (Polytron), followed by centrifugation for 20 min at 
4°C and 10,000 G. The supernatant was removed and a small portion used to determine protein 
concentration (Pierce BCA assay kit). Samples were subsequently diluted to a final concentration of 3 
µg.µl-1, using homogenization buffer and Laemmli sample buffer (Sigma) and boiled for 5 min. Equal 
quantities of protein (45 µg) were separated by electrophoresis on 12% SDS-polyacrylamide gels and 
transferred to nitrocellulose membranes at 25 V for 1.5 hours. Ponceau S staining was performed to 
assess transfer efficacy and subsequently imaged using a ChemiDoc XRS+ system (Bio-Rad, UK). 
This image was used to quantify the total protein stain of each lane, and this was used as a measure 
of equal loading when the inter-lane variation was less than 10%. Membranes were subsequently 
destained (0.1M NaOH) and blocked for 1 h in 5% non-fat dried milk (NFDM) in phosphate-buffered 
saline with 0.1% Tween (PBST) followed by incubation overnight at room temperature with either the 
anti-adipophilin (Cat. #03-610102, American Research Products, MA, USA) or anti-OXPAT (Cat. 
#GP31, Progen Biotechnik, Germany) primary antibody diluted in 3% NFDM in PBST. The 
membranes were then washed 3 times in PBST, blocked in 5% NFDM in PBST for 1 h, followed by 
incubation for 1 h at room temperature with appropriate horseradish peroxidase-conjugated IgG 
secondary antibodies diluted in 3% NFDM in PBST. Antibody binding was detected using enhanced 
chemiluminescence HRP detection reagent (GE Healthcare, UK) and imaging and band quantification 
was performed using a ChemiDoc XRS+ system (Bio-Rad, UK). 
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Blood Sample Analysis 
Plasma glucose concentrations were determined spectrophotometrically using an ILab-600 semi-
automatic analyzer in combination with the glucose oxidase kit (Instrumentation Laboratory Ltd UK, 
Warrington, UK).  Insulin concentrations during the OGTT were determined using a commercially 
available direct insulin ELISA kit (Invitrogen, Paisley, UK). Insulin sensitivity index (Matsuda and 
DeFronzo, 1999) was calculated based on plasma glucose and insulin values. 
 
Calculations and statistical analysis 
Rates of whole body fat and carbohydrate oxidation (g.min-1) were calculated from the VO2 and VCO2 
values collected at 15, 30, 45 and 60 minutes during the steady state cycling exercise. The 
calculations were made assuming protein oxidation was negligible, and according to previously 
published equations (Jeukendrup and Wallis, 2005): 
Carbohydrate oxidation (g.min-1) = 4.210·VCO2 – 2.962·VO2 
Fat Oxidation = 1.695·VO2 – 1.701·VCO2 
 
Insulin sensitivity was calculated using the Matsuda index (Matsuda and DeFronzo, 1999), using the 
following equation:  
Matsuda ISI= 
10,000
FPG × FPI ×(PḠ ×PῙ) 
 
where FPG is fasting plasma glucose concentration, FPI is fasting plasma insulin concentration, PḠ is 
mean plasma glucose concentration (over 2 h OGTT), and PĪ is mean plasma glucose concentration. 
 
All data are expressed as means ± S.E.M. Significance was set at the 0.05 level of confidence. 
Changes in body composition, exercise capacity, insulin sensitivity and substrate utilization were 
assessed using a 2-factor repeated measures ANOVA, with the between-subject factor ‘group’ (SIT 
vs. ET) and the within-subject factor ‘training’ (pre- vs. post-training). Changes in mitochondrial density 
and PLIN2 and 5 content were assessed using a mixed 3-factor repeated measures ANOVA using the 
within-subject factors ‘fibre’ (type I versus type II fibres) and ‘training’ and between-subject (group) 
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factor used in the 2-factor analysis. To inspect differences in IMTG, we hypothesised a priori that 
IMTG content would be significantly different between type I and type II fibres. Thus, we used a 3-
factor repeated measures ANOVA with the between-subject factor as ‘group’, and the within-subject 
factor’s ‘training’ and ‘time’ (pre- versus post-exercise). The same three-factor repeated measures 
ANOVA and between-subject and within-subject factors were used when assessing differences in 
colocalisation, following an a priori hypothesis that colocalisation would be significantly different 
between actual and randomised images, based on a previous study (Lachmanovich et al., 2003). 
Significant main effects or interactions were assessed using Bonferroni adjustment post hoc analysis. 
Improvements in training performance (SIT group; e.g. mean power) were examined using a paired t 
test analysis.  A Pearson’s bivariate correlation analysis was used to investigate specific relationships 
between variables. 
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4.4 Results 
 
Exercise capacity, body composition, substrate utilization and insulin sensitivity 
At baseline, no differences between groups were observed for any of the variables mentioned in Table 
4.1. In response to training VO2peak was significantly improved irrespective of training type (SIT 7 ± 2%, 
ET 15 ± 3%, main effect for condition, P < 0.001, Table 4.1). The difference between the modes of 
exercise did not reach statistical significance (P = 0.064). Wmax was also increased after training, with 
no difference between groups (main effect for condition, P < 0.001). Fat free mass increased 
significantly post-training, with no difference between groups (main training effect, P = 0.039). The 
observed decrease in relative fat mass (Table 4.1) did not reach statistical significance, with no 
difference between groups (main training effect, P = 0.075). Glucose area under the curve (AUC) was 
reduced post-training (SIT 17 ± 2%, ET 12 ± 2%; main training effect, P < 0.001, Table 4.1), with no 
difference between groups. Similarly, training reduced insulin AUC (SIT 33 ± 3%, ET 18 ± 5%; main 
training effect, P < 0.001, Table 4.1), with no difference between groups. In accordance, training 
improved insulin sensitivity, calculated using the Matsuda index (Matsuda and DeFronzo, 1999) (SIT 
56 ± 15%, ET 29 ± 12%; main training effect, P < 0.01, Table 4.1), with no difference between groups. 
Carbohydrate (absolute and relative) and fat (relative only) oxidation, as well as RER, were all 
significantly altered compared to pre-training following ET only (P < 0.05, Table 4.2), with no effect 
apparent following SIT. RER tended to be lower in the SIT group (P = 0.055) before training. When 
considering the effectiveness of SIT, the first and final training sessions were examined. Specifically, 
mean power output increased during training by 14 ± 3% (P = 0.001) and peak power output 
increased by 21 ± 6% (P = 0.01). 
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Table 4.1. Subject characteristics 
 SIT ET 
 
Pre Post Pre Post 
Age (yrs) 22 ± 1  21 ± 1  
Height (m) 1.74 ± 0.02  1.77 ± 0.03  
Body mass (kg) 75.1 ± 3.0 75.2 ± 3.1 70.8 ± 4.4 70.8 ± 4.5 
BMI (kg.m-2) 24.8 ± 0.8 24.8 ± 0.9 22.6 ± 1.6 22.6 ± 1.2 
VO2 peak (l.min-1) * 3.13 ± 0.15 3.37 ± 0.18 2.93 ± 0.30 3.40 ± 0.38 
VO2 peak (l.min-1.kg-1) *  41.9 ± 1.8 45.1 ± 2.3 41.7 ± 4.1 48.2 ± 5.0 
Wmax (W) * 221 ± 11 241 ± 14 218 ± 11 253 ± 16 
FFM (kg) * 52.5 ± 1.9 53.6 ± 1.8 50.7 ± 1.5 51.1 ± 2.7 
FM (kg) 14.2 ± 1.6 13.6 ± 1.5 12.3 ± 1.5 12.2 ± 1.9 
Insulin AUC (µIU.ml-1.min-1) * 8847 ± 1140 5792 ± 688 8434 ± 880 6813 ± 711 
Glucose AUC (mg.dl-1.min-1) * 17634 ± 710 14551 ± 398 16835 ± 992 14783 ± 950 
ISI-Matsuda * 3.9 ± 0.3 5.8 ± 0.4 3.7 ± 0.5 4.7 ± 0.7 
 
Data provided are means ± S.E. (n = 8 per group).  BMI body mass index, Wmax maximum workload, 
OGTT oral glucose tolerance test, FFM fat free mass, FM fat mass, AUC area under the curve, ISI 
insulin sensitivity index. * Indicates main effect for training (P < 0.05), such that Pre ≠ Post.  No 
interaction effects (training x group) were observed for any of the variables. 
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Table 4.2. Substrate utilization during 60 min cycling at ~65% pre-training VO2 peak 
 
SIT ET 
 
Pre Post Pre Post 
Heart rate (b.min-1) * 164 ± 3 147 ± 3 165 ± 3 138 ± 4 
VO2 (l.min-1) * 2.22 ± 0.11 2.12 ± 0.12 2.19 ± 0.14 2.10 ± 0.13 
VCO2 (l.min-1) * 1.94 ± 0.09 2.01 ± 0.13 1.97 ± 0.11 1.81 ± 0.10 
CHO oxidation      
   (g.min-1) 1.61 ± 0.07 1.56 ± 0.13 1.80 ± 0.12 1.37 ± 0.07 † 
   (% of total oxidation)  62.3 ± 2.0 63.2 ± 4.4 70.9 ± 4.3 56.6 ± 3.1 † 
Fat oxidation      
   (g.min-1) 0.46 ± 0.04 0.42 ± 0.06 0.36 ± 0.07 0.49 ± 0.05 
   (% of total oxidation)  39.5 ± 1.9 38.6 ± 4.3 31.0 ± 4.3 45.1 ± 3.1 † 
RER 0.88 ± 0.01 0.88 ± 0.01 0.90 ± 0.01 0.86 ± 0.01 † 
 
Values obtained during 60 min of moderate-intensity cycling at ~65% pre-training VO2 peak.  Data 
provided are means ± S.E. (n = 8 per group).  RER respiratory exchange ratio, CHO carbohydrate.  * 
Main effect for training (P < 0.05) such that Pre ≠ Post (no significant differences between training 
interventions).  † Interaction effect (training x group; P < 0.05), such that the effect of ET was 
significantly different from the effect of SIT. 
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Analysis of mitochondrial content 
Immunofluorescence images demonstrated that COX protein expression (fluorescence intensity), 
representing mitochondrial density, was greater in type I fibres than type II fibres pre and post-training 
(main effect of fibre; P < 0.001, Table 4.3). No group differences were apparent at baseline. A main 
effect of training was observed, with increases in mitochondrial density in both type I fibres (SIT 39 ± 
4%, ET 46 ± 16%) and type II fibres (SIT 39 ± 3%, ET 50 ± 14%; P < 0.05, Table 4.3). No difference 
between groups was apparent following training. 
 
 
Table 4.3. Effect of 6 weeks of SIT or ET on fibre type specific mitochondrial content 
COX expression SIT ET 
(fluorescence intensity) Pre Post Pre Post 
Type I fibres 54.1 ± 4.6 74.4 ± 4.0† 60.1 ± 7.7 81.5 ± 5.9† 
Type II fibres* 41.1 ± 3.0 56.8 ± 3.5† 42.4 ± 4.8 60.4 ± 5.1† 
 
Mitochondrial density, quantified from immunofluorescence images of COX in type I and type II fibres 
obtained before and after 6 weeks of SIT or ET.  Values are presented as means ± S.E. (n = 8 per 
group).  * Main fibre effect (P < 0.05 vs. type I fibres).  † Main training effect (P < 0.05 vs. pre-training). 
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Intramuscular triglyceride analysis 
Our a priori hypothesis that IMTG content is greater in type I fibres compared to type II fibres meant 
that we examined IMTG fibre-type specific training effects separately. There were no differences in 
resting IMTG content between groups at baseline. A significant main effect of training was observed 
with increased resting IMTG content in type I fibres after both interventions (expressed as % fibre 
stained) (SIT 1.9-fold, ET 2.9-fold, main training effect ; P < 0.05, Fig. 4.1E). This finding was 
attributed to a significant rise in IMTG density, expressed as the number of LDs per area, after SIT 
(pre-training, 0.065 ± 0.009; post-training, 0.087 ± 0.010 µm2) and ET (pre-training, 0.064 ± 0.009; 
post-training, 0.109 ± 0.012 µm2). A main effect of training was observed for IMTG content in type II 
fibres after both interventions (SIT 1.4-fold, ET 2.5-fold, main training effect, P < 0.05, Fig. 4.1F).  This 
increase in IMTG content was again attributable to an increase in IMTG density. No changes in IMTG 
size were observed in response to training. There were no interaction effects between training and 
group in any of the measures of resting IMTG content. 
 
Before training, absolute IMTG content in type I fibres decreased significantly in response to 60 min 
steady state cycling, with no difference between groups (SIT 17 ± 9%, ET 15 ± 12%, main effect of 
time; P < 0.05, Fig. 4.1E). Following training, net IMTG breakdown during exercise in type I fibres was 
also significantly increased (SIT 27 ± 13%, ET 43 ± 5%; main effect of time; P < 0.05, Fig. 4.1E). In 
comparison to pre-training, net IMTG breakdown in type I fibres was significantly greater following 
training (training x time interaction; P < 0.05) with no difference in net IMTG breakdown between 
groups. Both pre- and post-training, the reduction in IMTG content in type I fibres was attributed to 
decreases in IMTG density after SIT (pre-training, 21 ± 13%; post-training, 38 ± 7%) and ET (pre-
training, 20 ± 17%; post-training, 32 ± 8%). No significant breakdown of IMTG occurred during the 
exercise bout in type II fibres either before or after training (Fig. 4.1F).  
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Fig. 4.1.  Effect of 6 weeks of SIT and ET on fibre type specific IMTG content and net IMTG 
breakdown during exercise. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative immunofluorescence images of IMTG (stained red) in combination with WGA to 
identify the cell border (stained blue) in skeletal muscle, pre (A) and post (B) 6 weeks of SIT.  Type I 
fibres are indicated with a “I”, all other fibres are assumed type II fibres.  White bar = 50µm.  Images 
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(C) and (D) display the ORO signal obtained after the intensity threshold was applied during 
quantitation (showing the LDs in white), before and after SIT, respectively.  IMTG content, quantified 
from immunofluorescence images of oil red O-stained muscle sections, before (Pre-Training) and after 
(Post-Training) 6 weeks of SIT (closed bars) or ET (open bars).  IMTG content was measured before 
(PreEx) and after (PostEx) 60 min steady state cycling, and net IMTG breakdown calculated 
(Breakdown), in type I (E) and type II fibres (F).  Values are presented as means ± S.E. (n = 8 per 
group).  * Main effect of training intervention (P < 0.05 vs. pre-training). 
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PLIN2 and PLIN5 analysis 
Immunofluorescence images show that PLIN2 content (expressed as % fibre stained) in type I fibres 
was significantly greater than in type II fibres both before and following training, irrespective of 
intervention (P < 0.001, Fig. 4.2C & D). A main effect of training was observed, with an increase in 
PLIN2 content in both type I (SIT 2.1-fold, ET 3.4-fold, Fig. 4.2C & D) and type II fibres (SIT 2.5-fold, 
ET 2.2-fold, main training effect, P < 0.001). This finding was attributed to an increase in PLIN2 
density in both type I (SIT: pre 0.057 ± 0.008, post 0.092 ± 0.010 µm2, ET: pre 0.051 ± 0.012, post 
0.100 ± 0.009 µm2) and type II fibres (SIT: pre 0.020 ± 0.004, post 0.044 ± 0.009 µm2, ET: pre 0.012 ± 
0.002, post 0.031 ± 0.006 µm2) (main training effect, P < 0.001). No significant condition and group 
interactions were observed for either PLIN2 content or density. PLIN5 content (expressed as % of 
fibre stained) was significantly greater in type I fibres than type II fibres at all time points, irrespective 
of intervention (P < 0.001, Fig. 4.3C & D). A main effect of training was observed for PLIN5 content, 
with significant increases occurring in both fibre types after training (type I fibres: SIT 2.2-fold, ET 2.8-
fold, type II fibres: SIT 2.2-fold, ET 3.4-fold, main training effect; P < 0.001, Fig. 4.3C & D). This finding 
was attributed to an increase in PLIN5 density in both type I (SIT: pre 0.054 ± 0.005, post 0.079 ± 
0.007 µm2, ET: pre 0.039 ± 0.003, post 0.107 ± 0.011 µm2) and type II fibres (SIT: pre 0.009 ± 0.001, 
post 0.018 ± 0.004 µm2, ET: pre 0.005 ± 0.001, post 0.025 ± 0.005 µm2) (main training effect, P < 
0.001). Again, no significant condition and group interaction effects were observed.  
 
We performed immunoblotting of whole muscle homogenates in order to confirm the finding of an 
increase in both PLIN2 and PLIN5 content in response to training using immunohistochemical 
methodology.  Immunoblot analysis revealed a main effect of training for PLIN2 content (SIT 3.9-fold, 
ET 5.8-fold; P = 0.02, Fig 4.2E), with no difference between groups. PLIN5 protein expression was 
also increased following training (SIT 2.0-fold, ET 2.4-fold, main training effect; P = 0.01, Fig 4.3E), 
again with no difference between groups. 
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Fig. 4.2.  Effect of 6 weeks of SIT and ET on fibre type specific PLIN2 expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative immunofluorescence images of PLIN2 (stained red) in combination with WGA to 
identify the cell border (stained blue) in skeletal muscle, pre (A) and post (B) 6 weeks of SIT.  Type I 
fibres are indicated with a “I”, all other fibres are assumed type II fibres.  White bar = 50µm.  PLIN2 
expression, quantified from immunofluorescence images of PLIN2, in type I and type II fibres obtained 
before (C)  and after (D) 6 weeks of SIT (closed bars) or ET (open bars).  PLIN2 expression quantified 
from immunofluorescence images correlated with PLIN2 expression determined following 
immunoblotting of whole muscle homogenates (E).  Values are presented as means ± S.E. (n = 8 per 
group).  * Main effect of fibre type (P < 0.05 vs. type I fibres).  † Main effect of training intervention (P < 
0.05 vs. pre-training). 
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Fig. 4.3.  Effect of 6 weeks of SIT and ET on fibre type specific PLIN5 expression. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative immunofluorescence images of PLIN5 (stained green) in combination with WGA to 
identify the cell border (stained blue) in skeletal muscle, pre (A) and post (B) 6 weeks of SIT.  Type I 
fibres are indicated with a “I”, all other fibres are assumed type II fibres.  White bar = 50µm.  PLIN5 
expression, quantified from immunofluorescence images of PLIN5, in type I and type II fibres obtained 
before (C)  and after (D) 6 weeks of SIT (closed bars) or ET (open bars).  PLIN5 expression quantified 
from immunofluorescence images correlated with PLIN5 expression determined following 
immunoblotting of whole muscle homogenates (E).  Values are presented as means ± S.E. (n = 8 per 
group).  * Main effect of fibre type (P < 0.05 vs. type I fibres).  † Main effect of training intervention (P < 
0.05 vs. pre-training).  ‡ Significant correlation (P < 0.05). 
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Colocalisation of PLIN2 and PLIN 5 with IMTG 
Before training, the fraction of PLIN2 colocalised with IMTG in resting muscle was similar between 
groups (SIT 0.58 ± 0.04, ET 0.61 ± 0.04; P = 0.96). This relationship was unchanged in response to 
both training interventions. Pre-training, 60 min steady state exercise induced a significant reduction in 
the fraction of PLIN2 colocalised with PLIN2 (SIT 30 ± 6%, ET 23 ± 4%; main training effect, P < 0.01). 
This reduction was the result of a decrease in IMTG content and an unchanged PLIN2 content. Post-
training, a significantly larger reduction in the fraction of PLIN2 associated with IMTG was observed in 
response to the exercise bout (SIT 37 ± 7%, ET 40 ± 4%; P = 0.01) with no difference between groups 
(data not shown). As a change in PLIN2 association with IMTG was observed following steady state 
exercise both before and after training, we investigated the number of LDs either associated (PLIN2-
LD) or not associated (PLIN2-null-LD) with PLIN2 at each time point. Both before and after training, 
the number of PLIN2-LD was greater than the number of PLIN2-null-LD before exercise. Pre-training, 
60 min steady state exercise induced a reduction in the number of PLIN2-LD (SIT 22 ± 10%, ET 28 ± 
6%; P = 0.01, Fig. 4.4E & F), whereas the number of PLIN2-null-LD was unchanged. In contrast, 
following training, exercise induced a significant reduction in both the PLIN2-LD (SIT 32 ± 6%, ET 39 ± 
6%; P < 0.001) and the PLIN2-null-LD (SIT 24 ± 12%, ET 35 ± 12%; P = 0.01, Fig. 4.4E & F). No 
group interactions were detected with either condition or time for variables of PLIN2 and IMTG 
association, indicating that observations were statistically similar between groups. 
 
Prior to training, the fraction of PLIN5 colocalised with IMTG was similar between groups (SIT 0.58 ± 
0.04, ET 0.50 ± 0.04; P = 0.20), and following both training interventions this relationship was 
unchanged. Pre-training, 60 min steady state exercise significantly reduced the fraction of PLIN5 
associated with IMTG (SIT 36 ± 4%, ET 33 ± 2%; main effect of time, P < 0.01), which was the result 
of a reduction in IMTG with no change in PLIN5 content. Following training, the exercise-induced 
reduction in the fraction of PLIN5 colocalised with IMTG tended to be larger compared to pre-training, 
which bordered on statistical significance (SIT 40 ± 3%, ET 41 ± 3%; P = 0.06), and with no difference 
between groups (data not shown).  As above, we subsequently investigated the absolute number of 
LDs either associated (PLIN5-LD) or not associated (PLIN5-null-LD) with PLIN5 at each time point. 
Pre-training, the number of PLIN5-LD was larger in the SIT than the ET group (P < 0.05), but no 
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difference in the number of PLIN5-null-LD was apparent.  Despite this discrepancy, a similar reduction 
in PLIN5-LD was observed in response to exercise (SIT 32 ± 4%, ET 35 ± 4%; P < 0.01, Fig. 4.4G & 
H), with no change in the number of PLIN5-null-LD, and no difference between groups for either 
variable. Following training, exercise induced a reduction in the number of PLIN5-LD only (SIT 38 ± 
3%, ET 41 ± 5%; P < 0.01, Fig. 4.4G & H), with no difference between groups. 
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Fig. 4.4.  Analysis of the colocalisation of PLIN2 and PLIN5 with LDs pre and post 60 min 
steady state cycling, before and after 6 weeks of SIT or ET. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Representative immunofluorescence images of PLIN5 (A), IMTG (B), and the merged images (C) with 
the yellow areas describing regions of overlap between PLIN5 and IMTG images.  The yellow objects 
were then extracted (D) and the number expressed relative to the total number of PLIN5 objects as a 
measure of colocalisation.  The same procedure was used to obtain values of colocalisation between 
PLIN2 and IMTG.  WSITe bar = 5µm.  The number of PLIN2-LD (closed bars) and PLIN2-null-LD 
(open bars) were quantified before (PreEx) and after exercise (PostEx), prior to (E) and following (F) 
training in both the SIT and ET groups.  The same analysis was repeated for PLIN5 for pre (G) and 
post training (H).  * Main effect of exercise bout (P < 0.05 vs. pre-exercise). 
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Correlation analyses 
Due to the lack of group x training interactions in all variables, significant training effects were detected 
independent of exercise modality. Therefore, the data from the SIT and ET interventions (type I and 
type II fibres, pre and post training) were pooled for correlation analysis (Table 4.4). Both PLIN2 (R = 
0.68; P < 0.001) and PLIN5 content (R = 0.72; P < 0.001) showed strong positive correlations with 
IMTG content. A very strong positive correlation was observed between pre-exercise IMTG 
concentrations and the decrease in IMTG content in response to 60 min steady state exercise (R = 
0.81, P < 0.001). In addition, PLIN2 (R = 0.57, P = 0.001) and PLIN5 content (R = 0.63, P < 0.001) 
were strongly associated with net IMTG breakdown. Insulin sensitivity were modestly associated with 
PLIN2 (R = 0.40; P = 0.02) and PLIN5 content (R = 0.42; P = 0.02), as well as IMTG content (R = 
0.53; P = 0.01). 
 
 
Table 4.4. Bivariate correlation analysis 
 IMTG Net IMTG breakdown Insulin sensitivity 
PLIN2 0.68‡ 0.57‡ 0.40* 
PLIN5 0.72‡ 0.63‡ 0.42* 
IMTG  0.81‡ 0.53† 
 
IMTG, PLIN2 and PLIN5 represent resting content. Net IMTG breakdown refers to absolute change in 
IMTG concentration from pre to post-exercise. Values represent Pearson’s squared correlation 
coefficients (R values) for relationships between variables. Due to the lack of group x training 
interactions in all variables, it was assumed that the exercise training was driving the changes 
independent of exercise modality. Therefore, the data from both intervention groups was pooled for 
correlation analysis. Significant correlations: *P < 0.05, †P < 0.01, ‡P < 0.001. 
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4.5 Discussion 
This is the first study to report that greater protein expression of PLIN2 and PLIN5 is associated with 
larger IMTG stores and enhanced net IMTG breakdown during exercise in type I muscle fibres 
following a period of traditional ET. This observation is consistent with our first hypothesis.  We also 
provide novel evidence that PLIN5-LDs are utilized during an acute bout of exercise irrespective of 
training status, whereas after a period of training both PLIN2-LDs and PLIN2-null-LDs are utilized 
during an acute bout of exercise.  In support of our second hypothesis, we demonstrate for the first 
time that like traditional ET, SIT also enhances IMTG content and net breakdown during 60 min of 
moderate intensity exercise and leads to increases in the protein expression of PLIN2 and PLIN5.  
This common metabolic response following both SIT and ET is also evident in the utilization of PLIN5-
LDs, PLIN2-LDs and PLIN2-null-LDs. Taken together, these adaptations may contribute to the 
mechanisms underlying the observed improvements in insulin sensitivity following SIT and ET. 
 
We report that ET leads to increases in IMTG content in both type I and type II fibres, and is 
accompanied by increased mitochondrial density, corroborating the findings of previous studies (Dubé 
et al., 2011; Pruchnic et al., 2004; Schrauwen-Hinderling et al., 2003; Tarnopolsky et al., 2007). In 
addition before training, 60 min moderate-intensity cycling induced a small but significant decrease in 
IMTG in type I fibres. Importantly, we report that ET leads to increased rates of whole body fat 
oxidation during exercise at 65% pre-training VO2peak and that this is accompanied by large increases 
in net IMTG breakdown primarily in type I fibres.  Previous studies combining IMTG content and A-V 
balance measurements using [U-13C]-palmitate demonstrate that oxidation of plasma fatty acids does 
not completely account for fat oxidation during exercise, indicating that other fat sources contribute to 
total fat oxidation (Sacchetti et al., 2002; van Hall et al., 2002; van Loon et al., 2003).  Therefore, it is 
reasonable to assume that fatty acids liberated through the net reduction in IMTG content contribute to 
total fat oxidation during exercise in lean but sedentary individuals and the IMTG contribution to total 
fat oxidation is increased following ET.  The latter observation is consistent with a number of recent 
training studies also examining net IMTG breakdown in a fibre type specific manner (Van Proeyen et 
al., 2011a; Van Proeyen et al., 2011b).  
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Our data demonstrate that net IMTG breakdown during exercise is positively correlated with resting 
IMTG concentration. This corroborates the findings of several other reports in trained individuals 
(Coggan et al., 2000; Stellingwerff et al., 2007; van Loon et al., 2003) and indicates that the ET-
induced increase in IMTG content contributes to the increase in net IMTG breakdown during 
endurance type exercise. However, it is worth noting that this is only one of a number of adaptations 
which likely explain the increase in IMTG breakdown during exercise following ET (Shaw et al., 2010; 
van Loon, 2004). The increase in IMTG content was due to a greater number of LDs rather than an 
increased volume of pre-existing LDs. This conclusion is in agreement with a previous report using 
transmission electron microscopy (Tarnopolsky et al., 2007). As smaller LDs maintain a higher surface 
area to volume ratio, they also provide a greater surface area for the interaction of lipolytic enzymes 
with the IMTG substrate and regulatory proteins on the LD surface. As a result, the mobilization of FA 
for oxidation during exercise would be enhanced.   
 
Using immunofluorescence microscopy we previously reported that trained athletes display a ~two-
fold greater PLIN2 concentration in type I compared to type II muscle fibres (Shaw et al., 2009). The 
present data extends this finding to sedentary individuals, and further reveals a ~four-fold difference in 
PLIN5 protein expression when comparing type I and type II fibres. In addition, we report that ET 
enhances the intramuscular content of both PLIN2 and PLIN5, assessed through immunoblotting of 
whole muscle homogenates. The findings are partly in agreement with a recent study showing 
increased PLIN5, but not PLIN2, protein abundance in the muscle of lean and obese males following 
12 weeks of endurance training (Peters et al., 2012) and with a cross-sectional study that reported a 
~seven-fold higher PLIN5 content in older athletes compared to age-matched sedentary controls 
(Amati et al., 2011). However, our study is the first to examine changes in the intramuscular 
expression of the PLIN proteins in response to training interventions in a fibre type specific manner 
using immunofluorescence microscopy. Accordingly, we demonstrate that, like the changes in IMTG, 
the increase in PLIN2 and PLIN5 protein expression occurs in both type I and type II muscle fibres.  
 
In agreement with data obtained in rodent (Minnaard et al., 2009) and human skeletal muscle (Amati 
et al., 2011; Peters et al., 2012), both PLIN2 and PLIN5 expression positively correlated with IMTG 
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content suggesting that the expression of these PLIN proteins is proportional to IMTG content in lean, 
healthy individuals. Future research will be required to clarify if the increase in PLIN expression is the 
primary event driving the increase in IMTG content (which is the mechanism that we propose) or the 
consequence of the increase in IMTG content.  Furthermore, the fraction of IMTG associated with 
either PLIN2 or PLIN5 at rest was similar pre and post training in type I fibres (~0.64 and ~0.59, 
respectively). These values are consistent with previous reports in rat (Macpherson et al., 2012; Prats 
et al., 2006) and human skeletal muscle (Shaw et al., 2009; Shepherd et al., 2012)(Chapter 2). 
Although the physiological significance of this partial colocalisation is currently unknown, this finding is 
in agreement with a number of observations demonstrating that the protein composition of LDs may 
vary (Ducharme and Bickel, 2008; Fujimoto et al., 2008; Wolins et al., 2005; Wolins et al., 2006b). To 
further investigate this relationship we assessed the colocalisation of these PLINs with LDs before and 
after 60 min moderate intensity endurance exercise. For each PLIN we describe two pools of LDs; 1) 
PLIN2-associated LDs (PLIN2-LD) and LDs that do not contain PLIN2 (PLIN2-null-LD) and 2) PLIN5-
associated LDs (PLIN5-LD) and LDs that do not contain PLIN5 (PLIN5-null-LD). In the untrained state, 
60 min moderate intensity endurance exercise induced a significant decrease in the number of PLIN2-
LD and PLIN5-LD, with no change in the number of PLIN2-null-LD and PLIN5-null-LD. These 
observations confirm a recent report from our laboratory showing a preferential utilization of PLIN2-LD, 
and not PLIN2-null-LD, in response to moderate intensity endurance exercise in sedentary individuals 
(Chapter 2), and provides novel evidence to suggest that a similar relationship exists for PLIN5. After 
6 weeks ET, a preferential decrease in the number of PLIN2-LD and PLIN5-LD also occurred in 
response to 60 min moderate intensity endurance exercise. Interestingly, in the trained state exercise 
also induced a decrease in the content of PLIN2-null-LD after 60 min moderate intensity endurance 
exercise, whereas the content of PLIN5-null-LD did not change. This is the first observation to suggest 
that PLIN5 is more important than PLIN2 in mediating the hydrolysis of intramuscular lipid stores 
during exercise and is in line with emerging evidence concerning the precise role of PLIN5 in lipolysis 
in cultured cells. Indeed, PLIN5 is the only PLIN thus far that has been shown to bind ATGL, and its 
coactivator, CGI-58. In this respect, overexpression of PLIN5  in cultured cells recruits ATGL and CGI-
58 under basal conditions, while expression of PLIN2 does not have this effect (Wang et al., 2011a). 
Furthermore, PLIN5 is phosphorylated in response to protein kinase A (PKA)-activation, and the 
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expression and PKA-induced activation of PLIN5 stimulates triacylglycerol hydrolysis in Chinese 
hamster ovary cells, whereas rates of lipolysis are unaffected by PKA activation in cells 
overexpressing PLIN2 (Wang et al., 2011a; Wang et al., 2011b). It is also important to note that 
electrical stimulation and adrenaline stimulation of rat skeletal muscle (Prats et al., 2006) has been 
reported to increase the colocalisation of HSL with PLIN2. However, it is not known whether this 
association occurs in man in vivo and whether it increases rates of lipolysis. It is also worth 
acknowledging that we only assessed colocalisation of either PLIN2 or PLIN5 with the LD's, and 
therefore cannot discriminate LDs containing both PLIN2 and PLIN5 from those LDs containing only 
PLIN2 or PLIN5. Nevertheless, the observation that the number of PLIN5-LD is reduced following 
exercise, while no reduction occurs in the number of PLIN5-null-LD appears to underpin the important 
role of PLIN5 in LD lipolysis and subsequent oxidation in skeletal muscle. In line with this conclusion, 
observations from various cell culture models and rat skeletal muscle preparations suggest that PLIN5 
also recruits mitochondria to the surface of LD’s, thus stimulating the formation of functional 
complexes between mitochondria and LDs (Bosma et al., 2011; Wang et al., 2011b). Accordingly, 
PKA activation in alpha mouse liver 12 (AML12) cells expressing PLIN5 has recently been shown to 
promote triacylglycerol hydrolysis and efficient channeling of liberated fatty acids to the mitochondria 
for β-oxidation (Wang et al., 2011b). IMTG and mitochondria in skeletal muscle of endurance athletes 
are observed in close proximity (Shaw et al., 2008), and ET enhances the spatial interaction between 
IMTG and mitochondria (Tarnopolsky et al., 2007). Collectively these observations suggest that 
increased expression and PKA activation of PLIN5 may also contribute to an increased net IMTG 
breakdown during moderate intensity endurance exercise by mediating stronger interactions between 
IMTG and mitochondria. 
 
It is worth noting that there was no net IMTG breakdown in type II fibres during 60 min moderate 
intensity exercise pre or post 6 weeks of training. This observation is in line with previous studies in 
well-trained athletes performing 2-3 h moderate-intensity exercise (De Bock et al., 2005; Stellingwerff 
et al., 2007; van Loon et al., 2003).  However, PLIN2 and PLIN5 protein expression was significantly 
increased in type II fibres, raising the question as to why IMTG breakdown was not enhanced in 
parallel as seen in the type I fibres.  However, as the exercise was performed at a moderate intensity, 
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it is likely that only a small proportion of the type II fibres were recruited, and this therefore may explain 
why no net IMTG breakdown was observed in type II fibres. In addition the higher PLIN2 and PLIN5 
content after training in both fibre types may also serve other metabolic roles such as to mediate IMTG 
storage under non-exercise conditions.  
 
Both PLIN2 and PLIN5 also appear to play an important role in limiting rates of lipolysis in the basal 
state, since expression of either PLIN2 or PLIN5 in cultured cells reduces basal lipolytic rates 
compared to when PLIN2 is knocked down or PLIN5 is not expressed (Bell et al., 2008; Listenberger 
et al., 2007; Wang et al., 2011a). Specifically, PLIN2 expression reduces the association of ATGL with 
the LD (Bell et al., 2008; Listenberger et al., 2007), and PLIN5 binds ATGL under basal conditions 
thereby reducing its activity (Wang et al., 2011a). Furthermore, it has recently been shown that PLIN5 
expression in AML12 cells reduces basal triacylglycerol hydrolysis and promotes palmitate 
incorporation into LD triacylglycerol (Wang et al., 2011b). If such mechanisms exist in vivo, these 
observations suggest that PLIN5 and/or PLIN2 may play a key role in the coupling of TAG hydrolysis 
to the metabolic demand for fatty acids.  As mentioned, ET increases the net breakdown of IMTG 
during exercise, therefore during an ET intervention IMTG concentrations are reduced on a regular 
basis. In addition, IMTG synthesis is upregulated in the period following IMTG-depleting exercise 
(Schenk and Horowitz, 2007).  Therefore, undertaking repeated bouts of exercise during an exercise 
training programme likely results in high rates of IMTG synthesis (Bergman et al., 2010).  As a result of 
this combination of training adaptations in the enzymes controlling IMTG metabolism, insulin 
resistance-inducing-FA metabolites have been suggested to be maintained at a lower concentration in 
skeletal muscle, thereby preserving higher insulin sensitivity in trained individuals. (Dubé et al., 2008; 
Dubé et al., 2011). 
 
The most well-documented adaptations to SIT are an improved VO2peak and an enhanced skeletal 
muscle oxidative capacity (reviewed (Gibala et al., 2012), both of which are increased by a similar 
magnitude as ET (Burgomaster et al., 2008).  We also demonstrate that SIT and ET improve VO2peak 
in sedentary individuals as previously described (Burgomaster et al., 2008), although in the present 
study the improvement in VO2peak tended to be greater in the ET group (P = 0.064). Like ET, SIT also 
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increased mitochondrial density, as previously reported (Burgomaster et al., 2008), and we provide 
novel data showing that SIT leads to higher IMTG content in type I and type II muscle fibres. In 
contrast to ET, no changes in whole body fat oxidation rates were observed following SIT.  This finding 
is in contrast to the findings of Burgomaster et al. (2008), who reported an increase in fat oxidation 
during exercise following SIT.  The SIT group tended to exhibit a lower RER than the ET group pre-
training, suggesting that rates of fat oxidation were higher in the SIT group before training, despite the 
groups being matched for physical activity level, aerobic capacity and fat mass, and diet was 
controlled in the 48 h prior to the exercise bout. Nevertheless, we observe clear increases in IMTG 
breakdown in type I fibres during moderate-intensity exercise in response to SIT, suggesting that the 
source of oxidised fat is shifted from plasma fatty acids towards IMTG. Importantly, the expression of 
both PLIN2 and PLIN5 correlated with IMTG content, net IMTG breakdown in type I fibres during 
exercise, and insulin sensitivity. Therefore, the data suggests that the increase in IMTG content and 
net breakdown during exercise that results from the increased expression of PLIN2 and PLIN5 likely 
maintains low intramuscular fatty acid metabolite concentrations leading to improvements in insulin 
sensitivity following both ET and SIT.  Accordingly, the present study adds to the growing body of 
evidence that SIT is a time-efficient exercise intervention to improve insulin sensitivity in healthy 
individuals and patient populations (Babraj et al., 2009; Hood et al., 2011; Little et al., 2011a; Richards 
et al., 2010). 
 
It is important to note that the primary aim of the study was to investigate exercise training-induced 
increases in net IMTG breakdown during 60 min moderate-intensity exercise and PLIN2 and PLIN5 
protein expression.  However, it is likely that the number of subjects in the present study is not 
sufficiently high to detect between groups differences for some of the measured variables.  Therefore, 
although many of the training effects are of a similar magnitude, larger-scale studies are required to 
determine which exercise mode is superior in increasing the main metabolic outcome measures 
(IMTG breakdown during exercise and PLIN2 and PLIN5 expression) and/or in increasing whole body 
insulin sensitivity and aerobic exercise capacity. Studies involving a larger number of participants 
should be completed before advice can be given about which exercise training mode is the best for 
the general population and for specific patient populations. 
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In conclusion, PLIN2 and PLIN5 expression are upregulated in response to ET, and the upregulation 
of these proteins appears to be important to facilitate the enhanced rates of net IMTG breakdown 
during exercise. In addition, PLIN2 and PLIN5 expression may contribute to an increase in IMTG 
content, which likely results in lower fatty acid metabolite concentrations, and in turn may drive the ET-
induced improvements in insulin sensitivity. Despite the large differences in duration and energy 
expenditure between SIT and ET, we provide novel evidence indicating that SIT induces similar 
improvements in net IMTG breakdown, PLIN2 and PLIN5 protein expression, aerobic exercise 
capacity and insulin sensitivity as traditional ET.  This study, therefore, generates novel information on 
the mechanism by which net IMTG breakdown during endurance type exercise increases following 
both modes of exercise training, and provides evidence that SIT provides a time-efficient exercise 
alternative to achieve improvements in aerobic fitness and insulin sensitivity. 
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Chapter 5 
 
Resistance training enhances skeletal muscle 
oxidative capacity and increases intramuscular 
triglyceride breakdown during exercise in type I 
and type II fibres of sedentary males 
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5.1 Abstract 
Increases in oxidative capacity and intramuscular triglyceride (IMTG) mobility are fundamental 
adaptations to endurance training and are mechanistically linked to enhanced skeletal muscle insulin 
sensitivity.  Currently, it is not known whether resistance training (RT) also increases mitochondrial 
density and IMTG utilisation during endurance-type exercise. Thirteen sedentary males (20±1 yrs, 
24.8±0.8 kg.m-2) performed 6 weeks of whole-body RT (3 times per week), after which changes in 
VO2peak and insulin sensitivity (Matsuda index) were assessed.  Muscle biopsies from the m. vastus 
lateralis were obtained from 8 individuals before and after 60 min steady state cycling at ~65% pre-
training VO2peak.  Immunofluorescence microscopy was used to assess muscle fibre type-specific 
changes in mitochondrial density, IMTG content and expression of PLIN2 and PLIN5.  RT increased 
VO2peak (8±3%), mitochondrial density (46±13% and 61±13% in type I and II fibres respectively; 
P<0.05) and the Matsuda insulin sensitivity index (47±6%; P<0.05).  In type I fibres IMTG (52±11%; 
P<0.05) and PLIN2 content was increased (107±19%; P<0.05) and PLIN5 content tended to increase 
(54±22%; P=0.054) post-training.  In type II fibres PLIN2 content increased (57 ± 20%; P<0.05), and 
IMTG (46 ± 17%; P=0.1) and PLIN5 (44 ± 24%; P=0.054) content tended to increase post-training.  
Pre-training, net IMTG breakdown occurred during endurance-type exercise in type I fibres only 
(30±8%; P<0.05). Post-training, IMTG breakdown occurred in both type I and II fibres (43±5%, 37±5%, 
respectively; P<0.05).    The results demonstrate for the first time that RT enhances mitochondrial 
density and increases IMTG utilisation in both type I and type II fibres during endurance-type exercise 
in previously sedentary males. 
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5.2 Introduction 
Elevated intramuscular triglyceride (IMTG) concentrations have been linked to a reduced skeletal 
muscle insulin sensitivity in sedentary and obese individuals and type 2 diabetes patients (Pan et al., 
1997; Phillips et al., 1996a; van Loon et al., 2004).  Endurance training (ET) is also associated with 
elevated IMTG concentrations, although muscle insulin sensitivity remains high in a phenomenon 
termed the ‘athlete's paradox’ (Goodpaster et al., 2001; van Loon et al., 2004).  As ET increases the 
breakdown of IMTG during exercise (Schrauwen et al., 2002; Van Proeyen et al., 2011a; Van Proeyen 
et al., 2011b)(Chapter 4), the capacity to oxidise IMTG is suggested to be mechanistically linked to the 
preservation of muscle insulin sensitivity alongside elevated IMTG concentrations (Bruce et al., 2003; 
Goodpaster et al., 2001; van Loon and Goodpaster, 2006).  The prevailing hypothesis is that regular 
breakdown and resynthesis of the IMTG pool during exercise training leads to a metabolic state in 
which a high IMTG content is combined with low concentrations of fatty acid metabolites, such as long 
chain acyl-CoA, diacylglycerol (DAG) and ceramides, which are thought to otherwise reduce insulin 
sensitivity (Moro et al., 2008; Shaw et al., 2010; van Loon and Goodpaster, 2006). 
 
Resistance training (RT) is also associated with improvements in insulin sensitivity in healthy 
individuals (Miller et al., 1994), those with impaired glucose tolerance (Eriksson et al., 1998), and 
overweight and obese individuals with type 2 diabetes (Hills et al., 2010; Holten et al., 2004).  
Accordingly it is recommended that RT is included in exercise programmes which aim to reduce the 
risk of developing metabolic disease (Gordon et al., 2009; Ratamess et al., 2009).  As skeletal muscle 
is the predominant site for insulin-stimulated glucose uptake, improvements in insulin sensitivity 
following RT are often attributed to skeletal muscle hypertrophy (Eriksson et al., 1997; Poehlman et 
al., 2000; Takala et al., 1999) and/or a greater abundance of insulin signalling intermediates and 
GLUT4 (Holten et al., 2004; Iglay et al., 2007; Krisan et al., 2004).  Such adaptations would increase 
the total capacity for glucose uptake and glycogen synthesis in skeletal muscle and improve insulin-
mediated glucose clearance from the blood.  However, whether the described improvements in IMTG 
metabolism that contribute to ET-induced improvements in insulin sensitivity also occur following RT 
has not yet been investigated. 
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An increased capacity for IMTG breakdown is linked to a greater skeletal muscle oxidative capacity 
and mitochondrial density following ET (Moro et al., 2008; van Loon, 2004).  However, whether RT 
enhances skeletal muscle oxidative capacity is equivocal, as some (Balakrishnan et al., 2010; Pesta et 
al., 2011; Tang et al., 2006), but not all studies (Bell et al., 2000; Chilibeck et al., 1999; Green et al., 
1999; MacDougall et al., 1979) report an increased mitochondrial density following RT.  In contrast, a 
number of studies have convincingly shown that net IMTG breakdown occurs during a single session 
of resistance exercise (Creer et al., 2005; Essen-Gustavsson and Tesch, 1990; Koopman et al., 
2006). Consequently, the possibility that RT will have a similar effect as ET in terms of being able to 
increase IMTG content and the ability to breakdown IMTG during subsequent endurance-type 
exercise cannot be excluded. Therefore, we first hypothesize that RT will increase IMTG content and 
mitochondrial density, and enhance IMTG breakdown during endurance-type exercise.  We (Chapter 
4), and others (Amati et al., 2011; Peters et al., 2012), have reported that ET augments the expression 
of two lipid droplet (LD)-associated proteins, perilipin 2 (PLIN2) and perilipin 5 (PLIN5), in skeletal 
muscle, and that the increase in these proteins occurs in parallel to the increase in IMTG content 
(Chapter 4).  Although the precise role of these proteins in skeletal muscle is not known, data obtained 
in vitro suggests that PLIN2 and/or PLIN5 compete with lipases at the LD surface to downregulate 
basal lipolysis and upregulate exercise or PKA stimulated lipolysis (Bell et al., 2008; Imamura et al., 
2002; Listenberger et al., 2007; Wang et al., 2011a; Wang et al., 2011b; Wolins et al., 2006b).  
Accordingly, we recently reported that both PLIN2 and PLIN5-containing LDs are preferentially utilised 
during moderate intensity exercise in sedentary individuals (Chapter 2 & 4).  Therefore, we further 
hypothesize that increased IMTG content and breakdown during exercise following RT would occur 
alongside increases in PLIN2 and PLIN5 protein expression. 
 
To investigate these hypotheses we employed immunohistochemical methodology described in 
Chapter’s 2, 3 and 4 to obtain muscle fibre type-specific information on muscle mitochondrial density, 
IMTG content and the protein expression of PLIN2 and PLIN5 in percutaneous muscle biopsies of the 
m. vastus lateralis obtained from sedentary males before and after 6 weeks of RT.       
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5.3 Methods 
 
Subject Characteristics 
Thirteen healthy, lean sedentary males (see Table 5.1 for characteristics) provided written, informed 
consent following a verbal and written explanation of the nature and risks involved in the study, which 
was approved by the Black Country NHS Research Ethics Committee (West Midlands, UK).  All 
subjects were free of known metabolic or cardiovascular disorders assessed using a general health 
questionnaire.  In addition, subjects had performed less than two 30 min sessions of physical activity 
per week in the preceding year, and were not involved in a structured exercise programme. 
 
Pre-experimental procedures 
All subjects initially underwent a progressive exercise test to exhaustion on an electronically braked 
cycle ergometer (Lode BV, Groningen, The Netherlands) in order to determine peak oxygen uptake 
(VO2 peak), as previously described (Chapter 2 & 4).  After sufficient recovery, individual one repetition 
maximum’s (1RM) were determined for all exercises to be performed during the training programme, 
which included chest press, leg press, latissimus pull down, leg extension, leg curl, shoulder press, 
bicep curls, and tricep extensions.  For each exercise a short warm up was performed, which included 
6 repetitions at an estimate of 50% 1RM, 4 repetitions at ~70% 1RM, and 2 repetitions at ~80% 1RM, 
with a 2 min recovery period between each set.  An estimate of 1RM was made based on the 
maximum number of repetitions performed for a specific load, using the following equation (Bryzicki, 
1998): 
1RM= 
Load
(1.0278-[0.0278×repetitions]) 
Subsequently, each exercise was performed at the estimated 1RM until only 1 repetition was possible, 
at which point the load was determined to be 1RM.  Sufficient rest was provided between each 1RM 
effort.  Post-training 1RM was determined for leg press, chest press, leg extension and shoulder 
press, as a measure of programme efficacy.  All exercises were performed on commercially available 
exercise machines (Cybex International Inc., MA, USA). 
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Experimental procedures 
Pre and post-training testing procedures were identical in all respects, and were undertaken across 
two consecutive days.  On both occasions, subjects were instructed to refrain from performing 
vigorous exercise in the preceding 48 h period.  In addition, subjects were provided with all food and 
drinks to be consumed in the preceding 24 h.  The diet was of a standard macronutrient composition 
(50% carbohydrate, 35% fat, 15% protein), but adjusted for each individual’s habitual caloric intake, 
assessed through the completion of a 3 day weighed-intake diet diary.  During the exercise training 
period subjects were asked to maintain their habitual physical activity and dietary patterns, with the 
latter being assessed through completion of a 3 day diet diary post-training. 
 
Day 1:  Subject’s reported to the laboratory after an overnight fast (>10 h) to undergo a 2 h oral 
glucose tolerance test (OGTT) as previously described (Chapter 4).  Plasma glucose and insulin 
concentrations were determined and subsequently used to calculate an index of insulin sensitivity 
(Matsuda and DeFronzo, 1999), as previously reported (Chapter 4).  Body composition analysis was 
performed immediately following the OGTT using Dual energy X-ray Absorptiometry (DXA).  Regional 
fat mass and fat-free mass of each subject was determined using specialist software (QDR software, 
Hologic Inc., MA, USA).  Relative fat mass was calculated for each region using absolute fat mass as 
a proportion of total mass.   
 
Day 2:  8 out of the 13 subject’s taking part in the study agreed to provide muscle samples.  These 
subject’s again reported to the laboratory after an overnight fast (>10 h) at ~7am, and the thigh of one 
leg was prepared for muscle biopsy collection.  Two incisions were made approximately 2 cm apart.  
The leg that was to undergo biopsy was randomised in the pre-training condition; the contralateral leg 
was sampled post-training.  A resting muscle biopsy was obtained from the distal incision of the vastus 
lateralis using the Bergström technique and prepared for immunohistochemical analysis, as described 
previously (Chapter 2 & 4).  Subsequently, subjects underwent 1 h of steady state cycling at a 
workload equivalent to 65% pre-training VO2 peak on an electronically braked cycle ergometer (Lode 
BV, Groningen, The Netherlands).  A second muscle biopsy was taken immediately post-exercise from 
the proximal incision.      
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 Training procedures 
The training programme was designed to increase strength and induce hypertrophy, reflecting the 
most recent ACSM position stand for strength training in healthy adults (Ratamess et al., 2009).  
Specifically, subjects undertook three training sessions per week for six weeks in the resistance 
training laboratory.  During each session a total of 9 exercises were performed: chest press, leg press, 
lat pull down, leg curl, leg extension, shoulder press, bicep curl, tricep extension, abdominal crunches.  
For each exercise, subjects performed 3 sets consisting of 12 repetitions per set.  In session 1, the 
workload for each exercise was equal to 50% of each individuals 1RM.  In sessions 2 and 3 this was 
increased to 60 and 70% of 1RM respectively.  The workload was further increased to 80% 1RM in 
session 4, at which point the workload was fixed.  In order to progress, subjects had to achieve 3 
complete sets of 12 repetitions, after which the workload was increased 5 lb.  Importantly, subjects 
were encouraged to work to fatigue on the final set of each exercise, irrespective of the number of 
repetitions achieved.  All training sessions were supervised to ensure programme adherence and form 
quality was maintained. 
 
Muscle analysis 
Serial 5 µm cryosections from pre and post training muscle biopsies were cut at -30°C and transferred 
on to ethanol-cleaned glass slides and stained for fibre type determination of IMTG (oil red O), 
cytochrome c oxidase (COX), PLIN2, and PLIN5 content using immunofluorescence, as described 
previously (Chapter 2, 3, & 4).  Oxidative capacity was also estimated by determining maximal 
succinate dehydrogenase (SDH) activity.  Accordingly, cryosections were incubated in 0.2M 
phosphate buffer (13 ml 0.2 M NaH2PO4 + 87 ml 0.2 M Na2HPO4, pH 7.6) containing 0.1 M Na 
succinate and 1.2 mM nitro-blue tetrazolium (all chemicals obtained from Sigma, UK) for 60 min at 
37ºC.  Slides were rinsed (3 x 30s deionised water), after which the unbound nitro-blue tetrazolium 
was removed with three consecutive washes in increasing solutions of acetone (30%, 60%, and 90%).  
Slides were air dried for 15 min followed by incubation with appropriate primary and secondary 
antibodies for determination of fibre type (as described in Chapter 2, 3 & 4).  Capture of 
immunofluorescence-stained cross-sectional orientated images was performed as previously reported 
(Chapter 2, 3 & 4).  Brightfield images of cross-sectional orientated sections displaying fibre type-
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specific distributions of SDH activity were captured using an Olympus BX61 microscope with a 20x 
0.50 NA objective coupled to a SPOT RT3 colour camera (Diagnostic Instruments Inc., MI, USA).  All 
image processing was performed using Image-Pro Plus 5.1 software (Media Cybernetics, MD, USA).  
Both widefield and brightfield images were used to assess the fibre specific distribution of IMTG, 
PLIN2, PLIN5 and mitochondria.  Analysis was performed for 97 ± 9 fibres per muscle cross-section 
(38 ± 4 type I fibres, 59 ± 6 type II fibres).  COX and SDH staining intensity was used to indicate 
changes in mitochondrial content after training.  An intensity threshold was uniformly selected to 
represent positive signal for IMTG, PLIN2 and PLIN5.  The content of IMTG, PLIN2 and PLIN5 was 
expressed as the positively stained area fraction relative to the area of each muscle fibre.  Confocal 
microscope images of IMTG, PLIN2 and PLIN5 were used to identify changes in size and density 
(calculated as the number of objects relative to area).         
 
Statistics 
All data are expressed as means ± S.E.  Significance was set at the 0.05 confidence level.  Changes 
in parameters of exercise capacity, body composition, and insulin sensitivity were assessed using a 
paired t-test analysis.  A two-factor repeated measures ANOVA was used to assess mitochondria, and 
PLIN2 and 5 content, using the two within subject factors as ‘training’ (pre- versus post-training) and 
‘fibre’ (type I versus type to II fibres).  To inspect differences in IMTG, we hypothesised a priori that 
IMTG content would be significantly different between type I and type II fibres.  Thus, we employed a 
two-factor repeated measures ANOVA, using the within subject factors ‘training’ (pre- versus post-
training) and ‘time’ (pre- versus post-exercise).  Significant main effects or interactions were assessed 
using Bonferroni adjustment post hoc analysis.  In order to investigate specific relationships between 
variables, a simple linear regression analysis was used.       
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5.4 Results 
 
Whole-body measures (n=13) 
Exercise capacity, body composition and insulin sensitivity (Table 5.1):  The effectiveness of the RT 
programme employed in the current study was underlined through the observed improvements in 1RM 
for leg press, chest press, leg extension and shoulder press (43 ± 7%, 34 ± 4%, 35 ± 5% and 34 ± 4%, 
respectively; P < 0.001).  Training also induced an 8 ± 3% (P = 0.015) improvement in VO2 peak and a 7 
± 2% increase in Wmax (P = 0.001).  No changes in BMI or body mass were observed following 
training.  Both an increase in free-fat mass (FFM) (3 ± 1%; P = 0.010) and a decrease in fat mass 
(FM) (8 ± 3%; P = 0.036) occurred in response to training, which corresponded to an 8 ± 2% decrease 
in relative fat mass.  Training induced a 12 ± 3% (P = 0.023) and 24 ± 6% (P < 0.001) decrease in 
glucose and insulin area under the curve (AUC), respectively.  Insulin sensitivity, calculated using the 
Matsuda index, was improved 47 ± 6% (P < 0.001) following training. 
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Table 5.1.  Subject characteristics 
 Pre-Training Post-Training 
Age (yrs) 20 ± 1  
Height (m) 1.76 ± 0.03  
Weight (m) 76.7 ± 3.3 76.1 ± 3.1 
BMI (kg.m-2) 24.8 ± 0.8 24.6 ± 0.7 
Exercise capacity 
  
   Leg press 1RM (kg) * 194 ± 10 278 ± 15 
   Chest press 1RM (kg) * 54 ± 3 71 ± 3 
   Leg extension 1RM (kg) * 119 ± 5 158 ± 5 
   Shoulder press 1RM (kg) * 47 ± 2 64 ± 2 
   VO2 peak (l.min-1) * 3.24 ± 0.16 3.46 ± 0.21 
   VO2 peak (l.min-1.kg-1) * 42.3 ± 1.4 45.5 ± 1.7 
   Wmax (W) * 216 ± 11 231 ± 12 
Body composition 
  
   FM (kg) * 16.0 ± 1.4 14.8 ± 1.4 
   FFM (kg) * 51.1 ± 2.0 52.8 ± 2.1 
   % FM * 22.9 ± 1.7 21.0 ± 1.6 
Whole-body insulin sensitivity 
  
   Glucose AUC (mg.dl-1.120 min-1) * 16329 ± 724 14567 ± 826 
   Insulin AUC (µU.ml-1.120 min-1) * 9548 ± 1006 7484 ± 863 
   ISI-Matsuda * 2.9 ± 0.3 3.8 ± 0.3 
 
Data provided are means ± S.E. (n=13).  BMI body mass index, Wmax maximum workload, FFM fat 
free mass, FM fat mass.  Body composition data was obtained using a DXA scan.  * indicates main 
training effect (P < 0.05), such that Pre ≠ Post. 
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Skeletal muscle sample analysis (n=8) 
Intramuscular triglyceride analysis (Figure 5.1): To investigate the a priori hypothesis that IMTG 
content is greater in type I fibres versus type II fibres, we examined training effects separately for the 2 
fibre types.  Training increased IMTG content in type I fibres (52 ± 11%; P = 0.01) and tended to 
increase IMTG content in type II fibres (46 ± 17%; P = 0.1).  The increase in IMTG content was 
attributed to greater IMTG density in both type I (pre 0.049 ± 0.008 LDs.µm-2, post 0.074 ± 0.008 
LDs.µm-2; P = 0.047) and type II fibres (pre 0.013 ± 0.004 LDs.µm-2, post 0.027 ± 0.005 LDs.µm-2; P = 
0.07).  No significant changes in lipid droplet size were observed. 
 
Pre-training, 60 min steady state cycling induced a 30 ± 8% decrease in IMTG content in type I fibres  
(main time effect; P = 0.04), with no changes apparent in type II fibres.  Post-training, significant IMTG 
breakdown during steady state exercise occurred in both type I (43 ± 5%, main time effect; P < 0.01) 
and type II fibres (37 ± 5%,main time effect; P = 0.01).  In comparison to pre-training, net IMTG 
utilisation in type I and type II fibres was significantly greater following training (training x time 
interaction; P < 0.05).  All reported changes in IMTG content in response to exercise were attributed to 
significant reductions in IMTG density, with no changes in IMTG size observed. 
 
Mitochondrial analysis (Figure 5.2):  Immunofluorescence images of the mitochondrial marker COX 
revealed a greater mitochondrial density (expressed as fluorescence intensity) in type I fibres 
compared to type II fibres both pre and post-training (P < 0.001).  Mitochondrial density was 
significantly increased in response to training in both type I and type II fibres (46 ± 13% and 61 ± 13%, 
respectively; P < 0.001).  The magnitude of change in mitochondrial density was significantly greater 
in type II fibres compared to type I fibres (P = 0.02).  In addition, brightfield images demonstrated that 
SDH activity (expressed as optical density) was significantly greater in type I fibres compared to type II 
fibres both pre and post-training (P < 0.01).  Furthermore, SDH activity in both type I and type II fibres 
was significantly increased following training (17 ± 5%, 23 ± 5%, respectively; P < 0.001).   
 
PLIN2 and PLIN5 analysis (Figure 5.3):  Both PLIN2 and PLIN5 content (expressed as a % of fibre 
stained) was significantly greater in type I fibres compared to type II fibres, irrespective of training state 
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(main fibre effect; P < 0.001).  Training induced a significant increase in PLIN2 content in both type I  
and type II fibres (107 ± 19% and 57 ± 20%, respectively, main training effect; P < 0.01).  This was 
attributed to a greater PLIN2 density in both fibre types (type I fibres: pre-training 0.046 ± 0.005  
PLIN2.µm-2, post-training 0.085 ± 0.009 PLIN2.µm-2, type II fibres: pre-training 0.011 ± 0.003  
PLIN2.µm-2, post-training 0.015 ± 0.004 PLIN2.µm-2; main training effect; P < 0.001).  PLIN5 content 
tended to increase following training in both type I and type II fibres (58 ± 22% and 44 ± 24%, 
respectively, main training effect; P = 0.054).  This was again attributable to a greater PLIN5 density in 
both fibre types (type I fibres: pre-training 0.060 ± 0.007 PLIN5.µm-2, post-training 0.093 ± 0.008 
PLIN5.µm-2; type II fibres: pre-training 0.007 ± 0.003 PLIN5.µm-2, post-training 0.019 ± 0.004 
PLIN5.µm-2, main training effect; P = 0.026). 
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Fig. 5.1. Effect of 6 weeks RT on fibre type specific IMTG content and utilisation during exercise 
 
 
 
 
Representative immunofluorescence images of IMTG (stained red) in combination with WGA to identify the cell border (stained blue) in skeletal muscle, 
pre (A) and post (B) 6 weeks of RT.  Type I fibres are indicated with “I”, all other fibres are assumed type II fibres.  White bar = 50µm.  Images (C) and 
(D) display the ORO signal obtained after the intensity threshold was applied during quantitation (showing the LDs in white), before and after RT, 
respectively.  IMTG content quantified from immunofluorescence images of oil red O-stained muscle sections, before (closed bars) and after (open 
bars) 6 weeks of RT, in type I (E) and type II (F) fibres.  IMTG content was measured before (PreEx) and after (PostEx) 60 min steady state cycling at 
65% pre-training VO2 peak, and net IMTG breakdown calculated (Breakdown).  Values are presented as means ± S.E. (n = 8).  Type I fibres: Training 
effect; P = 0.024, time effect; P < 0.01, training x time interaction; P = 0.04.  Type II fibres: training effect; P = 0.098, time effect; P < 0.041, training x 
time interaction; P = 0.033.  * Significant training effect (P < 0.05).  
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Fig. 5.2 Effect of 6 weeks of RT on fibre type-specific mitochondrial density 
 
 
 
 
 
Fibre type specific immunofluorescence visualisation of COX (stained red) in combination with WGA to identify the cell border (stained blue) in skeletal 
muscle, (A) pre and (B) post 6 weeks of RT. Type I fibres are indicated with a “I”, all other fibres are assumed type II fibres. White bar = 50µm. (C) 
Mitochondrial content, quantified from immunofluorescence images of COX, obtained before and after 6 weeks of RT in type I fibres (closed bars) and 
type II fibres (open bars). Training effect; P < 0.001, fibre effect; P < 0.001.  Fibre specific visualisation of SDH activity in skeletal muscle, (C) pre and 
(D) post 6 weeks of RT. Black bar in panel C and D = 100µm. (F) SDH activity in type I fibres (closed bars) and type II fibres (open bars).  COX protein 
expression and SDH activity was significantly different between type I and type II fibres at all time-points (P < 0.05). Values are presented as means ± 
S.E (n = 8).  Training effect, P = 0.001; fibre effect, P < 0.001. * Significant training effect, † significant fibre effect (P < 0.05). 
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Fig. 5.3 Effect of 6 weeks of RT on fibre type specific PLIN2 and PLIN5 content 
 
 
 
 
 
Fibre type specific visualisation of PLIN2 (stained green) (A: Pre, B: Post) and PLIN5 (C: Pre, D: Post) in combination with WGA to identify the cell 
border (stained blue) in skeletal muscle, following 6 weeks of RT.  Type I fibres are indicated with a “I”, all other fibres are assumed type II fibres.  White 
bar = 50µm.  Fluorescence images were used to quantify PLIN2 (E) and PLIN5 (F) content in type I (closed bars) and type II (open bars) fibres.  Values 
are presented as means ± S.E (n = 8).  (E) Training effect, P < 0.001; fibre effect, P = 0.002; training x fibre interaction, P = 0.017.  (F) training effect; P 
= 0.054, fibre effect, P < 0.001; training x fibre interaction; P = 0.06.  * Significant training effect, † significant fibre effect (P < 0.05). 
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Correlation analyses 
For correlation analyses, data obtained for type I and type II fibres, pre and post-training were pooled 
(Table 5.2).  Pre-exercise IMTG content showed a strong positive correlation with PLIN2 content (R = 
0.55; P < 0.001), PLIN5 content (R = 0.61; P < 0.001) and COX intensity (R = 0.58, P < 0.001).  Pre-
exercise IMTG content (R = 0.66; P < 0.001), PLIN5 content (R = 0.50; P = 0.003), COX intensity (R = 
0.60; P < 0.001) and SDH intensity (R = 0.43; P = 0.02) were all strongly associated with IMTG 
utilisation, whereas PLIN2 content (R = 0.36; P = 0.044) was moderately associated with IMTG 
utilisation.  Insulin sensitivity was moderately associated with IMTG content (R = 0.39; P = 0.037) and 
strongly associated with COX intensity (R = 0.71; P < 0.001), but did not correlate with PLIN2 or 
PLIN5 expression. 
 
Table 5.2. Bivariate correlation analysis  
 IMTG Net IMTG breakdown Insulin sensitivity 
IMTG  0.66‡ 0.39* 
PLIN2 0.55‡ 0.36* 0.14 
PLIN5 0.61‡ 0.51† 0.24 
COX 0.58‡ 0.60‡ 0.71‡ 
 
IMTG, PLIN2 and PLIN5 content and COX fluorescence intensity represent pre-exercise values. IMTG 
utilisation refers to the absolute change in IMTG concentration from pre to post-exercise. Values 
represent Pearson’s squared correlation coefficients (R values) for relationships between variables. All 
data obtained for type I and type II fibres, pre and post-training were pooled for correlation analysis. 
Significant correlations: *P < 0.05, †P < 0.01, ‡P < 0.001. 
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5.5 Discussion 
This is the first study to show that 6 weeks of RT increases IMTG content, muscle mitochondrial 
oxidative capacity, and net IMTG breakdown during endurance-type exercise, in line with our first 
hypothesis.  The increase in IMTG content and breakdown following RT was also accompanied by 
greater expression of PLIN2 and PLIN5, consistent with our second hypothesis.  Both PLIN2 and 
PLIN5 are present in the protein coat surrounding LDs (Brasaemle et al., 1997; Wolins et al., 2006b) 
and have recently been shown to play a role in the training-induced increases in IMTG breakdown 
during endurance-type exercise (Chapter 4).  Together, these observations confirm the underlying 
hypothesis of the study that improvements in insulin sensitivity following 6 weeks RT are, at least in 
part, attributable to increased mobility of the IMTG pool and an enhanced skeletal muscle oxidative 
capacity.  It should be noted, however, that the increase in mitochondrial density and IMTG utilisation 
during endurance-type exercise is significant after 6 weeks of RT in both type I and type II fibres.  In 
contrast, increases in IMTG breakdown are restricted to type I fibres following 6 weeks of ET and 
sprint interval training (SIT) (Chapter 4).  This observation is likely to be important as it implies that a 
combination of ET and RT is required to iincrease IMTG breakdown, oxidative capacity and insulin 
sensitivity of type II fibres. 
 
Regular breakdown and resynthesis of IMTG during exercise training is postulated to increase IMTG 
content whilst maintaining low concentrations of fatty acid metabolites, such as long chain acyl-CoA, 
DAG and ceramides (Moro et al., 2008; Shaw et al., 2010; van Loon and Goodpaster, 2006), the 
accumulation of which leads to increased IRS-1 serine phosphorylation and Akt/PKB 
dephosphorylation (Gual et al., 2005; Summers, 2006), thereby reducing insulin-mediated glucose 
uptake.  An increased rate of IMTG turnover is proposed to contribute to the improvement in insulin 
sensitivity observed following both ET and HIT in sedentary individuals (Chapter 4), and we 
hypothesized that a similar mechanism contributes to the enhanced insulin sensitivity following RT in 
the present study.  In support, we report for the first time that 6 weeks of whole-body RT in sedentary 
individuals enhances IMTG content in type I fibres, with a strong trend for an increase in type II fibres.  
A number of studies have previously shown that IMTG are reduced following an acute bout of 
resistance exercise (Creer et al., 2005; Essen-Gustavsson and Tesch, 1990; Koopman et al., 2006), 
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and that rates of IMTG synthesis increase in the period following endurance-type exercise-induced 
IMTG depletion (Schenk and Horowitz, 2007). Therefore, our data are compatible with the hypothesis 
that repeated depletion and subsequent resynthesis of IMTG stores with each bout of resistance 
exercise leads to a higher set-point for IMTG content after 6 weeks of RT. 
 
To investigate the impact of RT on IMTG breakdown, we examined IMTG breakdown in type I and 
type II fibres during the acute bout of endurance-type exercise both before and after RT.  Before 
training, 60 min steady state cycling induced a ~30% decrease in IMTG content in type I fibres only, 
confirming that IMTG contribute to energy expenditure during exercise in young, sedentary individuals 
(Coggan et al., 2000; Shepherd et al., 2012).  Following RT, endurance-type exercise at the same 
absolute workload induced a significantly greater decline in IMTG content than that observed at 
baseline, with a ~43% and ~37% decrease occurring in type I and type II fibres, respectively.  Thus, 
we provide clear evidence that, in a similar manner to the well described effects of ET and HIT (Hurley 
et al., 1986; Schrauwen et al., 2002; Van Proeyen et al., 2011b)(Chapter 4), 6 weeks of RT also 
improves IMTG utilisation during endurance-type exercise.  In lean, physically active individuals, IMTG 
utilisation during exercise is strongly associated with pre-exercise IMTG content (Stellingwerff et al., 
2007; van Loon et al., 2003), a finding that is replicated in the present study. Therefore, the RT-
induced elevation in IMTG concentration at least partly explains the enhanced IMTG utilisation during 
endurance-type exercise following RT.  However, this relationship is not observed in obese type 2 
diabetes patients who display large concentrations of IMTG but low rates of IMTG utilisation during 
exercise (Blaak et al., 2000; Schrauwen et al., 2002; van Loon et al., 2003), indicating that a high 
IMTG content alone does not determine the degree of IMTG breakdown during exercise. 
 
Importantly, 6 weeks of RT also enhanced skeletal muscle oxidative capacity, which occurred 
concomitant with a significant improvement in maximal aerobic exercise capacity.  As skeletal muscle 
oxidative capacity is strongly determined by fibre type composition, we used both immunofluorescence 
and brightfield microscopy to measure fibre-type specific changes in oxidative capacity.  Accordingly, 
we demonstrate that both COX protein content and SDH activity are significantly increased following 
RT, and these increases occur in both type I and type II muscle fibres.  Interestingly, the magnitude of 
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the increase in COX expression is greater in type II fibres compared to type I fibres, which is likely 
explained by the primary recruitment of type II fibres during resistance exercise.  The finding of an 
increase in oxidative capacity following RT is in agreement with a number of previous studies 
(Balakrishnan et al., 2010; Pesta et al., 2011; Tang et al., 2006), although it should be noted that some 
studies show no change (Bell et al., 2000; Green et al., 1999) or even a decrease in mitochondrial 
content following prolonged RT (Chilibeck et al., 1999; MacDougall et al., 1979). Nevertheless, in line 
with the present study, an acute bout of resistance exercise is known to enhance rates of 
mitochondrial protein synthesis and the expression of PGC1α (Wilkinson et al., 2008; Burd et al., 
2011).    However, the stimulation of mitochondrial protein synthesis following an acute bout of 
resistance exercise is lost following 10 weeks of RT (Wilkinson et al., 2008). Thus, it could be 
speculated that an increase in oxidative capacity is an early (<6 weeks) adaptation to RT in sedentary 
individuals.  Given that fat oxidation rates are dependent on the capacity for β-oxidation and therefore 
mitochondrial density (Simoneau et al., 1999), the elevations in oxidative capacity observed in the 
present study likely provide an enhanced capacity for fatty acid oxidation, thus enabling an increased 
contribution of the expanded IMTG pool. 
 
The oxidation rate of IMTG-derived fatty acids is also dependent on rates of IMTG lipolysis, and the 
regulation of basal and stimulated lipolysis is determined by the activation and/or localisation of the 
lipolytic enzymes.  Expression of either PLIN2 or PLIN5, two LD-associated proteins, in cultured cells 
reduces the rate of basal TAG lipolysis (Listenberger et al., 2007; Bell et al., 2008; Wang et al., 
2011a), and increases palmitate incorporation into LD TAG (Wang et al., 2011b; Bosma et al., 2012a).  
In contrast, protein kinase A (PKA)-activation in PLIN5-expressing alpha mouse liver 12 (AML12) cells 
increases TAG hydrolysis, releasing fatty acids for β-oxidation (Wang et al., 2011b).  Moreover, 
adrenaline stimulation of rat skeletal muscle increases the colocalisation of HSL with PLIN2 (Prats et 
al., 2006), and PLIN5 is able to bind ATGL, and its co-activator, CGI-58 (Granneman et al., 2011; 
Wang et al., 2011a).  Taken together, these data suggest that PLIN2 and PLIN5 may mediate the 
interaction of lipolytic enzymes with the LD, and therefore contribute to the regulation of the rate of 
lipolysis.  Our observations (Chapter 2 & 4) that PLIN2 and PLIN5-containing-LDs are preferentially 
broken down during endurance-type exercise support this role, and the protein expression of both 
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PLIN2 and PLIN5 is enhanced following both ET and HIT, in line with the observed increase in IMTG 
breakdwon during exercise (Chapter & 4).  In the present study we found that 6 weeks RT in 
sedentary individuals increases the protein expression of PLIN2 and PLIN5 in both type I and type II 
fibres.  This is the first study to report an effect of RT on PLIN expression at the protein level, although 
it was recently reported that 11 weeks of RT had no effect on the mRNA expression of any of the 
PLINs in skeletal muscle (Gjelstad et al., 2012).  Nevertheless, it is notable that in the present study 
when all pre-exercise data was pooled, IMTG content positively correlated with the expression of 
PLIN2 and PLIN5, in agreement with previous observations in rodent (Minnaard et al., 2009) and 
human skeletal muscle (Amati et al., 2011)(Chapter 4).  Furthermore, both PLIN2 and PLIN5 
expression showed a positive correlation with IMTG breakdown during exercise.  Although the precise 
significance of this relationship is unknown, it is likely that greater PLIN2 and PLIN5 expression 
preserves the PLIN coverage of the expanded LD surface area, thereby maintaining adequate lipolytic 
control over the LD pool at rest and during exercise.  In addition, it is worth acknowledging that recent 
data obtained in rat cardiomyocytes and human and rat skeletal muscle demonstrate that PLIN5 also 
mediates the spatial interaction of the LD with the mitochondrial network (Bosma et al., 2011; Wang et 
al., 2011b), thereby increasing the efficiency by which FA released by LD lipolysis are channelled into 
the mitochondria for β-oxidation (Wang et al., 2011b). Previously it has also been observed that the 
physical distance between LD and mitochondria is smaller in skeletal muscle of ET-individuals 
(Tarnopolsky et al., 2007). Therefore, as RT induced an increase in mitochondrial density, the number 
of LDs and the expression of PLIN5, it is likely that RT also may improve the physical interaction 
between LD and mitochondria that results in a more efficient channelling of FA released by lipolyis into 
the muscle for β-oxidation in the current study. 
 
The 6 week whole-body RT programme employed in the present study induced a small but significant 
elevation in total fat free mass.  As such, it should be noted that the increase in skeletal muscle mass 
will increase the total capacity for glucose disposal, and therefore contributes to the improvement in 
insulin sensitivity.  RT has also been shown to enhance the total number of GLUT4 transporters and 
insulin signalling intermediates per muscle mass unit, independent of an increase in muscle mass 
(Holten et al., 2004; Krisan et al., 2004; Iglay et al., 2007).  Consequently, we do not claim that an 
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increase in IMTG mobility is the only mechanism by which RT improves insulin sensitivity.  Rather, this 
study highlights the underappreciated contribution of IMTG metabolism to the well described 
improvements in insulin sensitivity with RT.  Furthermore, additional muscular adaptations such as 
increased mitochondrial density and PLIN protein expression are likely to be important to support such 
improvements in IMTG metabolism and insulin sensitivity.  
 
In conclusion, this study confirms the effectiveness of a RT intervention in sedentary males for 
improving insulin sensitivity and supports the current recommendations that RT should be included as 
one of the components in mixed exercise programmes which aim to reduce the risk of developing 
sarcopenia and metabolic disease, or programmes that aim to maintain muscle mass and strength in 
frail individuals. 
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Chapter 6 
 
Constant-workload sprint interval and 
traditional endurance training both increase 
insulin sensitivity and expression of perilipin 2 
and 5 in obese males 
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6.1 Abstract 
In Chapter 4 it was demonstrated that in previously sedentary young males both Wingate-based sprint 
interval training (SIT) and traditional endurance-based training (ET) enhance skeletal muscle oxidative 
capacity, intramuscular triglyceride (IMTG) concentration and whole-body insulin sensitivity. Evidence 
was also presented demonstrating that increases in perilipin 2 (PLIN2) and perilipin 5 (PLIN5) protein 
expression were instrumental to increases in net IMTG breakdown observed after both training 
modes.  The current study first investigated the hypothesis that constant workload SIT (repeated 30s 
sprints at 200% Wmax) also improves insulin sensitivity and VO2peak in sedentary obese males.  
Secondly, this study investigated the hypothesis that constant workload SIT and traditional ET 
enhance IMTG concentration and PLIN2 and PLIN5 expression.  Sixteen sedentary obese males 
performed 4 weeks of either SIT (4-7x 30s sprints at 200% Wmax, 3d.wk-1) or ET (40-60 min cycling at 
~65% VO2 peak, 5d.week-1).  Training increased skeletal muscle oxidative capacity (SIT 47±6%, ET 
38±75; P<0.05) and the Matsuda insulin sensitivity index (SIT 13±5%, ET 23±4%; P < 0.05).  Training 
also increased PLIN2 (SIT 92±19%, ET 82±23%; P<0.05) and PLIN5 protein expression (SIT 54±15%, 
ET 36±10%; P<0.05) in type I fibres, whereas IMTG concentration only showed a trend to increase 
(SIT 51±21%, ET 31±25%; P=0.086).  Fasting plasma cholesterol concentration was reduced 
following training (SIT 13±6%, ET 10±7%; P<0.05), and fasting plasma triglyceride concentration 
tended to decrease (SIT 16±8%, ET 10±7%; P=0.06).  In conclusion, the data in this study show that 4 
weeks constant workload SIT or ET both lead to increases in insulin sensitivity in sedentary obese 
males. The data are also consistent with the hypothesis that increased expression of PLIN2 and 
PLIN5, leading to improved regulation of IMTG, is instrumental in the underlying mechanism. 
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6.2 Introduction 
Improvements in insulin sensitivity typically observed in response to endurance training (ET) are 
associated with an increased skeletal muscle oxidative capacity, enhanced intramuscular triglyceride 
(IMTG) concentration, and a greater capacity to oxidise IMTG during exercise (reviewed in van Loon & 
Goodpaster, 2006; Moro et al., 2008; Shaw et al., 2010).  In accordance, overweight and obese 
individuals undertaking ET for 16 weeks or more demonstrate increased IMTG storage in parallel to 
improved insulin sensitivity and/or glycaemic control (Dubé et al., 2008; Dubé et al., 2011)(Chapter 3), 
a relationship which may be mechanistically linked to reduced intramuscular concentrations of specific 
diacylglycerol (DAG) and ceramide species (Bruce et al., 2006; Dubé et al., 2008; Amati et al., 2011; 
Dubé et al., 2011).  Improvements in insulin sensitivity have also been observed in response to sprint 
interval training (SIT) in sedentary lean individuals (Babraj et al., 2009; Richards et al., 2010), and 
following constant-load high intensity interval training in lean sedentary individuals (Hood et al., 2011) 
and obese type 2 diabetes patients (Little et al., 2011a). However, in these studies no attempt has 
been made to investigate whether changes in IMTG metabolism are potentially instrumental in the 
underlying mechanism.  In Chapter 4 of this thesis it was demonstrated for the first time that 6 weeks 
of SIT in lean, sedentary, insulin sensitive individuals enhances the content and breakdown of IMTG 
during moderate-intensity exercise in parallel with increased protein expression of the lipid droplet 
(LD)-associated proteins, perilipin 2 (PLIN2) and perilipin 5 (PLIN5).  No studies have yet investigated 
the potentially beneficial effects of SIT and ET on IMTG content, perilipin protein expression and 
insulin sensitivity in obese, sedentary individuals who likely demonstrate pre-existing elevated IMTG 
stores (van Loon et al., 2004; Amati et al., 2011) and are at an increased risk of developing insulin 
resistance and type 2 diabetes. 
 
The SIT protocol traditionally consists of 4-6 30 s Wingate cycling tests interspersed with 4.5 minutes 
rest, performed on three separate occasions per week (reviewed in Gibala et al., 2012).  This equates 
to 2-3 min exercise per session, and a total weekly exercise commitment of 6-9 min (Table 6.1).  
Notably, the resistance during a Wingate test is determined by a combination of the subject’s body 
weight (equivalent to 7.5% of body mass) and the number of revolutions achieved per minute 
(cadence).  Therefore, Wingate-based SIT requires an ‘all-out’ effort against a very high resistance on 
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a specialized cycle ergometer, necessitating high levels of internal and external motivation and 
expensive equipment.  As a result, the practicality of Wingate-based SIT for the general population is 
questionable, especially in overweight and obese individuals who may benefit most from the effects of 
SIT.  In line with this notion, a number of previous studies have employed a constant load high 
intensity interval training protocol to induce positive metabolic adaptations (Talanian et al., 2007; Perry 
et al., 2008; Little et al., 2010).  Specifically, these studies have employed intervals ≥1 min in duration 
performed at an intensity of 90-100% peak power output, and therefore energy production will be 
predominantly met by aerobic metabolism (Medbo & Tabata, 1993).  In contrast, anaerobic energy 
production predominates during shorter (≤ 30s) high intensity exercise (Medbo & Tabata, 1993), 
although the contribution from oxidative phosphorylation increases during consecutive bouts of high 
intensity exercise (Parolin et al., 1999).  The present study aimed to employ a practical high intensity 
interval training protocol that retained both the metabolic stimulus and time saving benefits associated 
with Wingate-based SIT.  To this end, a protocol employing repeated bouts of high intensity interval 
training performed at a constant workload equivalent to 200% peak power output was chosen for 
investigation in the present study. 
 
Obese individuals exhibit increased plasma concentrations of triglyceride and total cholesterol (Pi-
Sunyer, 2002; Mokdad et al., 2003), and these factors are associated with a greater risk of developing 
cardiovascular disease (Hokanson & Austin, 1996).  ET has been shown to reduce the plasma 
concentrations of triglyceride and cholesterol (Durstine & Haskell, 1994), although whether high 
intensity interval training has a similar effect is yet to be investigated.  Notably, in Chapter 4 it was 
reported that like moderate-intensity ET, 6 weeks of Wingate-based SIT in sedentary lean males 
improved insulin sensitivity.  Therefore, to test the effectiveness of the constant-workload SIT protocol 
developed in the present study, the hypothesis that 4 weeks of constant-workload SIT would improve 
insulin sensitivity, VO2peak, and reduce cardiovascular disease riskin sedentary obese males was first 
investigated.  It was also reported in Chapter 4 that improvements in IMTG metabolism following both 
SIT and ET likely contribute to the underlying mechanism of an increase in insulin sensitivity.  The 
second hypothesis therefore investigated whether constant workload SIT would enhance IMTG 
concentration and the protein expression of PLIN2 and PLIN5.    
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6.3 Methods 
 
Subjects and ethical approval 
Sixteen healthy, sedentary obese (BMI >30 kg.m-2) males volunteered to take part in the study (see 
table 2 for characteristics), which was approved by the Black Country NHS Research Ethics 
Committee (West Midlands, UK).  Following a verbal and written explanation of the nature and risks 
involved in the experimental procedure, written, informed consent was obtained from all volunteers.  
Prior to entering the study, all subjects underwent a medical screening procedure to check that there 
were no underlying cardiovascular abnormalities and they were free of any known metabolic disease.  
Specifically, all subjects completed a general health questionnaire, after which a resting 12 lead ECG 
was performed by a medical professional, who also obtained a brief medical history from each subject.   
Following this examination, volunteers were deemed eligible if they had also engaged in less than two 
30 min sessions of physical activity per week in the preceding year. 
 
Experimental procedures 
Subject’s initially performed a progressive exercise test to volitional exhaustion on an electronically 
braked cycle ergometer (Lode BV, Groningen, The Netherlands) in order to determine peak oxygen 
uptake (VO2peak) and maximum workload (Wmax), as previously described (Chapters 2, 4, 5).  During 
this visit subjects were allocated to their training intervention.  Accordingly the 16 subjects were 
divided into pairs with the best possible match for age, BMI and VO2peak, with one member from each 
pair randomly assigned to SIT and the other to the ET group.  Following sufficient rest, those subjects 
assigned to the SIT group were familiarised to the SIT protocol through the performance of one 30 s 
constant-workload sprint on a cycle ergometer.  The load that the subject’s pedalled against during 
each sprint was equivalent to 200% Wmax achieved during the progressive exercise test.   
 
At least 3 days following the progressive exercise test subject’s reported to the laboratory after an 
overnight fast (> 10 h) and the thigh of one leg was prepared for muscle biopsy collection.  The leg 
undergoing muscle biopsy before training was randomised such that the contralateral leg was 
sampled post-training.  A resting muscle biopsy was obtained and prepared for immunohistochemical 
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analysis as previously described (Chapters 2, 4, 5).  Following the muscle biopsy, a 2 h oral glucose 
tolerance test was performed and plasma glucose and insulin concentrations determined as previously 
reported (Chapters 4 & 5).  Plasma glucose and insulin concentrations were subsequently used to 
calculate an index of insulin sensitivity (Matsuda & DeFronzo, 1999).  An ILab-600 semi-automatic 
spectrophotometric analyzer was used to determine non-esterified fatty acid (NEFA), triglyceride and 
total cholesterol concentrations using compatible commercially available kits (NEFA: Randox 
Laboratories Ltd, Co. Antrim, UK, triglyceride and cholesterol: Instrumentation Laboratory Ltd UK, 
Warrington, UK).  Following the OGTT, body composition analysis was performed using Dual energy 
X-ray Absorptiometry (DXA), and analyzed for fat mass and fat-free mass.  All experimental 
procedures were repeated at least 48 h following completion of the training period in order to negate 
any acute effects of the last exercise training bout, and were identical in all respects to those 
performed before training. 
 
Subjects were provided with all food and drink to be consumed in the 24 h period preceding the 
experimental procedures.  The diet was of a standard macronutrient composition (50% CHO, 30% fat, 
20% protein), but adjusted for each individuals habitual energy intake, assessed through the 
completion of 3 day diet diary.  When completing diet diaries, subjects were provided with electronic 
scales in order to increase the accuracy of portion size determination.  All subjects were asked to 
continue their habitual dietary and physical activity patterns during the training period. 
 
Training interventions 
High intensity interval training (SIT): The SIT protocol in the present study was adapted from the 
protocol previously used by Burgomaster et al. (2008) and ourselves (Chapter 4).  From our previous 
study (Chapter 4), we recognised that Wingate-based SIT elicited a mean power output that was 
equivalent to ~200% maximal workload (Wmax) achieved during a progressive exercise test to 
determine VO2peak.  Thus, to closely match the work performed during a Wingate test, we developed a 
SIT protocol that maintains both the metabolic stimulus and the time saving benefits of Wingate-based 
SIT (Table 6.1).  Specifically, subjects in the present study performed repeated 30s sprints on a cycle 
ergometer against a constant load equivalent to 200% of their Wmax, as determined during the 
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progressive exercise test.  Each 30s sprint was separated by 2 minutes recovery, during which 
subjects cycled against a small workload (30 W) maintaining a cadence of < 50 rpm.  All participants 
trained three times a week for four weeks, and were excluded from the study if they were absent from 
more than two sessions.  Participants initially performed four 30 s sprints per training session during 
week one, after which an additional sprint was included on each consecutive week, such that seven 
30 s sprints were performed in the final week of training.   Heart rate was recorded throughout each 
session. 
 
Table 6.1.  Comparison of SIT protocol  
Variable 
Wingate SIT 
(Burgomaster et al., 
2005) 
60 s constant-load 
SIT 
(Little et al., 2010) 
30 s constant-
workload SIT 
(present study) 
Protocol 30 s ‘all out’ effort 60 s constant-load 30 s constant-workload 
Training Intensity Resistance equivalent to 7.5% body mass 100% Wmax 200% Wmax 
Rest 4.5 min 75 s 2 min 
Repetitions 4-7 8-12 4-7 
Time commitment:    
   Intervals per session 2-3.5 min 8-12 min 2-3.5 min 
   Total time per session 20-35 min 18-26 min 10-18 min 
   Total time per week 60-105 min 60-90 min 30-60 min 
Energy expenditure ~225 kJ ~210 kJ ~235 kJ 
 
Wmax maximum workload, kJ kilojoules 
 
 
Endurance training (ET): Subjects in the ET group trained 5 times per week over the 4 week training 
period, and were excluded from the study if they were absent from more than 2 training sessions.  All 
subjects cycled at a workload equivalent to ~65% VO2 peak for 40 minutes during the first 7 sessions, 
increasing to 50 minutes during sessions 8 to 14, and 60 minutes during sessions 15 to 20. VO2 peak 
was reassessed after 2 weeks of training and workload adjusted accordingly. 
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Muscle analysis 
Pre- and post-training muscle biopsies were cryosectioned (5 µm) at -30°C on to ethanol-cleaned 
glass slides and stained for fibre type determination of IMTG (oil red O), cytochrome c oxidase (COX), 
PLIN2, and PLIN5 content using immunofluorescence, as previously described (Chapter 5).  Capture 
of cross-sectional orientated images was identical in all respects to that described previously (Chapter 
5).  All image processing was undertaken using Image-Pro Plus 5.1 software (Media Cybernetics, MD, 
USA).  Specifically, widefield images were used to assess the fibre specific distribution of IMTG, 
PLIN2, PLIN5 and mitochondria.  In this respect 8 ± 2 images were used per muscle section, resulting 
in 98 ± 8 fibres analysed per time-point for each subject.  The COX staining intensity was used to 
indicate changes in mitochondrial content after training.  An intensity threshold was uniformly selected 
to represent positive signal for IMTG, PLIN2 and PLIN5.  The positively stained area fraction was 
expressed as a percentage of the total area of each muscle fibre, and was used as a measure of 
IMTG, PLIN2 and PLIN5 content.  Images captured using confocal microscopy were used to assess 
changes in mean IMTG, PLIN2 and PLIN5 size and density.  Density was calculated as the number of 
IMTG, PLIN2 or PLIN5 objects relative to area.  The mean area of individual IMTG (LDs), PLIN2 or 
PLIN5 objects was used as a measure of size.  
 
Statistics 
All data are expressed as means ± S.E.M.  Significance was set at the 0.05 level of confidence.  A 
two-factor repeated measures ANOVA was used to assess training-induced changes in parameters of 
exercise capacity, body composition, and insulin sensitivity, using the between-subject factor ‘group’ 
(SIT vs. ET) and the within-subject factor ‘training status’ (pre- vs. post-training).  A three-factor 
repeated measures ANOVA was used to assess changes in COX, IMTG, PLIN2 and PLIN5 content 
using the within-subject factors ‘fibre type’ (type I versus type II fibres) and ‘training status’ and 
between-subject (group) factor used in the 2-factor analysis.  Bonferroni adjustment post hoc analysis 
was employed to assess significant main effects or interactions. 
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6.4 Results 
 
Exercise capacity, body composition, and insulin sensitivity (Table 6.2) 
At baseline, no differences between groups were observed for any of the variables mentioned in Table 
6.2.  The ET group lost 2.2±0.5 kg in response to training (2±1%, group x training interaction; P < 
0.01), which corresponded to a significant decrease in BMI (2±1%, group x training interaction; P = 
0.01).  No significant changes in weight or BMI occurred in the SIT group.  Fasting plasma total 
triglyceride concentration showed a trend to decrease in response to training (SIT 16±8, ET 10±7%, P 
= 0.058).  Both fasting cholesterol concentration (SIT 13±6%, ET 7±5%, main training effect; P = 
0.017) and fasting NEFA concentration (SIT 21±11%, ET 9±7%, main training effect; P = 0.023) was 
significantly reduced following training.  Training induced a significant increase in absolute VO2peak 
(SIT 7±3%, ET 11±3%, main training effect; P = 0.01), and this increase remained when VO2peak was 
expressed relative to body weight (SIT 7±3%, ET 12±4%, main training effect; P = 0.01), with no 
difference between groups.  Wmax was also increased after training, with no difference between groups 
(SIT 13±3%, ET 11±4%, main training effect; P < 0.001).  Absolute fat mass decreased in response to 
ET only (5±1%; group x training interaction; P < 0.01), as did relative fat mass (4±1%; group x training 
interaction; P < 0.01), but no significant changes occurred following SIT.  Glucose area under the 
curve (AUC) was reduced post-training (SIT 7±2%, ET 11±5%, main training effect; P = 0.003) with no 
difference between groups.  Similarly, training reduced insulin AUC (HIT 14±3%, ET 17±9%, main 
training effect; P = 0.006).  Accordingly, training improved insulin sensitivity, calculated using the 
Matsuda index (Matsuda & DeFronzo, 1999) (HITSIT 13±5%, ET 23±4%; main training effect, P = 
0.001, Table 2), with no difference between groups. 
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Table 6.2. Subject characteristics 
 
 SIT  ET  Training 
effect 
Training x group 
interaction 
 Variable Pre Post Pre Post (P value) (P value) 
 Age (yrs) 24 ± 2  26 ± 2    
 Height (m) 1.75 ± 0.03  1.84 ± 0.03    
 Weight (kg) 109.7 ± 4.5 109.4 ± 4.5 113.3 ± 5.5 111.1 ± 5.6* 0.003 0.016 
 BMI (kg.m-2) 35.8 ± 0.8 35.7 ± 0.8 33.7 ± 1.5 33.1 ± 4.4* 0.004 0.019 
Body composition 
FM (kg) 32.0 ± 3.0 31.6 ± 3.1 32.5 ± 2.7 30.9 ± 2.7* <0.001 0.016 
FFM (kg) 66.2 ± 1.9 66.3 ± 1.9 69.8 ± 3.3 70.1 ± 3.2   
% FM 31.4 ± 2.0 30.9 ± 2.2 30.9 ± 1.8 29.6 ± 1.7* 0.002 0.049 
Exercise capacity 
VO2 peak (L.min-1) 3.69 ± 0.15 3.97 ± 0.24 3.94 ± 0.14 4.36 ± 0.22 0.002  
VO2 peak (L.min-1.kg-1) 33.9 ± 1.2 36.3 ± 1.6 35.1 ± 1.5 39.8 ± 2.7 0.002  
Wmax (W) 214 ± 14 245 ± 15 249 ± 16 276 ± 16 <0.001  
200% Wmax (W) 429 ± 28 491 ± 31 499 ± 32 552 ± 33 <0.001  
Blood lipid profile 
Triglycerides (mmol.L-1) 1.69 ± 0.17 1.37 ± 0.16 1.63 ± 0.22 1.41 ± 0.21 0.058  
Total cholesterol (mmol.L-1) 6.0 ± 0.5 5.1 ± 0.3 5.4 ± 0.4 4.9 ± 0.3 0.017  
NEFA (mmol.L-1) 0.49 ± 0.04 0.35 ± 0.03 0.49 ± 0.04 0.44 ± 0.04 0.023  
Whole-body insulin 
sensitivity 
Fasting glucose (mmol.L-1) 5.5 ± 0.3 5.6 ± 0.2 5.9 ± 0.4 5.6 ± 0.2   
Fasting insulin (µIU.ml-1) 23.5 ± 1.7 23.6 ± 2.2 19.6 ± 2.6 20.4 ± 2.5   
Glucose AUC (mmol.L-1.min-1) 996 ± 50 915 ± 46 998 ± 70 880 ± 63 0.003  
Insulin AUC (µIU.ml-1.min-1) 11492 ± 1140 12607 ± 1264 16517 ± 828 13597 ± 1339 0.006  
ISI-Matsuda 1.8 ± 0.1 2.0 ± 0..2 1.8 ± 0.1 2.1 ± 0.2 0.001  
 
Data provided are means ± S.E.M. (n=8 per group).  BMI body mass index, Wmax maximum workload, FFM fat free mass, FM fat mass, NEFA non-
esterified fatty acids, AUC area under the curve, ISI insulin sensitivity index.  Body composition data was obtained using a DEXA scan.  * Significant 
training x group interaction, ET vs. SIT (P < 0.05). 
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Muscle analysis 
Mitochondrial density (Table 6.3): Immunofluorescence images of the mitochondrial marker COX 
revealed a greater mitochondrial density (expressed as fluorescence intensity) in type I fibres 
compared to type II fibres both pre and post-training (main effect of fibre; P < 0.001).  In response to 
training, mitochondrial density was significantly increased in both type I and type II fibres (32 ± 4%, 47 
± 8%, respectively, main training effect; P = 0.01). 
 
Table 6.3. Effect of 4 weeks of SIT or ET on fibre type specific mitochondrial content  
COX expression SIT ET 
(fluorescence intensity) Pre Post Pre Post 
Type I fibres 37.3 ± 4.3 48.0 ± 6.1† 34.3 ± 1.4 46.5 ± 2.8† 
Type II fibres* 22.6 ± 3.0 33.6 ± 4.2† 20.6 ± 1.7 28.0 ± 2.4† 
 
Mitochondrial density (expressed as fluorescence intensity), quantified from immunofluorescence 
images of COX in type I and type II fibres obtained before and after 6 weeks of SIT or ET.  Values are 
presented as means ± S.E. (n = 8 per group).  * Main fibre effect (P < 0.05 vs. type I fibres).  † Main 
training effect (P < 0.05 vs. pre-training). 
 
 
IMTG analysis (Fig. 6.1): IMTG content in type I fibres (expressed as % area stained) was significantly 
greater than that observed in type II fibres both pre and post-training (main fibre effect; P < 0.001).  
IMTG content showed a trend to increase in response to training in both type I (SIT 48±21%, ET 
49±28%) and type II fibres (SIT 55±38%, ET 62±49%) (main training effect; P = 0.086), with no 
difference between groups.  LD density (number of LD per area) significantly increased in response to 
training in both type I (SIT pre 0.079±0.018 LD.µm-2 vs. SIT post 0.085±0.011 LD.µm-2, ET pre 
0.047±0.007 LD.µm-2 vs. ET post 0.068±0.010 LD.µm-2) and type II fibres (SIT pre 0.022±0.005 
LD.µm-2 vs. SIT post 0.043±0.009 LD.µm-2, ET pre 0.017±0.008 LD.µm-2 vs. ET post 0.020±0.004 
LD.µm-2, main training effect; P = 0.033), with no difference between groups.  No significant changes 
in LD size were observed in response to training in type I fibres (SIT pre 0.48±0.06 µm2 vs. SIT post 
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0.51±0.06 µm2, ET pre 0.37±0.03 µm2 vs. ET post 0.36±0.02 µm2) or type II fibres (SIT pre 0.50±0.04 
µm2 vs. SIT post 0.41±0.05 µm2, ET pre 0.33±0.03 µm2 vs. ET post 0.32±0.03 µm2) (main training 
effect; P = 0.3), with no difference between groups. 
  
PLIN analysis: PLIN2 content in type I fibres (expressed as % area stained) was significantly greater 
than that observed in type II fibres both pre and post-training, irrespective of training type (main fibre 
effect; P < 0.001, Fig. 6.2).  A training x fibre interaction was observed in response to training, such 
that PLIN2 content significantly increased in type I fibres (SIT 92±19%, ET 87±23%; P < 0.001), but 
the change did not reach statistical significance in type II fibres  (SIT 17±11%, ET 40±10%; P = 0.186, 
Fig. 6.2).  No group interactions with fibre type or training mode were observed for PLIN2 content.  
The increase in PLIN2 content in type I fibres was attributed to a greater PLIN2 density (SIT pre 
0.054±0.005 PLIN2.µm-2 vs. SIT post 0.075±0.007 PLIN2.µm-2, ET pre 0.069±0.023 PLIN2.µm-2 vs. 
ET post 0.105±0.028 PLIN2.µm-2, training x fibre; P = 0.01). 
 
PLIN5 content in type I fibres was significantly greater than observed in type II fibres both pre- and 
post-training, with no difference between groups (main fibre effect; P < 0.001, Fig. 6.3).  A training x 
fibre interaction was observed in response to training, such that PLIN5 content increased in type I 
fibres (SIT 54±15%, ET 36±10%; P = 0.003), but not in type II fibres (P = 0.287, Fig. 6.3).  No group 
interactions with fibre type or training mode were observed for PLIN5 content.  The increase in PLIN5 
content in type I fibres was attributed to a greater PLIN5 density (SIT pre 0.057±0.008 PLIN5.µm-2 vs. 
SIT post 0.076±0.010 PLIN5.µm-2, ET pre 0.050±0.009 PLIN5.µm-2 vs. ET post 0.078±0.014 
PLIN5.µm-2, training x fibre; P = 0.006).    
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Fig. 6.1 Effect of 4 weeks constant-workload SIT and ET on fibre-specific IMTG content 
 
Representative immunofluorescence images of IMTG (stained red) in combination with WGA to identify the cell border (stained blue) in skeletal muscle, 
pre (A) and post (B) 4 weeks of SIT.  Type I fibres are indicated with “I”, all other fibres are assumed to be type II fibres.  White bar = 50µm.  Images (C) 
and (D) display the ORO signal obtained after the intensity threshold was applied during quantitation (showing the LDs in white), before and after HIT, 
respectively.  (E) IMTG content, quantified from immunofluorescence images of oil red O-stained muscle sections, in type I and type II fibres before and 
after 4 weeks of HIT (closed bars) and ET (open bars).  Values are presented as means ± S.E.M. (n=8 per group).  * Main effect of fibre (P < 0.05 vs. 
type I fibres). 
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Fig. 6.2 Effect of 4 weeks constant-workload SIT and ET on fibre-specific PLIN2 expression 
 
 
Representative immunofluorescence images of PLIN2 (stained green) in skeletal muscle, pre (A) and post (B) 4 weeks of SIT, and corresponding 
images (C, D) of MHC I (stained red), used for fibre type determination.  Type I fibres are indicated with a “I”, all other fibres are assumed type II fibres.  
White bar = 50µm.  (E) PLIN2 content, quantified from immunofluorescence images of PLIN2-stained muscle sections, in type I and type II fibres before 
and after 4 weeks of SIT (closed bars) and ET (open bars).  Values are presented as means ± S.E (n=8 per group).  * Main effect of fibre (P < 0.05 vs. 
type I fibres).  † Training x fibre interaction (P < 0.05 vs. type I fibres pre-training). 
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Fig. 6.3 Effect of 4 weeks constant-workload SIT and ET on fibre-specific PLIN5 expression 
 
Representative immunofluorescence images of PLIN5 (stained green) in skeletal muscle, pre (A) and post (B) 4 weeks of SIT, and corresponding 
images (C, D) of MHC I (stained red), used for fibre type determination.  Type I fibres are indicated with a “I”, all other fibres are assumed type II fibres.  
White bar = 50µm.  (E) PLIN5 content, quantified from immunofluorescence images of PLIN5-stained muscle sections, in type I and type II fibres before 
and after 4 weeks of SIT (closed bars) and ET (open bars).  Values are presented as means ± S.E (n=8 per group).  * Main effect of fibre (P < 0.05 vs. 
type I fibres).  † Training x fibre interaction (P < 0.05 vs. type I fibres pre-training). 
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Correlation analyses 
For correlation analyses, data obtained for type I and type II fibres, pre and post-training were pooled 
(Table 6.4).  IMTG content showed a positive correlation with PLIN2 content (R = 0.56; P < 0.01), 
PLIN5 content (R = 0.48; P < 0.05) and COX intensity (R = 0.51, P < 0.01).  Insulin sensitivity was 
strongly associated with COX intensity (R = 0.65; P < 0.001), but did not correlate with IMTG content 
PLIN2 or PLIN5 expression. 
 
Table 6.4. Bivariate correlation analysis 
 IMTG Insulin sensitivity 
IMTG  0.23 
PLIN2 0.56† 0.14 
PLIN5 0.48* 0.17 
COX 0.51† 0.65‡ 
 
IMTG, PLIN2 and PLIN5 content and COX fluorescence intensity represent pre-exercise values. IMTG 
utilisation refers to the absolute change in IMTG concentration from pre to post-exercise. Values 
represent Pearson’s squared correlation coefficients (R values) for relationships between variables. All 
data obtained for type I and type II fibres, pre and post-training were pooled for correlation analysis. 
Significant correlations: *P < 0.05, †P < 0.01, ‡P < 0.001. 
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6.5 Discussion 
This study is the first to report that 4 weeks of constant-workload SIT improves insulin sensitivity in 
sedentary, obese males, in line with the first hypothesis.  Further, this improvement was accompanied 
by both an increased aerobic exercise capacity (VO2peak) and greater mitochondrial density, as well as 
a reduction in fasting plasma free fatty acids and total cholesterol concentration.  In support of the 
second hypothesis, expression of both PLIN2 and PLIN5 was enhanced in type I muscle fibres 
following both constant-workload SIT and ET, although this occurred without a significant increase in 
IMTG content.  Together, these results suggest that greater expression of PLIN2 and PLIN5 contribute 
to the mechanism that leads to improvements in insulin sensitivity following 4 weeks of constant-
workload SIT and ET. 
 
The 4 week constant-workload SIT protocol, using 30s exercise bouts at 200% Wmax, employed in the 
present study elicited similar heart rate responses (~95% HRmax) to those observed using Wingate-
based SIT in Chapter 4 (data not shown).  The new protocol of constant-workload SIT successfully 
increased skeletal muscle mitochondrial density concomitant with an improved aerobic exercise 
capacity, which is consistent with a number of previous short term training studies in lean and obese 
individuals using both Wingate-based SIT (Burgomaster et al., 2005; Gibala et al., 2006; Burgomaster 
et al., 2008; Whyte et al., 2010) and 60 s constant-load HIT protocols (Little et al., 2010; Hood et al., 
2011; Little et al., 2011a).  Notably, mitochondrial density increased similarly in type I and type II 
fibres, in line with a previous study performed in lean sedentary individuals (Chapter 4), demonstrating 
that the 30s constant-workload SIT protocol employed in the present study is also an effective 
intervention to enhance skeletal muscle oxidative capacity in obese individuals.  This is an important 
finding, given that obese individuals and/or obese type 2 diabetes patients commonly display a 
reduced muscle oxidative capacity (Kelley et al., 2002; Ritov et al., 2005; Toledo et al., 2006), which 
appears to be due to a reduced mitochondrial density rather than diminished function (Boushel et al., 
2007; Holloway et al., 2007), and is strongly associated with the development of insulin resistance 
(Bruce et al., 2003).  In this respect, improvements in oxidative capacity in response to 4 weeks 
constant-workload SIT in the present study were paralleled by enhanced insulin sensitivity.  This 
finding is consistent with previous reports describing improved insulin sensitivity in lean, healthy 
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individuals undertaking Wingate-based SIT (Babraj et al., 2009; Richards et al., 2010)(Chapter 4) and 
overweight individuals and obese type 2 diabetes patients undertaking 60 s constant-load SIT (Hood 
et al., 2011; Little et al., 2011a).  Thus, the 30s constant-workload SIT protocol described in the 
present study provides an effective stimulus to induce improvements in insulin sensitivity in young, 
obese individuals. 
 
A high flux of fatty acids being delivered to and transported into skeletal muscle leads to reductions in 
insulin sensitivity (Bachmann et al., 2001).  In addition, high fasting plasma triglyceride concentrations 
are associated with insulin resistance and cardiovascular disease, as a result of greater lipid delivery 
and uptake into skeletal muscle.  Notably, there was a significant reduction in fasting plasma fatty acid 
and total cholesterol concentration, in addition to a trend for a reduction in the fasting plasma total 
triglyceride concentration (P = 0.058) in response to training.  These observations are consistent with 
previous reports in sedentary lean and obese individuals undertaking 12 weeks of ET (Schrauwen et 
al., 2002; Solomon et al., 2009), and for the first time illustrate the beneficial impact of constant-
workload SIT on risk factors of cardiovascular disease.      
 
Contrary to our hypothesis, IMTG concentration was not significantly increased following either 
constant-workload HIT or traditional moderate-intensity ET, although there was a trend for a main 
effect of training to enhance IMTG concentration (P = 0.086).  This finding is in contrast to Chapter 4 
where 6 weeks of Wingate-based SIT and ET resulted in similar increases in IMTG content in lean, 
sedentary individuals (Chapter 4).  Notably, obese individuals and/or type 2 diabetes patients 
demonstrate increased IMTG stores in response to long term ET (>16 weeks) (Dubé et al., 2008; 
Dubé et al., 2011)(Chapter 3), indicating that further increases in IMTG concentration with training 
occur in those individuals who may already exhibit elevated IMTG stores (van Loon et al., 2004; Amati 
et al., 2011).  This observation suggests that the duration of the training period may have been 
insufficient to induce significant increases in IMTG content, despite observing similar improvements in 
fibre-specific mitochondrial density using constant-workload SIT and ET compared to those previously 
reported for Wingate-based SIT and ET using the same number of subjects (Chapter 4).  Further 
inspection of the data in the present study revealed that two individuals from each group failed to 
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increase their IMTG content in type I fibres (Fig. 2), suggesting that a lack of statistical power may also 
contribute to the current finding.  Indeed, calculating the power required to obtain a significant increase 
in IMTG concentration using the observed variation in the current data set revealed that 12 
participants per group would have been needed to observe a main effect of training.  Despite the lack 
of an increase in IMTG concentration following training, a significant increase in IMTG density 
occurred, which is in line with previous reports following both SIT and ET interventions (Tarnopolsky et 
al., 2007)(Chapter 4).  Since a greater number of IMTG-containing LDs would present an enhanced 
surface area available for the interaction with lipolytic enzymes with the regulatory proteins contained 
on the LD surface, this finding indicates a shift to a more metabolically flexible intracellular lipid store.  
 
Two of the regulatory proteins contained within the phospholipid monolayer of IMTG-containing LDs 
are PLIN2 and PLIN5.  In the present study it was found that young, insulin-sensitive obese individuals 
demonstrate ~two-fold greater PLIN2 protein expression in type I compared to type II fibres, a finding 
that is consistent with previous observations in lean sedentary (Chapter 2, 4, 5) and trained (Shaw et 
al., 2009) individuals.  In addition, a large (~10-fold) difference in PLIN5 expression between type I 
and type II fibres was observed before training.  Importantly, the expression of PLIN2 and PLIN5 in 
type I fibres is significantly enhanced in response to constant-workload SIT in the present study.  
Furthermore, the increase in PLIN2 and PLIN5 expression following constant-workload HIT is similar 
to that induced by traditional moderate-intensity ET.  This finding is consistent with a previous report 
demonstrating similar increases in both PLIN2 and PLIN5 expression in response to Wingate-based 
HIT and traditional ET in lean sedentary individuals (Chapter 4).  In contrast, a recent study reported 
that only PLIN5 was enhanced in response to 12 weeks ET in obese males, whereas no change in 
PLIN2 expression was observed (Peters et al., 2012).  Although the observation regarding PLIN2 
expression contradicts the finding of the present study, this may be reconciled by differences in the 
methodology employed (immunofluorescence microscopy vs. immunoblotting in Peters et al., 2012).  
Indeed, given that training-induced increases in the expression of PLIN2 and PLIN5 was specific to 
type I fibres in the present study, this highlights the need to investigate proteins associated with IMTG 
metabolism in a fibre specific manner.  
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The data of the present study suggest that exercise training-induced increases in the expression of 
PLIN2 and PLIN5 appear to precede significant increases in IMTG concentration.  This observation is 
in line with the observation in Chapter 3 of this thesis, demonstrating that PLIN2 expression is 
enhanced following 2 months of ET in type 2 diabetes patients, whereas a significant increase in IMTG 
content was only detected following 6 months of ET.  Collectively these data suggest that the 
enhanced expression of the PLIN proteins is an early training adaptation that is necessary for 
increased IMTG content to occur in response to training interventions.  In support of this hypothesis, 
cultured cells overexpressing PLIN2 or PLIN5 exhibit lower rates of basal lipolysis compared to when 
PLIN2 or PLIN5 is not expressed or knocked-down, and as a result cellular TAG concentration is 
increased (Imamura et al., 2002; Wolins et al., 2006b; Listenberger et al., 2007; Bell et al., 2008; 
Wang et al., 2011a; Wang et al., 2011b).  Indeed, it appears that upregulating PLIN2 and/or PLIN5 
expression is a prerequisite for greater TAG storage, since PLIN2 knockdown in myotubes prevents 
TAG accumulation and LD formation upon oleate or palmitate incubation (Bosma et al., 2012a).  
Furthermore, PLIN5 overexpression in alpha mouse liver 12 cells enhances palmitate incorporation 
into TAG leading to an increase in cellular TAG concentration (Wolins et al., 2006b; Wang et al., 
2011b).  Therefore, it is likely that augmenting PLIN2 and PLIN5 expression is first required in order to 
facilitate an increase in IMTG content in response to both constant-workload SIT and ET.  Notably, 
overexpression of PLIN2 in vivo promotes intracellular lipid storage as TAG rather than DAG, thereby 
maintaining insulin sensitivity (Bosma et al., 2012a).  Therefore, greater PLIN2 and/or PLIN5 
expression following exercise training would presumably help maintain low concentrations of specific 
DAG and ceramide species leading to improved insulin sensitivity, as observed following ET (Dubé et 
al., 2008; Dubé et al., 2011).  In accordance, we propose that enhanced expression of PLIN2 and 
PLIN5 contributes to the improvements in insulin sensitivity observed in the current study in obese 
individuals following constant-workload SIT and ET. 
 
As PLIN2 and PLIN5 content is increased in the present study, while IMTG content is not significantly 
enhanced, this suggests that a greater PLIN2:IMTG and PLIN5:IMTG ratio exists following training.  
Presumably this implies that the LD surface coverage by PLIN2 and PLIN5 is enhanced following 
training, indicating that the capacity for lipolytic enzymes to target the LD and breakdown IMTG during 
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a bout of moderate-intensity exercise is increased.  Future research should investigate whether IMTG 
breakdown is already increased after 4 weeks of SIT and ET in obese individuals and whether further 
increases in IMTG content and the PLIN:IMTG ratio occurs after more prolonged training interventions 
also leading to higher rates of IMTG breakdown during exercise.   In addition, it will be of interest to 
determine whether SIT or ET is superior with regards to improving the primary outcome measure of 
the present study, insulin sensitivity.  Indeed, although many of the training effects in the present study 
were of a similar magnitude between the two groups (including insulin sensitivity), it is clear that larger-
scale studies are required in order to determine which training mode is superior for inducing positive 
metabolic adaptations.    
 
In conclusion, this study demonstrates that a new protocol of constant-workload SIT, using 30 s 
exercise bouts at 200% Wmax and thus preserving the time-efficient nature of the Wingate-based HIT 
protocol, provides an effective stimulus to induce improvements in whole body insulin sensitivity in 
sedentary obese individuals.  Furthermore, in accordance with previous studies the type I fibre-specific 
increase in PLIN2 and PLIN5 expression may be instrumental to the improvement in insulin sensitivity.  
Finally, this study is the first to show that a SIT protocol achieves measurable and similar reductions in 
the fasting plasma fatty acid, TG and cholesterol concentration as ET and leads to a reduction in these 
risk factors for cardiovascular disease after only 4 weeks. Therefore, this study adds to the growing 
evidence that SIT may provide an effective tool to improve metabolic health in sedentary obese 
individuals.    
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Chapter 7 
 
General Discussion 
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7.1 Overview 
Significant changes in lifestyle have occurred over the last 40 years, such that performing regular 
physical activity is no longer a priority, while the consumption of energy-dense food with poor 
nutritional value has increased.  As a result, the prevalence of many major non-communicable 
diseases has increased, including obesity, insulin resistance, metabolic syndrome, type 2 diabetes 
and cardiovascular disease.  The challenge to researchers is therefore to develop therapeutic 
interventions based on a thorough understanding of the underlying mechanisms.  Skeletal muscle is 
the predominant site of glucose disposal following the ingestion of a mixed meal (Ferrannini et al., 
1985; Capaldo et al., 1999), and therefore plays a key role in maintaining glucose homeostasis.  
However, dysregulation of lipid metabolism in skeletal muscle is associated with reductions in glucose 
tolerance and insulin sensitivity.  In contrast, acute and chronic exercise training is associated with 
improvements in glucose tolerance and insulin sensitivity, due in part to an increased capacity for 
IMTG breakdown and enhanced regulation of the turnover of the intramuscular lipid pool.  However, 
the underlying mechanisms regulating the turnover of the IMTG pool were only partially understood at 
the start of the PhD project.  In particular, very little information was available concerning the potential 
importance of the PLIN proteins in regulating both basal and stimulated lipolysis of intracellular lipid 
stores.  In addition, whether more time-efficient modes of exercise training, such as sprint interval 
training (SIT), elicit similar improvements in lipid metabolism and insulin sensitivity as traditional 
moderate-intensity endurance training (ET) had not been studied.  Consequently the aims of this 
thesis were 1) to investigate the effect of a single bout of moderate-intensity cycling exercise on the 
association between perilipin 2 (PLIN2) and intramuscular triglyceride (IMTG), 2) to assess the effect 
of ET on the expression of PLIN2 in type 2 diabetes patients, 3) to investigate whether PLIN2 and 
PLIN5 play a role in the ET-induced increase in IMTG utilisation during exercise in previously 
sedentary individuals, and if similar adaptations are observed following SIT, 4) to establish whether RT 
also enhances content and breakdown via a similar mechanism as ET and SIT, and 5) to investigate 
whether ET and constant-workload SIT-induced improvements in insulin sensitivity in obese 
individuals are associated with similar adaptations in IMTG metabolism as seen in previously 
sedentary individuals. 
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7.2 The role of PLIN2 and PLIN5 in TAG hydrolysis 
Studies performed under in vitro conditions in cultured cells have established that the perilipin (PLIN) 
proteins play a regulatory role in the hydrolysis of triacylglycerol (TAG) (outlined in Chapter 1.3.3ii).  
However, whether the PLIN proteins perform a similar function in skeletal muscle in vivo is currently 
not known.  Based on the evidence that IMTG in type I fibres provides a substrate source during 
exercise (Chapter 1.3.2), Chapter 2 demonstrates that LDs containing PLIN2 within the phospholipid 
monolayer are preferentially broken down during an acute bout of moderate-intensity endurance 
exercise in 7 sedentary males, compared to those LDs which do not contain PLIN2.  Therefore, the 
presence of PLIN2 in the protein coat of LDs appears to be one factor mediating IMTG breakdown 
during exercise.  Chapter 4 subsequently confirms this finding, and also establishes that a similar 
relationship exists for PLIN5, such that LDs containing PLIN5 are preferentially broken down during an 
acute bout of exercise, compared to those LDs not containing PLIN5.  As discussed in both Chapter 2 
and 4, the assays used in these studies do not permit identification of LDs that contain both PLIN2 and 
PLIN5, compared to those LDs that only contain PLIN2 or PLIN5.  Furthermore, whether other PLIN 
proteins, such as PLIN3 and PLIN4, are also found in the protein coat of LDs in skeletal muscle was 
not investigated.  Nevertheless, the findings of Chapters 2 and 4 do suggest that LDs containing either 
PLIN2 or PLIN5 may confer an advantage over those LDs not containing PLIN2 or PLIN5 when 
activation of lipolysis is required.  Therefore, the results of Chapter’s 2 and 4 are consistent with the 
mechanisms proposed by in vitro work in which PLIN2 and PLIN5 mediate the interaction of the 
lipolytic enzymes with the LD, thereby regulating the rate of IMTG hydrolysis.  It has recently been 
reported that PLIN5 also recruits mitochondria to the surface of LDs (Bosma et al., 2011; Wang et al., 
2011b).  Thus it appears that PLIN5 regulates the rate of TAG hydrolysis, and ensures that fatty acids 
liberated from intracellular TAG stores are efficiently channelled to mitochondria to undergo β-
oxidation.  
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7.3 The effect of exercise training on skeletal muscle PLIN2 and PLIN5 
expression and insulin sensitivity 
 
7.3.1 Endurance training 
A number of cross-sectional and longitudinal studies report that prolonged traditional moderate-
intensity ET leads to an increase in IMTG concentration and concomitantly enhances the capacity to 
break down IMTG during exercise (Chapter 1.6.3).  Chapter 4 confirms that 6 weeks ET induces these 
adaptations in lean, sedentary individuals.  In addition to augmenting IMTG concentration, 6 weeks ET 
also leads to an increase in the protein expression of PLIN2 and PLIN5 in skeletal muscle in both type 
I and type II fibres.  A recent study also demonstrates, using immunoblotting methodology, that PLIN5 
is increased in lean individuals following 12 weeks of ET (Peters et al., 2012).  However, the same 
study also reported a decrease in PLIN2 protein expression following ET (Peters et al., 2012), which is 
in contrast to the increase in PLIN2 protein content described in Chapter 4 and observed using both 
immunoblotting and immunofluorescence methodology. 
 
It is perhaps more relevant to understand the relationship between IMTG concentration and the 
expression of the PLIN proteins.  Indeed, it has been previously reported that the expression of PLIN2 
and PLIN5 correlates with IMTG concentration (Minnaard et al., 2009; Amati et al., 2011; Peters et al., 
2012), and more evidence was obtained to support this observation in Chapters 4, 5 and 6 of this 
thesis.  In addition, PLIN2 and PLIN5 expression is greater in type I compared to type II fibres in both 
lean and obese sedentary individuals (Chapters 2, 4, 5 & 6) (Shaw et al., 2009), and is consistent with 
the fibre type specific distribution of IMTG  (Koopman et al., 2001; Malenfant et al., 2001).  Notably, 
the fraction of IMTG associated with either PLIN2 or PLIN5 in type I fibres was similar before and after 
6 weeks ET (Chapter 4), and significant breakdown of PLIN2-containing LDs and PLIN5-containing 
LDs during exercise was observed both before and following ET in type I fibres.  Given that the 
association of PLIN2 and/or PLIN5 with IMTG appears to be one factor mediating IMTG breakdown 
(Chapters 2 & 4), an increase in the expression of PLIN2 and PLIN5 is therefore presumably required 
to enable greater use of IMTG as a substrate source during exercise following ET.  A number of 
studies performed in cultured cells in vitro also indicate that expression of PLIN2 and/or PLIN5 is 
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required to maintain low rates of basal lipolysis (Dalen et al., 2007; Listenberger et al., 2007; Bell et 
al., 2008; Wang et al., 2011a; Wang et al., 2011b).  Given that ET enhances the LD surface area 
available for the interaction of lipolytic enzymes with the stored TAG, presumably an increase in PLIN2 
and PLIN5 expression is required to preserve the coverage of the LD surface area, thereby 
maintaining    low basal lipolytic rates.  Taken together these observations suggest that PLIN2 and/or 
PLIN5 may play a key role in efficiently coupling the rate of TAG hydrolysis to the metabolic demand 
for fatty acids. 
 
Chapter 3 demonstrates that obese type 2 diabetes patients do not exhibit a fibre type difference in 
PLIN2 expression, as observed in lean individuals (Shaw et al., 2009)(Chapters 2 and 4), whereas 
IMTG concentration is greater in type I compared to type II fibres, as previously reported (Koopman et 
al., 2001; Malenfant et al., 2001).  Thus a disparity between PLIN2 expression and IMTG 
concentration in type I fibres appears to exist in type 2 diabetes patients.  Given the potential role of 
PLIN2 in IMTG hydrolysis, this observation may explain, at least partly, why type 2 diabetes patients 
are unable to break IMTG down as a substrate source during exercise (van Loon et al., 2005a).  
Similarly, Chapter 6 demonstrates that the protein expression of both PLIN2 and PLIN5 is increased 
following ET in obese individuals, whereas IMTG concentration is not significantly enhanced.  This 
provides further evidence to suggest that in sedentary obese individuals the expression of PLIN2 and 
PLIN5 is not well aligned to the concentration of IMTG and therefore potentially limits IMTG 
breakdown before training. 
 
The athlete’s paradox describes a state in which endurance trained athletes combine elevated IMTG 
concentrations with high levels of insulin sensitivity (Goodpaster et al., 2001; van Loon et al., 2004; 
Amati et al., 2011).  In contrast, elevated IMTG concentrations in sedentary obese individuals and type 
2 diabetes patients are associated with insulin resistance (Phillips et al., 1996a; Pan et al., 1997; 
Goodpaster et al., 2001).  Consequently, it is believed that the flexibility of the IMTG pool to respond to 
the metabolic demands placed on skeletal muscle, rather than the absolute concentration of IMTG per 
se, more accurately determines insulin sensitivity (van Loon & Goodpaster, 2006; Moro et al., 2008).  
To this end, an imbalance between free fatty acid uptake, IMTG synthesis, IMTG lipolysis and fatty 
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acid oxidation is associated with the accumulation of fatty acid metabolites, such as long chain acyl-
CoA, DAG and ceramide, which subsequently contribute to the development of insulin resistance (van 
Loon & Goodpaster, 2006; Moro et al., 2008; Shaw et al., 2010).  Thus, tight regulation of IMTG 
hydrolysis and IMTG synthesis in response to changes in intramuscular fatty acid concentration and 
the demand for fatty acids for energy production may be important in order to maintain high levels of 
insulin sensitivity.  In obese individuals and type 2 diabetes patients, where the expression of PLIN2 
and PLIN5 is low for the high IMTG content, it is plausible that intracellular lipases may have 
unregulated access to the stored TAG, leading to a mismatch between TAG hydrolysis and the 
oxidation of liberated fatty acids.  As a result, insulin resistance-inducing fatty acids metabolites will 
accumulate and contribute to the development of insulin resistance.  Importantly, in both obese 
individuals (Chapter 6) and type 2 diabetes patients (Chapter 3), prolonged ET was able to increase 
the expression of both PLIN2 and PLIN5.  Presumably, this adaptation would have corrected the 
shortfall in PLIN2 and/or PLIN5 expression in relation to IMTG content, thereby enhancing the 
regulation of IMTG hydrolysis at rest and during exercise, which in turn may drive the ET-induced 
improvements in insulin sensitivity. 
     
7.3.2 Resistance training 
Chapter 5 aimed to investigate whether improvements in IMTG metabolism contribute to the well-
documented increase in insulin sensitivity that occurs in response to chronic RT (Miller et al., 1994; 
Eriksson et al., 1997; Holten et al., 2004; Gordon et al., 2009; Hills et al., 2010).  6 weeks of whole-
body RT in lean, sedentary males enhanced insulin sensitivity concomitant with an increase in resting 
IMTG concentration and breakdown during an acute bout of moderate-intensity endurance-type 
exercise.  In addition, the protein expression of both PLIN2 and PLIN5 was enhanced, and the 
oxidative capacity of the muscle was also increased.  Taken together, these findings suggest that RT 
also leads to tighter regulation of IMTG hydrolysis at rest and during exercise, and that this adaptation, 
similar to ET, contributes to the improvements in insulin sensitivity.    
 
The finding of an increase in IMTG concentration following RT is in contrast to a recent study that 
reported no effect of 11 weeks RT on IMTG content (Ngo et al., 2012).  However, this study combined 
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lower-body ET with upper-body RT and sampled the vastus lateralis and deltoid muscles, respectively, 
in order to directly compare the effect of ET and RT in one individual.  Thus, it is not reasonable to 
directly compare the results from this study to those obtained in Chapter 5.  Furthermore, it is difficult 
to draw definitive conclusions from this study since large differences exist between upper and lower 
body muscles with regards to metabolism and fibre type differences (Mygind, 1995; Van Hall et al., 
2003).  However, the study of Ngo et al. (2012) does highlight an interesting comparison.  
Consequently, the results of Chapters 4 and 5 (ET and RT, respectively) are compared in Fig. 7.1, as 
the results of these studies were obtained using the same experimental conditions. 
 
Fig. 7.1 Comparison of ET and RT induced changes in IMTG content 
 
Relative change (%) in IMTG content in type I and type II fibres in response to 6 weeks of ET (closed 
bars) or RT (open bars) in lean sedentary males.   
 
Figure 7.1 demonstrates that when the two forms of exercise training are compared, ET promotes the 
greatest increase in IMTG content.  Nevertheless, the magnitude of the increase in the Matsuda index 
of insulin sensitivity is similar between the groups (ET 29 ± 12%, RT 37 ± 12%).  Therefore, whilst both 
forms of exercise training are similarly effective in enhancing insulin sensitivity, improvements in IMTG 
metabolism may explain a greater proportion of the increase in insulin sensitivity observed following 
ET.  However, as discussed in Chapter 5, improvements in IMTG metabolism should also be 
considered a contributing factor to the increase in insulin sensitivity following RT. 
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7.3.3 High intensity interval training  
Improvements in insulin sensitivity have been observed in response to HIT in lean sedentary (Babraj 
et al., 2009; Richards et al., 2010) and overweight individuals (Hood et al., 2011), and in type 2 
diabetes patients (Little et al., 2011a).  However, the mechanisms underlying the improvements in 
insulin sensitivity have not been well-studied.  Chapter 4 aimed to investigate whether improvements 
in IMTG metabolism may contribute to the observed increases in insulin sensitivity following SIT.  In 
response to 6 weeks of Wingate-based SIT in sedentary, lean males, insulin sensitivity was improved 
concomitant with an increase in IMTG concentration and an enhanced capacity for IMTG breakdown 
during moderate-intensity exercise was observed.  Furthermore, SIT increased skeletal muscle 
oxidative capacity, as previously reported (Burgomaster et al., 2005; Gibala et al., 2006; Burgomaster 
et al., 2008), and also augmented the protein expression of both PLIN2 and PLIN5, and together these 
adaptations appear to be mechanistically linked to the observed improvement in IMTG breakdown 
during exercise.  Therefore, like ET, the improvements in insulin sensitivity in response to SIT can be 
explained, at least partly, by an enhanced metabolic flexibility of the IMTG pool. 
 
In Chapter 4, a single SIT session required subjects to perform repeated Wingate tests interspersed 
with periods of active recovery, as established by Gibala and colleagues (Burgomaster et al., 2005; 
Gibala et al., 2006).  However, this form of SIT requires specialised equipment, high levels of internal 
and external motivation, and may also induce feelings of light headedness and nausea, suggesting 
that Wingate-based SIT is not particularly tolerable or appealing for many individuals.  To overcome 
these problems, Chapter 6 aimed to establish and investigate the effectiveness of a novel practical 
SIT protocol, using the ‘constant-workload’ approach, as a means to improve insulin sensitivity.  
Accordingly, Chapter 6 demonstrates that 4 weeks ‘constant-workload’ SIT in obese individuals 
improves insulin sensitivity.  Furthermore, constant-workload SIT tended to increase IMTG content, 
and significantly enhanced skeletal muscle oxidative capacity and the protein expression of both 
PLIN2 and PLIN5.  As with Wingate-based SIT, the magnitude of the changes in oxidative capacity, 
IMTG, PLIN2 and PLIN5 content and insulin sensitivity following ‘constant-workload’ SIT were similar 
to those observed following 4 weeks of traditional ET.  Therefore, as with ET, the improvements in 
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insulin sensitivity induced by ‘constant workload’ SIT appear to be, in part, attributable to enhanced 
regulation of IMTG metabolism. 
 
The results of Chapters 4 and 6 provide evidence to suggest that improved regulation of the IMTG 
pool is one mechanism that underlies the improvement in insulin sensitivity observed following SIT.  In 
addition, as a “lack of time” represents the most commonly cited barrier to regular exercise 
participation (Stutts, 2002), the observation that SIT and ET induce similar physiological and metabolic 
adaptations provides a basis for using SIT as a means to maintain or improve metabolic health.  
Whether SIT remains a viable alternative to ET outside of the laboratory in a ‘real world’ environment 
should form the basis of future investigations. 
 
7.3.4 General reflections on the role of PLINs in regulating IMTG utilization and insulin 
sensitivity in human skeletal muscle 
In Chapters 4 and 5 of this thesis, it is reported that exercise training enhances IMTG breakdown 
during a bout of moderate-intensity exercise.  These observations are consistent with reports 
demonstrating that the IMTG pool makes a significant contribution to total substrate oxidation during 
exercise in endurance-trained athletes (van Loon et al., 2003; Stellingwerff et al., 2007), and from 
cross-sectional comparisons between trained and untrained individuals (Klein et al., 1994; Coggan et 
al., 2000).  In contrast, it appears that IMTG does not provide a readily available fuel source during 
exercise in sedentary, obese and/or type 2 diabetes patients (Blaak et al., 2000; Schrauwen et al., 
2002).  Consequently, it is suggested that the capacity to utilise IMTG during exercise (indicative of a 
metabolically flexible IMTG pool) is associated with insulin sensitivity.   
 
A number of different methods of investigating IMTG utilisation during exercise are available, including 
the use of stable isotopic tracers to indirectly quantify the sum of IMTG plus lipoprotein-TG oxidation, 
as well as directly measuring IMTG content before and after exercise using both non-invasive (1P-
MRS) and invasive (biochemical extraction, immunofluorescence microscopy) techniques.  
Throughout this thesis IMTG content was measured using oil red O staining in combination with 
myosin heavy chain type I staining, in order to quantify fibre type-specific IMTG content and 
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breakdown during exercise.  In Chapter 2, a ~50% reduction in IMTG content in type I fibres was 
observed during exercise at ~65% VO2 peak, whereas in Chapter 4 a ~16% decrease in IMTG 
content in type I fibres was observed using an identical bout of exercise as described in Chapter 2.  
Despite the differences in the magnitude of change in IMTG content from pre to post exercise between 
Chapter’s 2 and 4, similar rates of fat oxidation (~0.41 g.min-1), measured through indirect calorimetry, 
were observed.  This suggests that the contribution of IMTG breakdown to total fat oxidation was 
different between the two groups, despite the exercise bout being of a similar intensity and duration.  
Whilst it is difficult to reconcile the differences in IMTG breakdown reported, it does highlight that a 
large variability in the capacity to use IMTG as a fuel source during exercise may exist in sedentary 
individuals.  This is reflected in the large variation observed in IMTG breakdown during exercise in 
Chapter 4 (S.E. = ~11%), although a much smaller variation was apparent in Chapter 2 (S.E. = 7%).  
Therefore, it is also important to consider any methodological limitations which may partly explain the 
differences in IMTG breakdown between Chapter’s 2 and 4.  For example, the coefficient of variation 
for repeated measurements of IMTG content through oil red O staining is between 7 and 14% 
(Shepherd et al., unpublished observations; De Bock et al., 2005; De Bock et al., 2007).  In addition, 
no estimation of the contribution of plasma FFA to total fat oxidation during exercise was made in 
Chapter’s 2 and 4, making it impossible to conclude that differences in plasma FFA oxidation were 
apparent between the two studies.  Given that plasma FFA availability likely regulates the contribution 
of IMTG utilisation to total fat oxidation, information regarding plasma FFA concentrations during 
exercise should be included in future studies, and estimates of plasma FFA oxidation using stable 
isotopic tracers would provide a more complete view.    
 
An interesting finding of both Chapter’s 2 and 4 was that PLIN2 and PLIN5 appear to be important in 
the breakdown of IMTG during exercise, since LDs containing either PLIN2 and/or PLIN5 are 
preferentially broken down (compared to those LDs that are not associated with either PLIN2 and/or 
PLIN5) during moderate-intensity exercise.  This finding stemmed from the observation that ~70% of 
LDs contain either PLIN2 and/or PLIN5 at rest, and in response to exercise it is those PLIN-associated 
LDs that are reduced.  Of course, it is possible, as acknowledged in Chapter 2, that PLIN2 and/or 
PLIN5 may be present at undetectable levels on those PLIN-null-LDs, rather than being completely 
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absent.  In addition, images used for colocalisation analysis only provide a two-dimensional view, 
whereas LDs, by nature, are three-dimensional objects and are not at a uniform depth throughout a 5 
µm muscle section (as used throughout this thesis).  Consequently, the plane in which each LD is 
imaged and the proportion of each LD that is observed will likely impact the true ‘colocalisation value’.  
Nevertheless, the inter-subject variation in colocalisation values for both PLIN2 and PLIN5 with IMTG 
before and after exercise was low, suggesting that the technical limitations of colocalisation analysis 
did not significantly impact the overall outcome.  Furthermore, the observation that not all LDs contain 
PLIN2 and/or PLIN5 is consistent with several in vitro observations suggesting that the protein 
composition of the LD could influence its function (Ducharme & Bickel, 2008; Fujimoto et al., 2008; 
Wolins et al., 2006), which appears logical given that there are >300 proteins associated with the LD 
proteome (Zhang et al., 2011). 
 
As described in the previous sections of this discussion, the most consistent finding of this thesis is 
that exercise training (including HIT, ET or RT) enhances the protein expression of both PLIN2 and 
PLIN5 in skeletal muscle, and this appears to occur concomitant with an increase in IMTG content.  
Although Chapter’s 4, 5 and 6 all suggest that the increase in PLIN2 and PLIN5 expression parallels 
the change in IMTG content, in line with several other reports (Minnaard et al., 2009; Amati et al., 
2011; Peters et al., 2012), the results of Chapter 3 provide evidence that this might not always be true.  
To this end, PLIN2 expression increased in type I fibres after 2 months of ET in type 2 diabetes 
patients, whereas IMTG content in type I fibres was not significantly enhanced (Chapter 3).  In 
addition, between 2 and 6 months of training no change in PLIN2 protein expression was observed in 
type I fibres, whereas IMTG content was significantly increased, although it is important to 
acknowledge that this was a significant change from baseline (rather than an increase from 2 to 6 
months).  Taken together, these data provide evidence that PLIN2 expression is dissociated from 
IMTG content, contrary to the findings of Chapters 4, 5 and 6, and several other reports (Minnaard et 
al., 2009; Amati et al., 2011; Peters et al., 2012).  However, given that PLIN2 expression did not 
demonstrate the ‘typical’ fibre type difference at baseline in Chapter 3, it could be argued that the 
increase in PLIN2 (and not IMTG content) is a mechanism by which the fibre type difference is re-
established.  Furthermore, it is possible that the increase in PLIN2 expression from baseline to 2 
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months is required in order to facilitate an increase in IMTG content from baseline to 6 months.  In 
support, a number of studies performed in cultured cells in vitro demonstrate that overexpression of 
PLIN2 enhances TAG concentration (Imamura et al., 2002; Fukushima et al., 2005; Listenberger et al., 
2007; Bosma et al., 2012a), whereas knockdown of PLIN2 reduces TAG concentration (Chang et al., 
2006; Bell et al., 2008; Bosma et al., 2012a).  Therefore, the possibility should be considered that in 
type 2 diabetes patients there is a dissociation between PLIN2 expression and IMTG content, and that 
6 months of ET re-establishes the relationship whereby PLIN2 expression mirrors IMTG content.          
 
Although linearity exists between IMTG content and the expression of PLIN2 and PLIN5 (in type 2 
diabetes following ET), the relationship between PLIN2 or PLIN5 expression and insulin sensitivity is 
less clear.  Indeed, PLIN2 and PLIN5 expression were both significantly related to insulin sensitivity in 
Chapter 4; however, on closer inspection of the data only ~16% of the variance in insulin sensitivity 
was attributed to PLIN2 and PLIN 5 expression.  Furthermore, no significant relationship between 
PLIN2 or PLIN5 expression and insulin sensitivity was observed in Chapters 5 and 6.  Together, these 
data raise the question as to the importance of the PLIN proteins to insulin sensitivity.  Data obtained 
in vitro support an important role for the PLIN proteins in maintaining insulin sensitivity.  Specifically, 
knockdown of PLIN proteins in AML12 cells reduces insulin-stimulated Akt/PKB phosphorylation and 
increase IRS-1 ser307 phosphorylation (Bell et al., 2008).  Furthermore, Bosma et al. (2012) recently 
reported that PLIN2 overexpression augments TAG storage and protects against palmitate-induced 
impairments in insulin-stimulated glucose uptake, whereas knockdown of PLIN2 increases palmitate 
incorporation into DAG.  These studies provide clear evidence to support a key role for the PLIN 
proteins in maintaining insulin sensitivity.  However, it should be noted that improvements in insulin 
sensitivity are observed following thiazolidinedione treatment concomitant with both an increase 
and a decrease in PLIN protein expression (Phillips et al., 2005; Minnaard et al., 2009), 
suggesting that a direct relationship between PLIN protein expression and insulin sensitivity 
is not apparent.  Furthermore, it should be noted that improvements in insulin sensitivity are 
observed following exercise training when IMTG content remains unchanged, is reduced or increased 
(reviewed in van Loon & Goodpaster, 2006; Shaw et al., 2010), and therefore in many instances IMTG 
content is disassociated from insulin sensitivity (Bruce et al., 2003).  Rather, it is well-appreciated that 
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greater flexibility of the IMTG pool to respond to changes in energy demand is linked to insulin 
sensitivity, and PLIN protein expression likely contributes to this relationship.  Given that both PLIN2 
and PLIN5 appear to be important for IMTG breakdown during exercise (Chapter 2 and 4), an 
increase in PLIN protein expression is likely to be important when an increase in IMTG content occurs 
following exercise training, in order to preserve lipolytic regulation of the expanded IMTG pool.  
Through this adaptation, the flexibility of the IMTG pool will be enhanced, providing a greater capacity 
for IMTG utilisation during exercise and more efficient storage of incoming FA into IMTG, thereby 
reducing the potential for the generation of FA metabolites which may otherwise reduce insulin 
sensitivity.  However, to truly appreciate the importance of the increases in PLIN protein expression to 
insulin sensitivity, a model of exercise training that does not promote greater IMTG storage 
concomitant with enhanced PLIN expression would be required.  In light of the observations regarding 
the regulation of IMTG metabolism and insulin sensitivity, it is important to note that the most robust 
correlate of insulin sensitivity is mitochondrial density (Chapter 4, 5 and 6), which is ultimately required 
in order to oxidise fatty acids generated from IMTG breakdown. 
 
7.4 Summary 
The results of this thesis firstly generate new evidence regarding the underlying mechanisms 
regulating IMTG breakdown during moderate-intensity exercise, by demonstrating the potential 
importance of PLIN2 and PLIN5 in this process.  Furthermore, the results provide new insight into the 
underlying mechanisms by which endurance, resistance and high intensity interval training elicit 
positive metabolic adaptations in lean sedentary, obese and obese type 2 diabetes patients.  In 
particular, the potential importance of upregulating PLIN2 and PLIN5 protein expression in response to 
exercise training in order to maintain metabolic regulation of the intramuscular lipid pool is 
demonstrated, and these adaptations likely contribute to the improvements in insulin sensitivity 
observed following exercise training.      
 
7.5 Future research directions 
 
7.5.1 High intensity interval training 
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The phrase ‘high intensity interval training’ or ‘HIT’ has, in this researcher’s opinion, become an 
umbrella term that now encompasses a range of HIT protocols.  For example, HIT could refer to 
Wingate-based or constant-workload SIT, as described in Chapters 2 and 4 of this thesis, or to other 
forms of low-volume HIT (Little et al., 2010; Metcalfe et al., 2012).  Therefore, the term ‘HIT’ actually 
refers to exercise training undertaken at a number of different workloads and interval durations, and it 
is likely that each different protocol will induce very different metabolic adaptations.  To this end, a 
series of studies are now required to evaluate the effectiveness of each HIT protocol with regards to 
physiological and clinical factors, such as aerobic capacity, insulin sensitivity and risk factors of 
cardiovascular disease. 
 
It is of significance that a HIT session incorporating a total of 2-3 min ‘all out’ effort may actually be 30 
min in duration when a warm-up, recovery intervals and cool down are included.  With this in mind, a 
recent study has investigated whether HIT, in which an exercise session consists of up to two bouts of 
high intensity interval exercise and has a total duration of 10 minutes, remains sufficient to improve 
insulin sensitivity (Metcalfe et al., 2012).  Indeed, 6 weeks of HIT improved maximal exercise capacity 
and insulin sensitivity in healthy male subjects, and therefore this study highlights that even 10 to 20 
seconds of HIT during a 10 minute bout of exercise is effective in improving insulin sensitivity.  
However, an interesting question arising from this and previous studies regarding the use of HIT is to 
determine the minimum amount of exercise required to improve insulin sensitivity.  In order to answer 
this question, a series of studies which systematically compare the training impulse and resultant 
training adaptations of different forms of HIT are now required.      
 
In addition to determining the optimum HIT protocol, future studies should focus on investigating the 
longer term benefits of performing regular HIT in comparison to more traditional ET.  Previously 
published studies generally engaged participants in 2-6 weeks of HIT, and therefore whether the 
positive adaptations observed following short term HIT still remain after many months of training is 
unknown.  In addition, it is apparent that HIT and ET induce similar whole body and cellular metabolic 
adaptations (Gibala et al., 2006; Burgomaster et al., 2008).  However, it is speculated that the time 
course of physiological changes may differ between HIT and ET, such that the highly intense nature of 
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HIT may induce rapid adaptations, whereas the low intensity exercise performed in ET may result in a 
slower adaptive response, but which may ultimately progress further (Gibala & McGee, 2008).  In 
addition, studies comparing the effects of HIT and ET have been performed with relatively small 
subject numbers (n ≤ 10), and the studies presented in this thesis (Chapters 4 & 6) suggest that 
greater subject numbers are required to determine differences in key outcomes such as insulin 
sensitivity and aerobic capacity.  Therefore, it is essential that long term studies are undertaken with a 
larger number of subjects before definitive conclusions can be drawn as to whether HIT and ET induce 
similar improvements in metabolic health and reduce the risk of developing cardiovascular disease. 
 
To date, all studies examining the effectiveness of HIT have been conducted within a laboratory 
setting, where the exercise is prescribed by the investigators and subjects are encouraged to 
complete the bouts of high intensity exercise.  However, if HIT is to become an accessible and 
feasible exercise mode for the general population, studies are required to explore ways that HIT can 
be performed by the general population in the setting of leisure facilities and/or exercise rehabilitation 
clinics.  This issue has been partially addressed by ourselves (Chapter 6) and Gibala and colleagues 
(Little et al., 2010) using a ‘constant-load’ approach to HIT.  In addition, a study recently started in 
Birmingham has employed HIT in an instructor-led class environment using spinning bikes.  In this 
study, 90 subjects (aged 25-60 years) are recruited and split into two groups of 45 individuals who 
then undertake 10 weeks of either HIT or ET.  Notably, the exercise intensity of the high intensity 
exercise bout is under each individual’s own control, meaning that each individual is performing 
exercise that they perceive to be of a ‘high intensity’.  Using a multi-disciplinary approach to compare 
the physiological and psychological adaptations to HIT and ET, this study will ultimately provide 
evidence as to whether HIT is a feasible exercise training mode for the general population. 
 
7.5.2 Current gaps in our understanding of the relationship between IMTG metabolism and 
insulin sensitivity 
Section 1.5.3 of the introduction concluded that an imbalance between the processes that increase 
intramuscular FA concentration (FA uptake and IMTG lipolysis) and those processes that consume FA 
(IMTG synthesis and mitochondrial β-oxidation) may lead to an increase in the concentration of FA 
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metabolites, which are proposed to contribute to the development of skeletal muscle insulin 
resistance.  Therefore, understanding the mechanisms regulating the balance between IMTG 
synthesis and IMTG hydrolysis remains an area of significant interest, 
In this respect, Chapters 2 and 4 of this thesis provide evidence to suggest that PLIN2 and PLIN5 
potentially play an important role in the use of IMTG during moderate-intensity exercise.  Although 
these findings provide an insight into the potential roles of PLIN2 and PLIN5 in skeletal muscle, further 
research is required to fully elucidate the mechanism through which PLIN2 and PLIN5 mediate IMTG 
use.  Clues are provided from cell culture studies performed in vitro showing that PLIN2 and/or PLIN5 
interact with HSL and/or ATGL.  However, whether PLIN2/PLIN5 interact with ATGL/HSL under 
lipolytic conditions in skeletal muscle remains to be determined.  To this end, colocalisation analysis of 
fluorescently-labelled proteins provides one tool to investigate whether two specific proteins of interest 
are associated with each other.  However, it is important to recognise that an accurate assessment of 
the co-distribution of two fluorophores is heavily dependent on the resolution of the microscope, and 
as such the colocalisation of two fluorescently-labelled probes does not necessarily confirm a physical 
apposition.  Therefore, future studies should employ a combination of methods in order to determine 
whether PLIN2 and/or PLIN5 interact with ATGL and/or HSL, and how these interactions are 
associated with IMTG use during exercise.  One such methodological option is to examine the co-
immunoprecipitation of two proteins from a skeletal muscle sample obtained before and after a period 
of moderate-intensity exercise.  Indeed, using this method it has recently been reported that PLIN2 co-
precipitation with ATGL is reduced in response to intermittent titanic stimulation of isolated rat soleus 
muscle (MacPherson et al., unpublished conference poster communication, IBEC, 2012).  However, 
further work is clearly warranted to fully elucidate how PLIN2 and/or PLIN5 interact with ATGL and/or 
HSL, and how this relationship affects the capacity to use IMTG as a substrate source during exercise.   
 
In mouse skeletal muscle it is reported that 324 proteins are associated with the intramuscular lipid 
pool (Zhang et al., 2011), although the precise role of many of these proteins in cellular metabolism is 
unknown.  Whilst this study particularly highlights the limitations of our understanding of LDs in 
skeletal muscle, it does provide one methodological option to further identify proteins which may be 
important in the regulation of IMTG metabolism.  Isolation of the LD fraction of skeletal muscle 
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generally involves a series of homogenisation and centrifugation steps.  Once the LD fraction is 
isolated, liquid chromatography coupled to mass spectrometry analysis is employed to determine the 
identity of all the proteins found in the LD fraction.  Thus, analysis of the LD proteome provides one 
method to first identify proteins which may be of interest for further investigation.  In particular, 
comparing the LD proteome of skeletal muscle samples obtained from lean, obese and obese type 2 
diabetes patients, or samples obtained before and after an exercise training programme, may provide 
insight as to whether differences in the LD proteome exist between groups, and should form the basis 
of future studies. 
 
In addition to PLIN2 and PLIN5, two other proteins of the PLIN family are expressed in skeletal 
muscle, known as PLIN3 and PLIN4 (originally termed TIP47 and S3-12, respectively).  In rat skeletal 
muscle, PLIN3 colocalizes with intramuscular LDs and is also found in the cytosolic pool, and this 
distribution is not altered by either muscle contraction or adrenaline stimulation (Prats et al., 2006).  
However, the distribution of PLIN3 has not been described in human skeletal muscle.  Furthermore, 
from studies performed in adipocytes it is proposed that PLIN3 plays a role in LD synthesis (Wolins et 
al., 2003; Wolins et al., 2005; Bulankina et al., 2009), suggesting that PLIN3 may be present at the 
endoplasmic reticulum, the proposed site of IMTG synthesis and the formation of new LDs (Brasaemle 
& Wolins, 2012).  As the LD, endoplasmic reticulum and various other muscle organelles are visible in 
electron micrographs, use of electron microscopy coupled to nanogold labelling of the various PLINs 
(which provides a greater resolution than a light-powered microscope) would provide information as to 
the cellular location and potential role of the PLINs in skeletal muscle.  This technique has recently 
been employed to demonstrate that PLIN5 is associated with both LDs and the mitochondria in rat 
soleus muscle (Bosma et al., 2011). 
 
Once developed, the use of LD proteomic analysis, co-immunoprecipitation assays and electron 
microscopy methods in combination with the immunofluorescence microscopy assays outlined in this 
thesis, should provide a powerful tool to further understand the mechanisms mediating IMTG lipolysis 
and utilisation and also the relationship between IMTG metabolism and insulin sensitivity.  However, it 
is also important to further understand the mechanism by which dysregulation of IMTG metabolism 
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directly influences insulin sensitivity.  In this respect, Chapters 3, 4, 5 and 6 of this thesis conclude that 
an increase in skeletal muscle oxidative capacity, IMTG content, IMTG breakdown and PLIN2 and 
PLIN5 protein expression all contribute to the mechanism underlying the improvement in insulin 
sensitivity observed following exercise training.  The mechanism for this improvement is proposed to 
be related to a reduction in the concentration of fatty acid metabolites, although in this thesis these 
measurements were not made.  Previous longitudinal studies have reported reduced concentrations of 
DAG and ceramide following a period of exercise training in obese individuals and obese type 2 
diabetes patients (Bruce et al., 2006; Dubé et al., 2008; Dubé et al., 2011).  However, cross-sectional 
studies are inconsistent with regards to the relationship between increased concentrations of total 
DAG and ceramide and the development of insulin resistance (Bosma et al., 2012b; Coen & 
Goodpaster, 2012).  More recently, it has been suggested that the saturation of the FA metabolites is 
a more important determinant of insulin sensitivity.  To this end, saturated DAG concentrations are 
higher in sedentary individuals compared to trained athletes (Bergman et al., 2010)but in a separate 
study, athletes had higher saturated DAG concentrations than obese individuals (Amati et al., 2011).  
Therefore, it may also be important to consider the subcellular location of the FA metabolites.  Indeed 
obese individuals and type 2 diabetes patients demonstrate greater saturated DAG concentrations in 
the membrane fraction of skeletal muscle compared to endurance-trained athletes (Bergman et al., 
2012).  Given that the inhibitory action of DAG on insulin signalling (DAG activation of PKCθ leading to 
IRS-1 ser307 phosphorylation) is thought to occur in close proximity to the plasma membrane and the 
site of insulin action, consideration of the subcellular location of the FA metabolites may be key to 
understanding their role in lipid-induced insulin resistance.  It is also important to mention that different 
stereo-specific DAG isoforms exist, based on the position at which the FA bind to the glycerol 
backbone (1,2-DAG, 2,3-DAG and 1,3-DAG).  However, only 1,2-DAG has so far been associated with 
defects in insulin signalling (Turinsky et al., 1990a).  Taken together, it is clear that a systematic 
evaluation of FA metabolite saturation, subcellular location and stereo-specific isoforms is required not 
only using sedentary lean and obese individuals and obese type 2 diabetes patients, but also 
habitually active lean and obese individuals and highly trained athletes.  The effect of exercise training 
interventions on the FA metabolite saturation, subcellular location and stereo-specific isoforms are 
also warranted. A series of carefully controlled studies using such methodologies are likely to greatly 
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improve our understanding of the role that lipid metabolites play in the development of skeletal muscle 
insulin resistance. 
 
7.6 Final conclusions 
The work contained within this thesis has developed novel immunofluorescence microscopy methods 
that have been used to generate new knowledge concerning the regulation of IMTG breakdown during 
moderate-intensity exercise.  In this respect, evidence demonstrating that the PLIN proteins are 
important for the use of IMTG during exercise is reported for the first time.  In addition, the effect of 
various forms of exercise training on the protein expression of the PLIN proteins is reported.  
Together, these findings suggest that the PLIN proteins are important in the regulation of IMTG 
metabolism, and therefore may be a key determinant of skeletal muscle insulin sensitivity.  Future 
studies should focus on determining the exact role of these proteins, and other LD-associated 
proteins, in skeletal muscle to fully appreciate their role in maintaining cellular lipid homeostasis.  The 
work in this thesis also provides important evidence that improvements in IMTG metabolism occur in 
response to high intensity interval training.  Therefore, this adds to the growing body of literature 
demonstrating that HIT is a time-efficient training strategy to induce positive metabolic outcomes.  It is 
expected that the evidence obtained in this thesis will inform future research into interventions that aim 
to tackle the worldwide health threat associated with physical inactivity.    
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